microRNA information: hsa-miR-200b-3p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-200b-3p | miRbase |
| Accession: | MIMAT0000318 | miRbase |
| Precursor name: | hsa-mir-200b | miRbase |
| Precursor accession: | MI0000342 | miRbase |
| Symbol: | MIR200B | HGNC |
| RefSeq ID: | NR_029639 | GenBank |
| Sequence: | UAAUACUGCCUGGUAAUGAUGA |
Reported expression in cancers: hsa-miR-200b-3p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-200b-3p | bladder cancer | upregulation | "MicroRNA expression signatures of bladder cancer r ......" | 21464941 | RNA-Seq |
| hsa-miR-200b-3p | bladder cancer | upregulation | "Samples were analyzed with a miRNA array containin ......" | 22863868 | Microarray |
| hsa-miR-200b-3p | breast cancer | downregulation | "miR 200b as a prognostic factor in breast cancer t ......" | 24447584 | qPCR; Microarray; in situ hybridization |
| hsa-miR-200b-3p | breast cancer | downregulation | "MicroRNA 200b targets protein kinase Cα and suppr ......" | 24925028 | |
| hsa-miR-200b-3p | breast cancer | downregulation | "In the present study we investigated the roles and ......" | 25639535 | |
| hsa-miR-200b-3p | breast cancer | downregulation | "Expression levels of miR-200a miR-200b miR-200c mi ......" | 26201425 | qPCR |
| hsa-miR-200b-3p | breast cancer | downregulation | "Loss of expression of miR-200 family members has b ......" | 27717206 | |
| hsa-miR-200b-3p | cervical and endocervical cancer | upregulation | "Previous studies have revealed the important role ......" | 27044840 | |
| hsa-miR-200b-3p | colorectal cancer | upregulation | "In this study we revealed a role for miR-200b in c ......" | 24151081 | |
| hsa-miR-200b-3p | colorectal cancer | upregulation | "The processes of EMT and metastasis are highly reg ......" | 25422078 | |
| hsa-miR-200b-3p | endometrial cancer | upregulation | "We evaluated the differential expressions of miRNA ......" | 21035172 | Microarray |
| hsa-miR-200b-3p | endometrial cancer | upregulation | "In this study we investigated miR-200b expression ......" | 23205572 | |
| hsa-miR-200b-3p | endometrial cancer | upregulation | "Using integrated statistical analyses we identifie ......" | 25750291 | |
| hsa-miR-200b-3p | esophageal cancer | downregulation | "To further our understanding of the pathobiology o ......" | 24064224 | qPCR |
| hsa-miR-200b-3p | gastric cancer | downregulation | "miR 200b and miR 200c as prognostic factors and me ......" | 23995857 | qPCR; Microarray |
| hsa-miR-200b-3p | gastric cancer | downregulation | "Although microRNA-200 miR-200 family members are t ......" | 25502084 | |
| hsa-miR-200b-3p | gastric cancer | downregulation | "To find a potentially useful prognostic predictor ......" | 26137064 | |
| hsa-miR-200b-3p | head and neck cancer | downregulation | "The miR-200 family and miR-203 were downregulated ......" | 26882562 | |
| hsa-miR-200b-3p | kidney renal cell cancer | downregulation | "The set of miRNAs with significantly decreased exp ......" | 23074016 | |
| hsa-miR-200b-3p | liver cancer | downregulation | "We investigated the diagnostic impact of microRNA- ......" | 24895326 | qPCR |
| hsa-miR-200b-3p | liver cancer | downregulation | "MiR-200 family is an important regulator of epithe ......" | 25909223 | |
| hsa-miR-200b-3p | liver cancer | downregulation | "Significant downregulation of microRNA-200b was ob ......" | 26919246 | |
| hsa-miR-200b-3p | lung cancer | upregulation | "However the molecular mechanisms involved in the s ......" | 24830600 | |
| hsa-miR-200b-3p | lung cancer | upregulation | "Among these 28 miRNAs were up-regulated in both th ......" | 27189341 | qPCR |
| hsa-miR-200b-3p | melanoma | deregulation | "A functional role of microRNAs miRNAs or miRs in n ......" | 20957176 | |
| hsa-miR-200b-3p | ovarian cancer | upregulation | "The prognostic value of the miR 200 family in ovar ......" | 26910180 | |
| hsa-miR-200b-3p | pancreatic cancer | upregulation | "Profiling of 95 microRNAs in pancreatic cancer cel ......" | 19030927 | qPCR |
| hsa-miR-200b-3p | prostate cancer | downregulation | "miR 200b suppresses cell proliferation migration a ......" | 24317363 | |
| hsa-miR-200b-3p | prostate cancer | deregulation | "Comparative microRNA profiling of prostate carcino ......" | 24337069 | RNA-Seq; qPCR |
| hsa-miR-200b-3p | prostate cancer | upregulation | "miR 200b inhibits prostate cancer EMT growth and m ......" | 24391862 | |
| hsa-miR-200b-3p | sarcoma | deregulation | "The most significantly downregulated miRNAs were m ......" | 24027049 | |
| hsa-miR-200b-3p | thyroid cancer | upregulation | "The miR-200 family was recently identified as a su ......" | 22797360 | |
| hsa-miR-200b-3p | thyroid cancer | downregulation | "MiR 200 Regulates Epithelial Mesenchymal Transitio ......" | 25542369 |
Reported cancer pathway affected by hsa-miR-200b-3p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-200b-3p | breast cancer | cell cycle pathway; Apoptosis pathway | "The genes encoding microRNAs of the human miR-200 ......" | 20514023 | Luciferase |
| hsa-miR-200b-3p | breast cancer | Epithelial mesenchymal transition pathway | "Phosphoglucose isomerase/autocrine motility factor ......" | 21389093 | |
| hsa-miR-200b-3p | breast cancer | Epithelial mesenchymal transition pathway | "Global miRNA expression profiling was performed on ......" | 22294488 | |
| hsa-miR-200b-3p | breast cancer | Epithelial mesenchymal transition pathway | "Epigenetic modulation of the miR 200 family is ass ......" | 23525011 | |
| hsa-miR-200b-3p | breast cancer | Epithelial mesenchymal transition pathway | "MiR 200 can repress breast cancer metastasis throu ......" | 24037528 | |
| hsa-miR-200b-3p | breast cancer | Epithelial mesenchymal transition pathway | "miR 200b as a prognostic factor in breast cancer t ......" | 24447584 | Western blot; Luciferase; MTT assay |
| hsa-miR-200b-3p | breast cancer | Epithelial mesenchymal transition pathway | "Some miRNAs especially the miR-200 family miR-9 an ......" | 25086633 | |
| hsa-miR-200b-3p | breast cancer | Apoptosis pathway; cell cycle pathway | "MiR 200b expression in breast cancer: a prognostic ......" | 25639535 | Western blot; Luciferase |
| hsa-miR-200b-3p | breast cancer | Wnt signaling pathway; Apoptosis pathway; Notch signaling pathway | "The miRNAs and their clusters such as the miR-200 ......" | 26712794 | |
| hsa-miR-200b-3p | cervical and endocervical cancer | Epithelial mesenchymal transition pathway | "MicroRNA 200b suppresses cell invasion and metasta ......" | 26935156 | Cell migration assay; Western blot |
| hsa-miR-200b-3p | cervical and endocervical cancer | Epithelial mesenchymal transition pathway | "MicroRNA 200b inhibits epithelial mesenchymal tran ......" | 26935796 | Transwell assay; Luciferase |
| hsa-miR-200b-3p | cervical and endocervical cancer | Apoptosis pathway | "MiR 200b promotes the cell proliferation and metas ......" | 27044840 | Western blot; Luciferase |
| hsa-miR-200b-3p | colon cancer | Epithelial mesenchymal transition pathway | "MicroRNA 200 miR 200 cluster regulation by achaete ......" | 25371200 | |
| hsa-miR-200b-3p | colon cancer | Apoptosis pathway; Notch signaling pathway | "Niclosamide inhibits colon cancer progression thro ......" | 27460529 | Flow cytometry; Cell migration assay |
| hsa-miR-200b-3p | colorectal cancer | cell cycle pathway | "MicroRNA 200b stimulates tumour growth in TGFBR2 n ......" | 24151081 | |
| hsa-miR-200b-3p | colorectal cancer | Epithelial mesenchymal transition pathway | "Epithelial-mesenchymal transition EMT and changes ......" | 25757925 | |
| hsa-miR-200b-3p | colorectal cancer | Epithelial mesenchymal transition pathway | "The miR-200 family presented as the most powerful ......" | 27157610 | |
| hsa-miR-200b-3p | endometrial cancer | Epithelial mesenchymal transition pathway | "Tamoxifen represses miR 200 microRNAs and promotes ......" | 23295740 | |
| hsa-miR-200b-3p | endometrial cancer | cell cycle pathway | "The expression of miRNAs and related genes were de ......" | 23680357 | Western blot; Flow cytometry; Colony formation |
| hsa-miR-200b-3p | esophageal cancer | cell cycle pathway; Apoptosis pathway | "miR 200b induces cell cycle arrest and represses c ......" | 27496804 | |
| hsa-miR-200b-3p | gastric cancer | Epithelial mesenchymal transition pathway | "MicroRNA 200b regulates cell proliferation invasio ......" | 22311119 | |
| hsa-miR-200b-3p | gastric cancer | Apoptosis pathway | "Diallyl disulfide suppresses proliferation and ind ......" | 23851184 | |
| hsa-miR-200b-3p | gastric cancer | Epithelial mesenchymal transition pathway | "Epigenetic modulation and repression of miR 200b b ......" | 25411357 | |
| hsa-miR-200b-3p | glioblastoma | Epithelial mesenchymal transition pathway | "NPV LDE 225 Erismodegib inhibits epithelial mesenc ......" | 23482671 | Luciferase; Western blot |
| hsa-miR-200b-3p | head and neck cancer | Epithelial mesenchymal transition pathway | "Epithelial-mesenchymal-transition EMT is a critica ......" | 24424572 | |
| hsa-miR-200b-3p | liver cancer | cell cycle pathway | "Expression of the microRNA-200 miR-200 family has ......" | 23760980 | Flow cytometry; MTT assay |
| hsa-miR-200b-3p | liver cancer | Epithelial mesenchymal transition pathway | "We investigated the diagnostic impact of microRNA- ......" | 24895326 | |
| hsa-miR-200b-3p | liver cancer | Epithelial mesenchymal transition pathway | "MiR-200 family is an important regulator of epithe ......" | 25909223 | |
| hsa-miR-200b-3p | liver cancer | cell cycle pathway; Apoptosis pathway | "Methylation associated silencing of miR 200b facil ......" | 26919246 | Luciferase; Colony formation |
| hsa-miR-200b-3p | lung cancer | cell cycle pathway; Apoptosis pathway | "MicroRNA 200b reverses chemoresistance of docetaxe ......" | 22139708 | Luciferase |
| hsa-miR-200b-3p | lung cancer | Epithelial mesenchymal transition pathway | "Nobiletin inhibited hypoxia induced epithelial mes ......" | 26012256 | |
| hsa-miR-200b-3p | lung cancer | Epithelial mesenchymal transition pathway | "BMP4 depletion by miR 200 inhibits tumorigenesis a ......" | 26395571 | Western blot; Luciferase |
| hsa-miR-200b-3p | lung squamous cell cancer | Epithelial mesenchymal transition pathway | "The microRNA‑200 miR-200 family is a powerful re ......" | 23708087 | Western blot |
| hsa-miR-200b-3p | lung squamous cell cancer | Epithelial mesenchymal transition pathway | "The difference in miRNA expression profiles betwee ......" | 26783187 | |
| hsa-miR-200b-3p | ovarian cancer | Epithelial mesenchymal transition pathway | "Differences in miRNA expression between HGSC CCC a ......" | 24512620 | |
| hsa-miR-200b-3p | ovarian cancer | Epithelial mesenchymal transition pathway | "Epithelial mesenchymal transition associated miRNA ......" | 24952258 | |
| hsa-miR-200b-3p | ovarian cancer | Epithelial mesenchymal transition pathway | "The miR 200 family differentially regulates sensit ......" | 26025631 | |
| hsa-miR-200b-3p | prostate cancer | Epithelial mesenchymal transition pathway | "miR 200 regulates PDGF D mediated epithelial mesen ......" | 19544444 | |
| hsa-miR-200b-3p | prostate cancer | Apoptosis pathway | "Nevertheless decreased expressions of tumor suppre ......" | 26843836 | |
| hsa-miR-200b-3p | sarcoma | PI3K/Akt signaling pathway | "CCL5 promotes VEGF dependent angiogenesis by down ......" | 25301739 | Western blot |
| hsa-miR-200b-3p | thyroid cancer | Epithelial mesenchymal transition pathway | "We identified two significantly decreased microRNA ......" | 20498632 | |
| hsa-miR-200b-3p | thyroid cancer | Epithelial mesenchymal transition pathway | "The miR 200 family regulates the epithelial mesenc ......" | 22797360 | Western blot |
| hsa-miR-200b-3p | thyroid cancer | Epithelial mesenchymal transition pathway | "MiR 200 Regulates Epithelial Mesenchymal Transitio ......" | 25542369 | Western blot |
Reported cancer prognosis affected by hsa-miR-200b-3p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-200b-3p | B cell lymphoma | worse prognosis | "Inhibition of ZEB1 by miR 200 characterizes Helico ......" | 24390222 | |
| hsa-miR-200b-3p | bladder cancer | drug resistance; cell migration | "miR 200 expression regulates epithelial to mesench ......" | 19671845 | Western blot; Luciferase |
| hsa-miR-200b-3p | bladder cancer | staging; progression | "Coordinated epigenetic repression of the miR 200 f ......" | 20473948 | |
| hsa-miR-200b-3p | bladder cancer | staging | "Samples were analyzed with a miRNA array containin ......" | 22863868 | |
| hsa-miR-200b-3p | bladder cancer | staging; poor survival; recurrence | "Expression levels of miRNAs were assessed by quant ......" | 23169479 | |
| hsa-miR-200b-3p | bladder cancer | malignant trasformation | "Analyses in human urothelial cells identify methyl ......" | 23867826 | |
| hsa-miR-200b-3p | breast cancer | drug resistance | "The drug resistance of MCF-7/ADR cells was evaluat ......" | 18971180 | Flow cytometry; MTT assay |
| hsa-miR-200b-3p | breast cancer | metastasis | "miR 200 enhances mouse breast cancer cell coloniza ......" | 19787069 | |
| hsa-miR-200b-3p | breast cancer | progression | "Recent evidence demonstrates that up-regulation of ......" | 19839049 | |
| hsa-miR-200b-3p | breast cancer | progression | "The genes encoding microRNAs of the human miR-200 ......" | 20514023 | Luciferase |
| hsa-miR-200b-3p | breast cancer | motility; metastasis | "Phosphoglucose isomerase/autocrine motility factor ......" | 21389093 | |
| hsa-miR-200b-3p | breast cancer | metastasis | "Decreased expression of miRNAs of the miR-200 fami ......" | 21682933 | |
| hsa-miR-200b-3p | breast cancer | staging; metastasis | "Mapping the regulatory sequences controlling 93 br ......" | 22231446 | |
| hsa-miR-200b-3p | breast cancer | metastasis; staging; progression | "Global miRNA expression profiling was performed on ......" | 22294488 | |
| hsa-miR-200b-3p | breast cancer | differentiation | "In order to identify which miRNAs are involved in ......" | 22562546 | |
| hsa-miR-200b-3p | breast cancer | progression; poor survival | "Circulating miRNAs from plasma of CTC-positive and ......" | 22952344 | |
| hsa-miR-200b-3p | breast cancer | differentiation | "As the family of miR-200 microRNAs has been shown ......" | 23112837 | |
| hsa-miR-200b-3p | breast cancer | progression | "Epigenetic modulation of the miR 200 family is ass ......" | 23525011 | |
| hsa-miR-200b-3p | breast cancer | drug resistance; progression; cell migration | "Reduced expression of miR 200 family members contr ......" | 23626803 | |
| hsa-miR-200b-3p | breast cancer | metastasis; staging; poor survival | "MiR 200 can repress breast cancer metastasis throu ......" | 24037528 | |
| hsa-miR-200b-3p | breast cancer | drug resistance | "miR 200b as a prognostic factor in breast cancer t ......" | 24447584 | Western blot; Luciferase; MTT assay |
| hsa-miR-200b-3p | breast cancer | drug resistance | "In summary our results indicate that higher miR-20 ......" | 24469723 | |
| hsa-miR-200b-3p | breast cancer | metastasis | "The expression of miRNAs in patients with primary ......" | 24846313 | |
| hsa-miR-200b-3p | breast cancer | metastasis; cell migration | "MicroRNA 200b targets protein kinase Cα and suppr ......" | 24925028 | |
| hsa-miR-200b-3p | breast cancer | metastasis; progression | "Members of three miRNA families i.e miR-17 miR-200 ......" | 25001613 | |
| hsa-miR-200b-3p | breast cancer | worse prognosis | "Some miRNAs especially the miR-200 family miR-9 an ......" | 25086633 | |
| hsa-miR-200b-3p | breast cancer | staging | "MiR 200b expression in breast cancer: a prognostic ......" | 25639535 | Western blot; Luciferase |
| hsa-miR-200b-3p | breast cancer | drug resistance | "Therefore we investigated the role of known EMT re ......" | 25746005 | |
| hsa-miR-200b-3p | breast cancer | progression | "ADAM12 L is a direct target of the miR 29 and miR ......" | 25886595 | Western blot; Luciferase |
| hsa-miR-200b-3p | breast cancer | metastasis | "The upregulation of fibronectin and lysyl oxidase ......" | 26068592 | |
| hsa-miR-200b-3p | breast cancer | metastasis | "Expression levels of miR-200a miR-200b miR-200c mi ......" | 26201425 | |
| hsa-miR-200b-3p | breast cancer | metastasis | "These included miR-141 miR-144 miR-193b miR-200a m ......" | 26785733 | |
| hsa-miR-200b-3p | breast cancer | cell migration; metastasis | "MicroRNA 200b Impacts Breast Cancer Cell Migration ......" | 27276064 | Western blot; Transwell assay; Wound Healing Assay |
| hsa-miR-200b-3p | breast cancer | differentiation | "miR 9 and miR 200 Regulate PDGFRβ Mediated Endoth ......" | 27402080 | |
| hsa-miR-200b-3p | breast cancer | drug resistance | "Loss of expression of miR-200 family members has b ......" | 27717206 | |
| hsa-miR-200b-3p | breast cancer | drug resistance | "Specifically we will discuss key miRNAs involved i ......" | 27721895 | |
| hsa-miR-200b-3p | breast cancer | worse prognosis; drug resistance | "The aim of this study was to investigate the role ......" | 27746365 | |
| hsa-miR-200b-3p | cervical and endocervical cancer | metastasis | "MicroRNA 200b suppresses cell invasion and metasta ......" | 26935156 | Cell migration assay; Western blot |
| hsa-miR-200b-3p | cervical and endocervical cancer | metastasis; progression; cell migration | "MiR 200b promotes the cell proliferation and metas ......" | 27044840 | Western blot; Luciferase |
| hsa-miR-200b-3p | cervical and endocervical cancer | progression | "Long noncoding RNA PVT1 promotes cervical cancer p ......" | 27272214 | |
| hsa-miR-200b-3p | colon cancer | progression | "Niclosamide inhibits colon cancer progression thro ......" | 27460529 | Flow cytometry; Cell migration assay |
| hsa-miR-200b-3p | colorectal cancer | metastasis | "Applying real-time PCR we detected the expression ......" | 21827717 | |
| hsa-miR-200b-3p | colorectal cancer | metastasis | "Although the microRNA-200 miR-200 family is a cruc ......" | 22735571 | |
| hsa-miR-200b-3p | colorectal cancer | metastasis; staging | "Here we used in situ hybridization and immunohisto ......" | 23441132 | |
| hsa-miR-200b-3p | colorectal cancer | staging; metastasis | "In the first phase we selected candidate miRNAs as ......" | 23982750 | |
| hsa-miR-200b-3p | colorectal cancer | progression | "MicroRNA 200b stimulates tumour growth in TGFBR2 n ......" | 24151081 | |
| hsa-miR-200b-3p | colorectal cancer | poor survival; staging | "Role of miR 200 family members in survival of colo ......" | 24510588 | |
| hsa-miR-200b-3p | colorectal cancer | metastasis | "The processes of EMT and metastasis are highly reg ......" | 25422078 | |
| hsa-miR-200b-3p | colorectal cancer | staging | "The Agilent Human miRNA Microarray V19.0 was used ......" | 25484364 | |
| hsa-miR-200b-3p | colorectal cancer | drug resistance | "Epithelial-mesenchymal transition EMT and changes ......" | 25757925 | |
| hsa-miR-200b-3p | colorectal cancer | metastasis | "MiR 200 suppresses metastases of colorectal cancer ......" | 26242262 | Luciferase |
| hsa-miR-200b-3p | colorectal cancer | poor survival; worse prognosis | "Survival analyses showed that plasma miR-96 and mi ......" | 26863633 | |
| hsa-miR-200b-3p | colorectal cancer | worse prognosis; poor survival | "The miR-200 family presented as the most powerful ......" | 27157610 | |
| hsa-miR-200b-3p | colorectal cancer | worse prognosis | "Plasma miR 122 and miR 200 family are prognostic m ......" | 27632639 | |
| hsa-miR-200b-3p | endometrial cancer | tumorigenesis | "We compared the expression profiles of 723 human m ......" | 21897839 | |
| hsa-miR-200b-3p | endometrial cancer | metastasis | "MicroRNA 200b is overexpressed in endometrial aden ......" | 23205572 | Western blot; Luciferase |
| hsa-miR-200b-3p | endometrial cancer | motility; drug resistance | "Tamoxifen represses miR 200 microRNAs and promotes ......" | 23295740 | |
| hsa-miR-200b-3p | endometrial cancer | progression; metastasis; tumorigenesis | "The expression of miRNAs and related genes were de ......" | 23680357 | Western blot; Flow cytometry; Colony formation |
| hsa-miR-200b-3p | endometrial cancer | metastasis | "The abnormal expression of the long noncoding RNA ......" | 27693631 | |
| hsa-miR-200b-3p | esophageal cancer | staging; metastasis; poor survival | "miR 200b suppresses invasiveness and modulates the ......" | 24064224 | |
| hsa-miR-200b-3p | esophageal cancer | progression; poor survival | "miR 200b induces cell cycle arrest and represses c ......" | 27496804 | |
| hsa-miR-200b-3p | gastric cancer | tumorigenesis | "The effect of microRNA abnormalities in carcinogen ......" | 20484038 | |
| hsa-miR-200b-3p | gastric cancer | differentiation; metastasis | "MicroRNA 200b regulates cell proliferation invasio ......" | 22311119 | |
| hsa-miR-200b-3p | gastric cancer | progression; worse prognosis; staging; metastasis; poor survival | "miR 200b and miR 200c as prognostic factors and me ......" | 23995857 | Luciferase; Cell proliferation assay; Cell migration assay; Cell Proliferation Assay |
| hsa-miR-200b-3p | gastric cancer | worse prognosis; poor survival; cell migration | "Integrated microRNA network analyses identify a po ......" | 24352645 | |
| hsa-miR-200b-3p | gastric cancer | metastasis; worse prognosis | "Epigenetic modulation and repression of miR 200b b ......" | 25411357 | |
| hsa-miR-200b-3p | gastric cancer | tumorigenesis; progression | "Although microRNA-200 miR-200 family members are t ......" | 25502084 | Wound Healing Assay |
| hsa-miR-200b-3p | gastric cancer | staging; metastasis | "In the first step of this study preliminary experi ......" | 26233325 | |
| hsa-miR-200b-3p | glioblastoma | metastasis | "We determined CSF levels of several cancer-associa ......" | 22492962 | |
| hsa-miR-200b-3p | head and neck cancer | metastasis; tumorigenesis | "Epithelial-mesenchymal-transition EMT is a critica ......" | 24424572 | |
| hsa-miR-200b-3p | kidney renal cell cancer | malignant trasformation | "We performed genome-wide expression profiling of m ......" | 19228262 | |
| hsa-miR-200b-3p | kidney renal cell cancer | progression; tumorigenesis | "MicroRNA-429 miR-429 a short noncoding RNA belongi ......" | 25953723 | |
| hsa-miR-200b-3p | kidney renal cell cancer | staging | "Comparisons of RCC and BC expression signatures re ......" | 27357429 | |
| hsa-miR-200b-3p | liver cancer | malignant trasformation | "Our study identified and validated miR-224 overexp ......" | 18433021 | |
| hsa-miR-200b-3p | liver cancer | metastasis | "Epigenetic activation of the MiR 200 family contri ......" | 23222811 | |
| hsa-miR-200b-3p | liver cancer | metastasis; cell migration; differentiation | "miR 200b restoration and DNA methyltransferase inh ......" | 23552699 | |
| hsa-miR-200b-3p | liver cancer | drug resistance | "Expression of the microRNA-200 miR-200 family has ......" | 23760980 | Flow cytometry; MTT assay |
| hsa-miR-200b-3p | liver cancer | metastasis; progression | "The aim of this study was to assess the role of th ......" | 24135722 | |
| hsa-miR-200b-3p | liver cancer | cell migration | "Transfection of Huh7 cell with an activated mutant ......" | 25065598 | |
| hsa-miR-200b-3p | liver cancer | tumorigenesis; cell migration; metastasis | "MiR-200 family is an important regulator of epithe ......" | 25909223 | |
| hsa-miR-200b-3p | liver cancer | progression | "Methylation associated silencing of miR 200b facil ......" | 26919246 | Luciferase; Colony formation |
| hsa-miR-200b-3p | lung cancer | metastasis; worse prognosis; tumorigenesis | "miR 200 Inhibits lung adenocarcinoma cell invasion ......" | 21115742 | |
| hsa-miR-200b-3p | lung cancer | metastasis | "The Notch ligand Jagged2 promotes lung adenocarcin ......" | 21403400 | |
| hsa-miR-200b-3p | lung cancer | drug resistance; worse prognosis | "MicroRNA 200b reverses chemoresistance of docetaxe ......" | 22139708 | Luciferase |
| hsa-miR-200b-3p | lung cancer | metastasis | "Loss of miR-200s has been shown to enhance cancer ......" | 24791940 | |
| hsa-miR-200b-3p | lung cancer | drug resistance | "HDAC 1/4 mediated silencing of microRNA 200b promo ......" | 24830600 | |
| hsa-miR-200b-3p | lung cancer | drug resistance | "Recently we have identified microRNA miR-200b as a ......" | 25279705 | |
| hsa-miR-200b-3p | lung cancer | metastasis; cell migration | "The miR 200 family and the miR 183~96~182 cluster ......" | 25798833 | |
| hsa-miR-200b-3p | lung cancer | staging; tumorigenesis | "MicroRNA-200 miR-200 has emerged as a regulator of ......" | 26314828 | |
| hsa-miR-200b-3p | lung cancer | metastasis; tumorigenesis | "BMP4 depletion by miR 200 inhibits tumorigenesis a ......" | 26395571 | Western blot; Luciferase |
| hsa-miR-200b-3p | lung cancer | drug resistance | "MiR 200b regulates autophagy associated with chemo ......" | 26416454 | |
| hsa-miR-200b-3p | lung cancer | progression | "Interestingly mir-200 family mir-200a mir-200b and ......" | 27695346 | |
| hsa-miR-200b-3p | lung squamous cell cancer | metastasis; immune resistance | "The microRNA‑200 miR-200 family is a powerful re ......" | 23708087 | Western blot |
| hsa-miR-200b-3p | lung squamous cell cancer | drug resistance | "Zinc finger E box binding homeobox 2 ZEB2 regulate ......" | 24769353 | Luciferase |
| hsa-miR-200b-3p | lung squamous cell cancer | worse prognosis; staging | "The miRNA family miR-200 has been associated with ......" | 25003366 | |
| hsa-miR-200b-3p | lung squamous cell cancer | drug resistance | "The difference in miRNA expression profiles betwee ......" | 26783187 | |
| hsa-miR-200b-3p | lung squamous cell cancer | metastasis | "miR 200b inhibits migration and invasion in non sm ......" | 27356635 | Luciferase |
| hsa-miR-200b-3p | lung squamous cell cancer | progression; tumorigenesis | "The microRNA miR-200 family has been demonstrated ......" | 27602157 | |
| hsa-miR-200b-3p | lymphoma | progression | "The profiles of miRNAs in conjunctival MALT lympho ......" | 22183793 | Luciferase |
| hsa-miR-200b-3p | melanoma | metastasis; progression; cell migration | "A functional role of microRNAs miRNAs or miRs in n ......" | 20957176 | |
| hsa-miR-200b-3p | melanoma | progression | "MiR-200 in situ hybridization and E-cadherin immun ......" | 22956368 | |
| hsa-miR-200b-3p | melanoma | metastasis | "From a discovery analysis using 40 thick primary m ......" | 26743475 | |
| hsa-miR-200b-3p | ovarian cancer | worse prognosis | "The microRNA expression profiles were examined usi ......" | 18451233 | |
| hsa-miR-200b-3p | ovarian cancer | staging | "Levels of 8 microRNAs miR-21 miR-141 miR-200a miR- ......" | 18589210 | |
| hsa-miR-200b-3p | ovarian cancer | staging; poor survival; recurrence; cell migration | "A miR 200 microRNA cluster as prognostic marker in ......" | 19501389 | |
| hsa-miR-200b-3p | ovarian cancer | tumorigenesis | "Regulation of miR 200 family microRNAs and ZEB tra ......" | 19854497 | Luciferase |
| hsa-miR-200b-3p | ovarian cancer | worse prognosis | "We highlight the role of the let-7 and miR-200 fam ......" | 20083225 | |
| hsa-miR-200b-3p | ovarian cancer | progression; poor survival; drug resistance | "The miR 200 family controls beta tubulin III expre ......" | 21051560 | |
| hsa-miR-200b-3p | ovarian cancer | poor survival | "The Cox proportional hazards model and the log-ran ......" | 21345725 | |
| hsa-miR-200b-3p | ovarian cancer | worse prognosis; staging | "Two families of miRNAs miR-200 and let-7 are frequ ......" | 23237306 | |
| hsa-miR-200b-3p | ovarian cancer | drug resistance | "Sequence variation among members of the miR 200 mi ......" | 24447705 | |
| hsa-miR-200b-3p | ovarian cancer | progression; poor survival | "Differences in miRNA expression between HGSC CCC a ......" | 24512620 | |
| hsa-miR-200b-3p | ovarian cancer | metastasis; recurrence | "We recently determined that the ectopic over-expre ......" | 24802724 | |
| hsa-miR-200b-3p | ovarian cancer | metastasis; drug resistance | "For example deficiencies of enzymes including Dice ......" | 24822185 | |
| hsa-miR-200b-3p | ovarian cancer | progression; metastasis | "Epithelial mesenchymal transition associated miRNA ......" | 24952258 | |
| hsa-miR-200b-3p | ovarian cancer | poor survival; staging; progression | "Clinicopathological and prognostic implications of ......" | 24966949 | |
| hsa-miR-200b-3p | ovarian cancer | progression; worse prognosis; poor survival | "Expression of serum miR 200a miR 200b and miR 200c ......" | 26063644 | |
| hsa-miR-200b-3p | ovarian cancer | progression; poor survival; malignant trasformation | "Plasma miR 200b in ovarian carcinoma patients: dis ......" | 26416421 | |
| hsa-miR-200b-3p | ovarian cancer | progression; poor survival | "The prognostic value of the miR 200 family in ovar ......" | 26910180 | |
| hsa-miR-200b-3p | ovarian cancer | malignant trasformation; staging; metastasis; poor survival; progression | "Diagnostic and prognostic relevance of circulating ......" | 26943577 | |
| hsa-miR-200b-3p | ovarian cancer | metastasis | "The miR-200 family especially miR-200c has been sh ......" | 27601996 | |
| hsa-miR-200b-3p | ovarian cancer | poor survival | "Furthermore some of the identified DNA-methylated ......" | 27746113 | |
| hsa-miR-200b-3p | ovarian cancer | malignant trasformation | "Circulating Cell Free miR 373 miR 200a miR 200b an ......" | 27753009 | |
| hsa-miR-200b-3p | pancreatic cancer | metastasis | "Additionally the miR-200 family regulates several ......" | 24040120 | Luciferase |
| hsa-miR-200b-3p | prostate cancer | cell migration | "miR 200 regulates PDGF D mediated epithelial mesen ......" | 19544444 | |
| hsa-miR-200b-3p | prostate cancer | metastasis | "Regulation of epithelial plasticity by miR 424 and ......" | 24193225 | |
| hsa-miR-200b-3p | prostate cancer | staging | "miR 200b suppresses cell proliferation migration a ......" | 24317363 | |
| hsa-miR-200b-3p | prostate cancer | staging; malignant trasformation | "Comparative microRNA profiling of prostate carcino ......" | 24337069 | |
| hsa-miR-200b-3p | prostate cancer | metastasis; progression | "miR 200b inhibits prostate cancer EMT growth and m ......" | 24391862 | |
| hsa-miR-200b-3p | prostate cancer | poor survival; metastasis | "Non-responders to docetaxel and patients with shor ......" | 24714754 | |
| hsa-miR-200b-3p | prostate cancer | poor survival; recurrence | "The expression of 10 genes and 18 miRNAs were asse ......" | 25409297 | |
| hsa-miR-200b-3p | prostate cancer | drug resistance | "Nevertheless decreased expressions of tumor suppre ......" | 26843836 | |
| hsa-miR-200b-3p | sarcoma | tumorigenesis | "MiR-141 which belong to miR-200 family take a part ......" | 24307282 | |
| hsa-miR-200b-3p | sarcoma | progression; staging; metastasis | "MicroRNA 200b acts as a tumor suppressor in osteos ......" | 27307751 | |
| hsa-miR-200b-3p | thyroid cancer | cell migration | "However specific miRNAs are downregulated in ATC s ......" | 25202329 |
Reported gene related to hsa-miR-200b-3p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-200b-3p | B cell lymphoma | ZEB1 | "Inhibition of ZEB1 by miR 200 characterizes Helico ......" | 24390222 |
| hsa-miR-200b-3p | bladder cancer | ZEB1 | "ZEB1 is also known to repress miR-200c-141 transcr ......" | 20473948 |
| hsa-miR-200b-3p | breast cancer | ZEB1 | "Conversely ectopic expression of miR-200 inhibited ......" | 27402080 |
| hsa-miR-200b-3p | breast cancer | ZEB1 | "Here we show that 53BP1 negatively regulated EMT b ......" | 26011542 |
| hsa-miR-200b-3p | breast cancer | ZEB1 | "Concomitant with miR-200 decrease there was an inc ......" | 23626803 |
| hsa-miR-200b-3p | breast cancer | ZEB1 | "MiR 200 can repress breast cancer metastasis throu ......" | 24037528 |
| hsa-miR-200b-3p | colorectal cancer | ZEB1 | "MiR 200 suppresses metastases of colorectal cancer ......" | 26242262 |
| hsa-miR-200b-3p | endometrial cancer | ZEB1 | "This finding was accompanied by a sharp downregula ......" | 23743934 |
| hsa-miR-200b-3p | gastric cancer | ZEB1 | "Functional experiments demonstrated that miR-200b ......" | 24352645 |
| hsa-miR-200b-3p | head and neck cancer | ZEB1 | "Furthermore our data suggest that the promoter hyp ......" | 24424572 |
| hsa-miR-200b-3p | lung squamous cell cancer | ZEB1 | "Nintedanib was able to reverse TGF-β1-induced EMT ......" | 26783187 |
| hsa-miR-200b-3p | ovarian cancer | ZEB1 | "We used qRT-PCR to examine expression of the miR-2 ......" | 19854497 |
| hsa-miR-200b-3p | ovarian cancer | ZEB1 | "GRHL2 miR 200 ZEB1 maintains the epithelial status ......" | 26887977 |
| hsa-miR-200b-3p | prostate cancer | ZEB1 | "Recent studies have shown that the miR-200 family ......" | 19544444 |
| hsa-miR-200b-3p | sarcoma | ZEB1 | "This circuit comprises the microRNA 200 miR-200 fa ......" | 27402864 |
| hsa-miR-200b-3p | sarcoma | ZEB1 | "Moreover a series of loss-of-function and gain-of- ......" | 24815002 |
| hsa-miR-200b-3p | sarcoma | ZEB1 | "MicroRNA 200b acts as a tumor suppressor in osteos ......" | 27307751 |
| hsa-miR-200b-3p | breast cancer | CDH1 | "β1 integrin inhibition elicits a prometastatic sw ......" | 24518294 |
| hsa-miR-200b-3p | breast cancer | CDH1 | "These findings are surprising since the miR-200 fa ......" | 19787069 |
| hsa-miR-200b-3p | breast cancer | CDH1 | "Here we demonstrate that the tumor suppressive miR ......" | 26062653 |
| hsa-miR-200b-3p | esophageal cancer | CDH1 | "Loss of miR 200b promotes invasion via activating ......" | 26334393 |
| hsa-miR-200b-3p | gastric cancer | CDH1 | "Functional experiments demonstrated that miR-200b ......" | 24352645 |
| hsa-miR-200b-3p | gastric cancer | CDH1 | "E-cadherin expression was partially restored by tr ......" | 20484038 |
| hsa-miR-200b-3p | gastric cancer | CDH1 | "There was a strong correlation between the levels ......" | 22311119 |
| hsa-miR-200b-3p | liver cancer | CDH1 | "Spearman's Rho analysis revealed a significant neg ......" | 24895326 |
| hsa-miR-200b-3p | liver cancer | CDH1 | "We found that overexpression of miR-200 family mem ......" | 22868917 |
| hsa-miR-200b-3p | liver cancer | CDH1 | "In mesenchymal cells forced expression of miR-200b ......" | 23552699 |
| hsa-miR-200b-3p | melanoma | CDH1 | "MiR-200 in situ hybridization and E-cadherin immun ......" | 22956368 |
| hsa-miR-200b-3p | ovarian cancer | CDH1 | "Our findings showed that miR-101 represents a redu ......" | 24677166 |
| hsa-miR-200b-3p | pancreatic cancer | CDH1 | "In a panel of 23 pancreatic cell lines we observed ......" | 20551052 |
| hsa-miR-200b-3p | thyroid cancer | CDH1 | "Restoration of miR-200 expression by pre-miR-200a/ ......" | 25542369 |
| hsa-miR-200b-3p | breast cancer | ZEB2 | "This switch involved activation of the transformin ......" | 24518294 |
| hsa-miR-200b-3p | breast cancer | ZEB2 | "These findings are surprising since the miR-200 fa ......" | 19787069 |
| hsa-miR-200b-3p | gastric cancer | ZEB2 | "MicroRNA 200b regulates cell proliferation invasio ......" | 22311119 |
| hsa-miR-200b-3p | head and neck cancer | ZEB2 | "Furthermore our data suggest that the promoter hyp ......" | 24424572 |
| hsa-miR-200b-3p | lung squamous cell cancer | ZEB2 | "Zinc finger E box binding homeobox 2 ZEB2 regulate ......" | 24769353 |
| hsa-miR-200b-3p | ovarian cancer | ZEB2 | "We used qRT-PCR to examine expression of the miR-2 ......" | 19854497 |
| hsa-miR-200b-3p | prostate cancer | ZEB2 | "Recent studies have shown that the miR-200 family ......" | 19544444 |
| hsa-miR-200b-3p | sarcoma | ZEB2 | "Moreover a series of loss-of-function and gain-of- ......" | 24815002 |
| hsa-miR-200b-3p | esophageal cancer | VIM | "Here we show that miR-200b represses ESCC cell inv ......" | 26334393 |
| hsa-miR-200b-3p | liver cancer | VIM | "Spearman's Rho analysis revealed a significant neg ......" | 24895326 |
| hsa-miR-200b-3p | prostate cancer | VIM | "In contrast mesenchymal markers fibronectin and vi ......" | 24391862 |
| hsa-miR-200b-3p | thyroid cancer | VIM | "Restoration of miR-200 expression by pre-miR-200a/ ......" | 25542369 |
| hsa-miR-200b-3p | breast cancer | FERMT2 | "Here we report that Kindlin 2 markedly downregulat ......" | 23483548 |
| hsa-miR-200b-3p | esophageal cancer | FERMT2 | "miR 200b suppresses invasiveness and modulates the ......" | 24064224 |
| hsa-miR-200b-3p | esophageal cancer | FERMT2 | "We revealed that miR-200b suppresses the integrin ......" | 26334393 |
| hsa-miR-200b-3p | endometrial cancer | VEGFA | "In contrast a positive correlation was observed be ......" | 22904162 |
| hsa-miR-200b-3p | kidney renal cell cancer | VEGFA | "We also found strong anti-correlation between VEGF ......" | 20420713 |
| hsa-miR-200b-3p | sarcoma | VEGFA | "CCL5 promotes VEGF dependent angiogenesis by down ......" | 25301739 |
| hsa-miR-200b-3p | thyroid cancer | ATM | "However specific miRNAs are downregulated in ATC s ......" | 25202329 |
| hsa-miR-200b-3p | thyroid cancer | ATM | "This study was set to study the molecular mechanis ......" | 25542369 |
| hsa-miR-200b-3p | lung cancer | E2F3 | "MicroRNA 200b reverses chemoresistance of docetaxe ......" | 22139708 |
| hsa-miR-200b-3p | lung cancer | E2F3 | "Previously we have shown that restoration of micro ......" | 24830600 |
| hsa-miR-200b-3p | ovarian cancer | GRHL2 | "GRHL2 miR 200 ZEB1 maintains the epithelial status ......" | 26887977 |
| hsa-miR-200b-3p | sarcoma | GRHL2 | "This circuit comprises the microRNA 200 miR-200 fa ......" | 27402864 |
| hsa-miR-200b-3p | lung cancer | HDAC9 | "HDAC 1/4 mediated silencing of microRNA 200b promo ......" | 24830600 |
| hsa-miR-200b-3p | lung cancer | HDAC9 | "Additionally overexpression of histone deacetylase ......" | 25279705 |
| hsa-miR-200b-3p | breast cancer | ITGA9 | "β1 integrin inhibition elicits a prometastatic sw ......" | 24518294 |
| hsa-miR-200b-3p | esophageal cancer | ITGA9 | "We revealed that miR-200b suppresses the integrin ......" | 26334393 |
| hsa-miR-200b-3p | endometrial cancer | MMP2 | "Using reverse gelatin zymography we showed that mi ......" | 23205572 |
| hsa-miR-200b-3p | ovarian cancer | MMP2 | "Interestingly our findings show that catalpol trea ......" | 25347277 |
| hsa-miR-200b-3p | ovarian cancer | MUC16 | "Plasma miR 200b in ovarian carcinoma patients: dis ......" | 26416421 |
| hsa-miR-200b-3p | ovarian cancer | MUC16 | "The increased levels of miR-200b and miR-200c were ......" | 26943577 |
| hsa-miR-200b-3p | lung cancer | NOTCH1 | "Nobiletin inhibited hypoxia induced epithelial mes ......" | 26012256 |
| hsa-miR-200b-3p | sarcoma | NOTCH1 | "We also found that reexpression of miR-34a and miR ......" | 23430952 |
| hsa-miR-200b-3p | pancreatic cancer | PTEN | "Re expression of miR 200 by novel approaches regul ......" | 22637745 |
| hsa-miR-200b-3p | pancreatic cancer | PTEN | "Anti tumor activity of a novel compound CDF is med ......" | 21408027 |
| hsa-miR-200b-3p | lung cancer | QRSL1 | "It was reported that miR-200 can activate PI3K/AKT ......" | 26314828 |
| hsa-miR-200b-3p | lung cancer | QRSL1 | "Mechanistically Jagged2 was found to promote metas ......" | 21403400 |
| hsa-miR-200b-3p | breast cancer | TAM | "miR-200 family expression was progressively reduce ......" | 23626803 |
| hsa-miR-200b-3p | endometrial cancer | TAM | "When treated with TAM ECC-1 and Ishikawa cells wer ......" | 23295740 |
| hsa-miR-200b-3p | breast cancer | ADAM12 | "ADAM12 L is a direct target of the miR 29 and miR ......" | 25886595 |
| hsa-miR-200b-3p | prostate cancer | AR | "We identified miR-200 b as a downstream target of ......" | 24391862 |
| hsa-miR-200b-3p | lung cancer | ATG12 | "In the present study an inverse correlation betwee ......" | 26416454 |
| hsa-miR-200b-3p | lung squamous cell cancer | ATRX | "Additionally miR-200 family downregulates HNRNPR3 ......" | 23708087 |
| hsa-miR-200b-3p | B cell lymphoma | BCL6 | "In 30 H pylori-positive and 30 H pylori-negative g ......" | 24390222 |
| hsa-miR-200b-3p | liver cancer | BMI1 | "Methylation associated silencing of miR 200b facil ......" | 26919246 |
| hsa-miR-200b-3p | lung cancer | BMP4 | "BMP4 depletion by miR 200 inhibits tumorigenesis a ......" | 26395571 |
| hsa-miR-200b-3p | colon cancer | CCL16 | "This observation indicates a common molecular axis ......" | 25832648 |
| hsa-miR-200b-3p | sarcoma | CCL5 | "CCL5 promotes VEGF dependent angiogenesis by down ......" | 25301739 |
| hsa-miR-200b-3p | colorectal cancer | CD2AP | "Importantly epigenetic silencing of the miR-200 fa ......" | 27157610 |
| hsa-miR-200b-3p | pancreatic cancer | CD44 | "In the current study we showed for the first time ......" | 21408027 |
| hsa-miR-200b-3p | esophageal cancer | CDK2 | "Correlating with the frequent loss of miR-200b in ......" | 27496804 |
| hsa-miR-200b-3p | colorectal cancer | CDKN1B | "This study suggests that miR-200b plays a tumour-p ......" | 24151081 |
| hsa-miR-200b-3p | melanoma | CHL1 | "Overall our findings call into question the genera ......" | 20957176 |
| hsa-miR-200b-3p | thyroid cancer | CHST14 | "We identified two significantly decreased microRNA ......" | 20498632 |
| hsa-miR-200b-3p | liver cancer | DNMT1 | "After the mesenchymal cells were treated with comb ......" | 23552699 |
| hsa-miR-200b-3p | bladder cancer | EGF | "miR 200 expression regulates epithelial to mesench ......" | 19671845 |
| hsa-miR-200b-3p | bladder cancer | EGFR | "Protein expression and signaling pathway modulatio ......" | 19671845 |
| hsa-miR-200b-3p | pancreatic cancer | EPCAM | "In the current study we showed for the first time ......" | 21408027 |
| hsa-miR-200b-3p | prostate cancer | ERG | "The tumor suppressive miR 200b subfamily is an ERG ......" | 27191272 |
| hsa-miR-200b-3p | breast cancer | ESR1 | "Further miR-200b and miR-200c overexpression sensi ......" | 23626803 |
| hsa-miR-200b-3p | breast cancer | ETV5 | "This study aimed to investigate the effect of miR- ......" | 27276064 |
| hsa-miR-200b-3p | breast cancer | EXOSC10 | "The novel promoter of the Hsa-mir-200b cluster den ......" | 22231446 |
| hsa-miR-200b-3p | lung cancer | FLT1 | "Forced miR-200 expression suppressed Flt1 levels i ......" | 21115742 |
| hsa-miR-200b-3p | prostate cancer | FN1 | "In contrast mesenchymal markers fibronectin and vi ......" | 24391862 |
| hsa-miR-200b-3p | lung cancer | FOXF2 | "The miR 200 family and the miR 183~96~182 cluster ......" | 25798833 |
| hsa-miR-200b-3p | cervical and endocervical cancer | FOXG1 | "MiR 200b promotes the cell proliferation and metas ......" | 27044840 |
| hsa-miR-200b-3p | breast cancer | FOXM1 | "SUMOylation of FOXM1B alters its transcriptional a ......" | 24918286 |
| hsa-miR-200b-3p | lung squamous cell cancer | FSCN1 | "miR 200b inhibits migration and invasion in non sm ......" | 27356635 |
| hsa-miR-200b-3p | lung cancer | GATA3 | "Reciprocally miR-200 inhibited expression of Gata3 ......" | 21403400 |
| hsa-miR-200b-3p | prostate cancer | GNA13 | "These data provide strong evidence that GNA13 is a ......" | 23329838 |
| hsa-miR-200b-3p | liver cancer | H19 | "Epigenetic activation of the MiR 200 family contri ......" | 23222811 |
| hsa-miR-200b-3p | lung cancer | HDAC1 | "Additionally overexpression of histone deacetylase ......" | 25279705 |
| hsa-miR-200b-3p | lung squamous cell cancer | HFE | "Additionally miR-200 family downregulates HNRNPR3 ......" | 23708087 |
| hsa-miR-200b-3p | lung squamous cell cancer | HMI | "The miR-200 family and these potential targets are ......" | 23708087 |
| hsa-miR-200b-3p | liver cancer | IBSP | "Methylation specific PCR MSP and bisulfite sequenc ......" | 26919246 |
| hsa-miR-200b-3p | breast cancer | IKBKB | "Importantly IKBKB overexpression attenuates the in ......" | 26433127 |
| hsa-miR-200b-3p | lung cancer | IRS1 | "Taken together our results suggest that miR-200 ma ......" | 26314828 |
| hsa-miR-200b-3p | lung cancer | JAG2 | "The Notch ligand Jagged2 promotes lung adenocarcin ......" | 21403400 |
| hsa-miR-200b-3p | endometrial cancer | KCNE1 | "Furthermore it was observed that the expression pa ......" | 26788150 |
| hsa-miR-200b-3p | esophageal cancer | KIAA0101 | "Correlating with the frequent loss of miR-200b in ......" | 27496804 |
| hsa-miR-200b-3p | colorectal cancer | KRAS | "In KRAS mutated tumours increased miR-200b and dec ......" | 22804917 |
| hsa-miR-200b-3p | endometrial cancer | MALAT1 | "The abnormal expression of the long noncoding RNA ......" | 27693631 |
| hsa-miR-200b-3p | breast cancer | MAPK8 | "SUMOylation of FOXM1B alters its transcriptional a ......" | 24918286 |
| hsa-miR-200b-3p | pancreatic cancer | MMP14 | "Re expression of miR 200 by novel approaches regul ......" | 22637745 |
| hsa-miR-200b-3p | breast cancer | MSN | "MiR 200 can repress breast cancer metastasis throu ......" | 24037528 |
| hsa-miR-200b-3p | endometrial cancer | MYC | "Tamoxifen represses miR 200 microRNAs and promotes ......" | 23295740 |
| hsa-miR-200b-3p | breast cancer | NR4A1 | "Mapping the regulatory sequences controlling 93 br ......" | 22231446 |
| hsa-miR-200b-3p | breast cancer | P1 | "P2 has comparable promoter activity to the previou ......" | 22231446 |
| hsa-miR-200b-3p | prostate cancer | PDGFD | "miR 200 regulates PDGF D mediated epithelial mesen ......" | 19544444 |
| hsa-miR-200b-3p | prostate cancer | PDZD2 | "In this study we investigated the role that the in ......" | 23389960 |
| hsa-miR-200b-3p | breast cancer | PELP1 | "Whole genome miR array analysis using PELP1-overex ......" | 23975430 |
| hsa-miR-200b-3p | breast cancer | PHLDA3 | "Our data indicate that Kindlin 2 plays a novel rol ......" | 23483548 |
| hsa-miR-200b-3p | breast cancer | PRDX2 | "Demethylating agent 5-aza-2'-deoxycytidine 5-aza-d ......" | 23626803 |
| hsa-miR-200b-3p | pancreatic cancer | PTGS2 | "In a xenograft mouse model of human PC CDF treatme ......" | 21408027 |
| hsa-miR-200b-3p | cervical and endocervical cancer | PVT1 | "Long noncoding RNA PVT1 promotes cervical cancer p ......" | 27272214 |
| hsa-miR-200b-3p | breast cancer | RAC1 | "Further mechanistic studies revealed that PKCα do ......" | 24925028 |
| hsa-miR-200b-3p | cervical and endocervical cancer | RND3 | "MicroRNA 200b inhibits epithelial mesenchymal tran ......" | 26935796 |
| hsa-miR-200b-3p | breast cancer | SGSM3 | "The genes encoding microRNAs of the human miR-200 ......" | 20514023 |
| hsa-miR-200b-3p | breast cancer | SLC10A4 | "Here we investigated P4 downregulation of miR-141 ......" | 25241899 |
| hsa-miR-200b-3p | colorectal cancer | SNAI1 | "EMT-TFs and microRNAs such as ZEB1/2 and miR-200 o ......" | 27573895 |
| hsa-miR-200b-3p | breast cancer | SP1 | "MiR 200b expression in breast cancer: a prognostic ......" | 25639535 |
| hsa-miR-200b-3p | endometrial cancer | SPEN | "This finding was accompanied by a sharp downregula ......" | 23743934 |
| hsa-miR-200b-3p | thyroid cancer | TGFB1 | "Inhibition of TGFbeta receptor 1 TGFBR1 in these c ......" | 20498632 |
| hsa-miR-200b-3p | thyroid cancer | TGFBR1 | "Inhibition of TGFbeta receptor 1 TGFBR1 in these c ......" | 20498632 |
| hsa-miR-200b-3p | colorectal cancer | TGFBR2 | "MicroRNA 200b stimulates tumour growth in TGFBR2 n ......" | 24151081 |
| hsa-miR-200b-3p | endometrial cancer | TIMP2 | "A novel target of miR-200b tissue inhibitor of met ......" | 23205572 |
| hsa-miR-200b-3p | breast cancer | TP53BP1 | "Here we show that 53BP1 negatively regulated EMT b ......" | 26011542 |
| hsa-miR-200b-3p | prostate cancer | TP73 | "Down regulation of miR 200b 3p by low p73 contribu ......" | 23389960 |
| hsa-miR-200b-3p | bladder cancer | TWIST1 | "In addition we observe that the mesoderm transcrip ......" | 20473948 |
| hsa-miR-200b-3p | lung cancer | ZFPM2 | "It was reported that miR-200 can activate PI3K/AKT ......" | 26314828 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-200b-3p | ETS1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan | TCGA BLCA -0.127; TCGA BRCA -0.246; TCGA CESC -0.249; TCGA COAD -0.353; TCGA ESCA -0.101; TCGA HNSC -0.426; TCGA KIRC -0.312; TCGA KIRP -0.112; TCGA LGG -0.249; TCGA LUAD -0.251; TCGA LUSC -0.52; TCGA OV -0.084; TCGA PAAD -0.339; TCGA UCEC -0.187 |
hsa-miR-200b-3p | FN1 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan | TCGA BLCA -0.598; TCGA CESC -0.638; TCGA COAD -0.962; TCGA ESCA -0.501; TCGA HNSC -0.855; TCGA KIRC -0.577; TCGA KIRP -0.858; TCGA LUAD -0.403; TCGA LUSC -0.589; TCGA PAAD -0.204; TCGA PRAD -0.108; TCGA SARC -0.164; TCGA STAD -0.371; TCGA UCEC -0.246 |
hsa-miR-200b-3p | KDR | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; PAAD; PRAD; UCEC | miRNAWalker2 validate; miRTarBase; TargetScan | TCGA BLCA -0.06; TCGA BRCA -0.263; TCGA CESC -0.289; TCGA COAD -0.237; TCGA HNSC -0.264; TCGA KIRC -0.272; TCGA KIRP -0.486; TCGA LGG -0.066; TCGA LIHC -0.05; TCGA LUSC -0.449; TCGA OV -0.114; TCGA PAAD -0.221; TCGA PRAD -0.142; TCGA UCEC -0.301 |
hsa-miR-200b-3p | KLF11 | 9 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.097; TCGA BRCA -0.181; TCGA COAD -0.109; TCGA ESCA -0.072; TCGA LUAD -0.08; TCGA LUSC -0.059; TCGA SARC -0.052; TCGA STAD -0.172; TCGA UCEC -0.166 |
hsa-miR-200b-3p | KLHL20 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; OV; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.067; TCGA BRCA -0.135; TCGA CESC -0.076; TCGA COAD -0.066; TCGA HNSC -0.051; TCGA KIRC -0.079; TCGA KIRP -0.154; TCGA LGG -0.109; TCGA OV -0.059; TCGA SARC -0.096; TCGA STAD -0.082; TCGA UCEC -0.133 |
hsa-miR-200b-3p | PTPRD | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUSC; OV; PAAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.496; TCGA BRCA -0.305; TCGA CESC -0.343; TCGA ESCA -0.413; TCGA HNSC -0.643; TCGA LUSC -0.328; TCGA OV -0.415; TCGA PAAD -0.272; TCGA SARC -0.186; TCGA STAD -0.289; TCGA UCEC -0.392 |
hsa-miR-200b-3p | RASSF2 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.092; TCGA BRCA -0.133; TCGA CESC -0.153; TCGA COAD -0.549; TCGA ESCA -0.176; TCGA HNSC -0.258; TCGA KIRC -0.501; TCGA KIRP -0.13; TCGA LGG -0.146; TCGA LUAD -0.134; TCGA LUSC -0.5; TCGA OV -0.078; TCGA PAAD -0.511; TCGA PRAD -0.055; TCGA SARC -0.135; TCGA STAD -0.253; TCGA UCEC -0.288 |
hsa-miR-200b-3p | RIN2 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; PAAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.145; TCGA BRCA -0.084; TCGA CESC -0.093; TCGA ESCA -0.071; TCGA HNSC -0.126; TCGA KIRC -0.056; TCGA LGG -0.118; TCGA PAAD -0.073; TCGA UCEC -0.088 |
hsa-miR-200b-3p | RND3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan | TCGA BLCA -0.199; TCGA BRCA -0.198; TCGA CESC -0.209; TCGA COAD -0.104; TCGA ESCA -0.197; TCGA HNSC -0.123; TCGA KIRC -0.095; TCGA KIRP -0.115; TCGA LUAD -0.259; TCGA PAAD -0.123; TCGA STAD -0.073; TCGA UCEC -0.101 |
hsa-miR-200b-3p | SEPT7 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; OV; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.094; TCGA BRCA -0.088; TCGA CESC -0.1; TCGA COAD -0.102; TCGA ESCA -0.106; TCGA HNSC -0.109; TCGA KIRC -0.121; TCGA LUAD -0.099; TCGA OV -0.076; TCGA PAAD -0.126; TCGA STAD -0.13; TCGA UCEC -0.128 |
hsa-miR-200b-3p | SHC1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; OV; UCEC | miRNAWalker2 validate; TargetScan | TCGA BLCA -0.074; TCGA CESC -0.22; TCGA COAD -0.063; TCGA ESCA -0.09; TCGA HNSC -0.174; TCGA KIRC -0.303; TCGA KIRP -0.092; TCGA OV -0.084; TCGA UCEC -0.06 |
hsa-miR-200b-3p | TCF7L1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LGG; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.344; TCGA BRCA -0.168; TCGA CESC -0.214; TCGA COAD -0.399; TCGA ESCA -0.416; TCGA KIRP -0.234; TCGA LGG -0.153; TCGA OV -0.142; TCGA PAAD -0.195; TCGA THCA -0.065; TCGA STAD -0.443; TCGA UCEC -0.084 |
hsa-miR-200b-3p | WASF3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; TargetScan | TCGA BLCA -0.077; TCGA BRCA -0.426; TCGA CESC -0.382; TCGA COAD -0.769; TCGA ESCA -0.328; TCGA LGG -0.09; TCGA LUSC -0.339; TCGA OV -0.168; TCGA PAAD -0.273; TCGA THCA -0.082; TCGA STAD -0.413; TCGA UCEC -0.281 |
hsa-miR-200b-3p | ZEB1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan | TCGA BLCA -0.379; TCGA BRCA -0.34; TCGA CESC -0.38; TCGA COAD -0.674; TCGA ESCA -0.275; TCGA HNSC -0.496; TCGA KIRC -0.224; TCGA KIRP -0.208; TCGA LGG -0.24; TCGA LUAD -0.21; TCGA LUSC -0.39; TCGA OV -0.264; TCGA PAAD -0.275; TCGA PRAD -0.078; TCGA SARC -0.079; TCGA STAD -0.487; TCGA UCEC -0.51 |
hsa-miR-200b-3p | ZEB2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget | TCGA BLCA -0.428; TCGA BRCA -0.387; TCGA CESC -0.382; TCGA COAD -0.602; TCGA ESCA -0.261; TCGA HNSC -0.538; TCGA KIRC -0.24; TCGA KIRP -0.104; TCGA LUAD -0.265; TCGA LUSC -0.562; TCGA PAAD -0.404; TCGA PRAD -0.081; TCGA SARC -0.157; TCGA STAD -0.271; TCGA UCEC -0.388 |
hsa-miR-200b-3p | ZFPM2 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; TargetScan | TCGA BLCA -0.509; TCGA BRCA -0.4; TCGA CESC -0.242; TCGA COAD -0.894; TCGA ESCA -0.46; TCGA HNSC -0.505; TCGA KIRC -0.344; TCGA KIRP -0.286; TCGA LGG -0.196; TCGA LUAD -0.269; TCGA LUSC -0.549; TCGA OV -0.232; TCGA PAAD -0.41; TCGA PRAD -0.203; TCGA SARC -0.177; TCGA STAD -0.563; TCGA UCEC -0.699 |
hsa-miR-200b-3p | LIX1L | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.294; TCGA BRCA -0.257; TCGA CESC -0.206; TCGA COAD -0.414; TCGA ESCA -0.237; TCGA HNSC -0.284; TCGA KIRC -0.266; TCGA KIRP -0.066; TCGA LGG -0.161; TCGA LUAD -0.11; TCGA LUSC -0.251; TCGA OV -0.214; TCGA PAAD -0.195; TCGA STAD -0.341; TCGA UCEC -0.298 |
hsa-miR-200b-3p | HLF | 9 cancers: BLCA; BRCA; COAD; ESCA; LIHC; PAAD; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.457; TCGA BRCA -0.413; TCGA COAD -0.501; TCGA ESCA -0.254; TCGA LIHC -0.18; TCGA PAAD -0.247; TCGA THCA -0.085; TCGA STAD -0.719; TCGA UCEC -0.576 |
hsa-miR-200b-3p | AFF3 | 12 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.443; TCGA CESC -0.276; TCGA COAD -0.647; TCGA ESCA -0.319; TCGA KIRC -0.347; TCGA KIRP -0.363; TCGA LGG -0.234; TCGA LUSC -0.54; TCGA PAAD -0.54; TCGA PRAD -0.202; TCGA STAD -0.564; TCGA UCEC -0.28 |
hsa-miR-200b-3p | WIPF1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.384; TCGA BRCA -0.191; TCGA CESC -0.368; TCGA COAD -0.511; TCGA ESCA -0.281; TCGA HNSC -0.338; TCGA KIRC -0.394; TCGA KIRP -0.27; TCGA LUAD -0.24; TCGA LUSC -0.374; TCGA OV -0.09; TCGA PAAD -0.384; TCGA STAD -0.215; TCGA UCEC -0.234 |
hsa-miR-200b-3p | CNN3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.154; TCGA BRCA -0.114; TCGA CESC -0.135; TCGA COAD -0.212; TCGA ESCA -0.148; TCGA HNSC -0.223; TCGA KIRP -0.097; TCGA LIHC -0.087; TCGA LUAD -0.165; TCGA LUSC -0.185; TCGA OV -0.062; TCGA PAAD -0.286; TCGA PRAD -0.055; TCGA STAD -0.237; TCGA UCEC -0.147 |
hsa-miR-200b-3p | SYDE1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.308; TCGA BRCA -0.201; TCGA CESC -0.568; TCGA COAD -0.536; TCGA ESCA -0.326; TCGA HNSC -0.377; TCGA KIRC -0.273; TCGA KIRP -0.175; TCGA LUAD -0.3; TCGA LUSC -0.311; TCGA OV -0.249; TCGA PAAD -0.19; TCGA PRAD -0.061; TCGA STAD -0.363; TCGA UCEC -0.416 |
hsa-miR-200b-3p | ABL2 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD | MirTarget | TCGA BLCA -0.148; TCGA CESC -0.166; TCGA COAD -0.152; TCGA ESCA -0.127; TCGA HNSC -0.244; TCGA KIRC -0.244; TCGA KIRP -0.104; TCGA LGG -0.131; TCGA LUAD -0.093; TCGA LUSC -0.18; TCGA PAAD -0.187 |
hsa-miR-200b-3p | ITPR2 | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.181; TCGA CESC -0.258; TCGA HNSC -0.303; TCGA KIRP -0.317; TCGA LIHC -0.132; TCGA LUSC -0.417; TCGA PAAD -0.213; TCGA STAD -0.084; TCGA UCEC -0.075 |
hsa-miR-200b-3p | CBL | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; TargetScan; mirMAP | TCGA BLCA -0.083; TCGA BRCA -0.118; TCGA CESC -0.08; TCGA ESCA -0.06; TCGA HNSC -0.087; TCGA KIRC -0.127; TCGA KIRP -0.079; TCGA LUAD -0.121; TCGA LUSC -0.056; TCGA PAAD -0.131; TCGA SARC -0.062; TCGA STAD -0.081; TCGA UCEC -0.124 |
hsa-miR-200b-3p | SULF1 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD | MirTarget; TargetScan | TCGA BLCA -0.439; TCGA CESC -0.253; TCGA COAD -0.883; TCGA ESCA -0.254; TCGA HNSC -0.485; TCGA KIRC -0.479; TCGA LUAD -0.272; TCGA LUSC -0.189; TCGA OV -0.213; TCGA PAAD -0.194; TCGA PRAD -0.087; TCGA SARC -0.159; TCGA STAD -0.138 |
hsa-miR-200b-3p | REEP1 | 9 cancers: BLCA; COAD; ESCA; KIRP; LGG; LUSC; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.421; TCGA COAD -0.323; TCGA ESCA -0.166; TCGA KIRP -0.397; TCGA LGG -0.109; TCGA LUSC -0.288; TCGA SARC -0.269; TCGA STAD -0.616; TCGA UCEC -0.298 |
hsa-miR-200b-3p | NOVA1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.294; TCGA BRCA -0.313; TCGA CESC -0.291; TCGA COAD -1.018; TCGA ESCA -0.538; TCGA LGG -0.224; TCGA LUSC -0.195; TCGA OV -0.433; TCGA PAAD -0.492; TCGA STAD -0.696; TCGA UCEC -0.581 |
hsa-miR-200b-3p | MCFD2 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.14; TCGA BRCA -0.109; TCGA CESC -0.138; TCGA COAD -0.096; TCGA HNSC -0.181; TCGA KIRC -0.092; TCGA KIRP -0.179; TCGA LIHC -0.071; TCGA LUAD -0.14; TCGA LUSC -0.154; TCGA OV -0.081; TCGA PAAD -0.116; TCGA PRAD -0.07; TCGA STAD -0.1; TCGA UCEC -0.132 |
hsa-miR-200b-3p | BNC2 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.584; TCGA BRCA -0.364; TCGA CESC -0.486; TCGA COAD -0.959; TCGA ESCA -0.442; TCGA HNSC -0.548; TCGA KIRC -0.141; TCGA KIRP -0.358; TCGA LUAD -0.336; TCGA LUSC -0.413; TCGA OV -0.239; TCGA PAAD -0.463; TCGA PRAD -0.069; TCGA SARC -0.068; TCGA STAD -0.55; TCGA UCEC -0.667 |
hsa-miR-200b-3p | CLIC4 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.404; TCGA BRCA -0.129; TCGA CESC -0.238; TCGA COAD -0.435; TCGA ESCA -0.29; TCGA HNSC -0.22; TCGA KIRC -0.078; TCGA LUAD -0.192; TCGA LUSC -0.174; TCGA PAAD -0.231; TCGA PRAD -0.099; TCGA SARC -0.16; TCGA STAD -0.373; TCGA UCEC -0.24 |
hsa-miR-200b-3p | DZIP1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.28; TCGA BRCA -0.235; TCGA CESC -0.301; TCGA COAD -0.731; TCGA ESCA -0.51; TCGA HNSC -0.156; TCGA LGG -0.068; TCGA LUAD -0.163; TCGA OV -0.177; TCGA PAAD -0.284; TCGA STAD -0.459; TCGA UCEC -0.377 |
hsa-miR-200b-3p | VAT1L | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.221; TCGA BRCA -0.303; TCGA CESC -0.341; TCGA COAD -0.378; TCGA HNSC -0.324; TCGA LGG -0.225; TCGA LUAD -0.449; TCGA LUSC -0.304; TCGA OV -0.266; TCGA PAAD -0.239; TCGA STAD -0.277; TCGA UCEC -0.401 |
hsa-miR-200b-3p | AMOTL2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.235; TCGA BRCA -0.198; TCGA CESC -0.269; TCGA COAD -0.144; TCGA ESCA -0.166; TCGA HNSC -0.147; TCGA LGG -0.234; TCGA LUAD -0.086; TCGA LUSC -0.24; TCGA OV -0.106; TCGA PAAD -0.175; TCGA PRAD -0.062; TCGA STAD -0.111; TCGA UCEC -0.167 |
hsa-miR-200b-3p | NDN | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.165; TCGA BRCA -0.419; TCGA CESC -0.348; TCGA COAD -0.661; TCGA ESCA -0.419; TCGA HNSC -0.28; TCGA KIRP -0.28; TCGA LGG -0.15; TCGA LUAD -0.121; TCGA LUSC -0.216; TCGA OV -0.156; TCGA PAAD -0.26; TCGA PRAD -0.072; TCGA STAD -0.523; TCGA UCEC -0.457 |
hsa-miR-200b-3p | DUSP1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.325; TCGA BRCA -0.375; TCGA CESC -0.271; TCGA COAD -0.414; TCGA ESCA -0.307; TCGA HNSC -0.113; TCGA KIRC -0.231; TCGA LUAD -0.171; TCGA LUSC -0.535; TCGA PAAD -0.301; TCGA STAD -0.341; TCGA UCEC -0.34 |
hsa-miR-200b-3p | GEM | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.486; TCGA BRCA -0.252; TCGA CESC -0.18; TCGA COAD -0.628; TCGA ESCA -0.193; TCGA HNSC -0.362; TCGA KIRC -0.118; TCGA LUSC -0.432; TCGA OV -0.263; TCGA PAAD -0.309; TCGA PRAD -0.1; TCGA SARC -0.197; TCGA STAD -0.415; TCGA UCEC -0.393 |
hsa-miR-200b-3p | VASH1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.185; TCGA BRCA -0.094; TCGA CESC -0.204; TCGA COAD -0.355; TCGA ESCA -0.107; TCGA HNSC -0.317; TCGA KIRC -0.469; TCGA LUAD -0.125; TCGA LUSC -0.366; TCGA OV -0.121; TCGA PAAD -0.255; TCGA STAD -0.053; TCGA UCEC -0.197 |
hsa-miR-200b-3p | RFTN2 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.124; TCGA BRCA -0.365; TCGA CESC -0.17; TCGA COAD -0.394; TCGA HNSC -0.145; TCGA KIRC -0.122; TCGA LGG -0.19; TCGA LUAD -0.137; TCGA LUSC -0.259; TCGA PAAD -0.238; TCGA PRAD -0.054; TCGA STAD -0.201; TCGA UCEC -0.342 |
hsa-miR-200b-3p | NPC1 | 9 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LUAD; LUSC; SARC | MirTarget; TargetScan | TCGA BLCA -0.15; TCGA BRCA -0.063; TCGA CESC -0.144; TCGA COAD -0.145; TCGA KIRC -0.164; TCGA KIRP -0.401; TCGA LUAD -0.152; TCGA LUSC -0.068; TCGA SARC -0.104 |
hsa-miR-200b-3p | SLC35B4 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.109; TCGA BRCA -0.162; TCGA CESC -0.154; TCGA COAD -0.185; TCGA ESCA -0.07; TCGA HNSC -0.153; TCGA KIRP -0.188; TCGA LIHC -0.101; TCGA LUAD -0.094; TCGA OV -0.1; TCGA PAAD -0.137; TCGA STAD -0.092; TCGA UCEC -0.137 |
hsa-miR-200b-3p | SERINC1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.104; TCGA BRCA -0.134; TCGA CESC -0.091; TCGA COAD -0.135; TCGA ESCA -0.062; TCGA HNSC -0.159; TCGA KIRP -0.168; TCGA LUAD -0.083; TCGA LUSC -0.163; TCGA OV -0.066; TCGA PAAD -0.09; TCGA STAD -0.151; TCGA UCEC -0.225 |
hsa-miR-200b-3p | RNGTT | 9 cancers: BLCA; COAD; ESCA; KIRP; LGG; LUAD; OV; PAAD; UCEC | MirTarget | TCGA BLCA -0.069; TCGA COAD -0.068; TCGA ESCA -0.051; TCGA KIRP -0.098; TCGA LGG -0.061; TCGA LUAD -0.116; TCGA OV -0.058; TCGA PAAD -0.22; TCGA UCEC -0.054 |
hsa-miR-200b-3p | CYTH3 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.167; TCGA BRCA -0.18; TCGA CESC -0.153; TCGA COAD -0.214; TCGA ESCA -0.098; TCGA HNSC -0.263; TCGA LUSC -0.178; TCGA PAAD -0.195; TCGA STAD -0.144; TCGA UCEC -0.146 |
hsa-miR-200b-3p | FSTL1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.317; TCGA BRCA -0.36; TCGA CESC -0.278; TCGA COAD -0.565; TCGA ESCA -0.312; TCGA HNSC -0.517; TCGA KIRC -0.453; TCGA LUAD -0.247; TCGA LUSC -0.247; TCGA OV -0.191; TCGA PAAD -0.297; TCGA STAD -0.317; TCGA UCEC -0.213 |
hsa-miR-200b-3p | OSTM1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.193; TCGA BRCA -0.176; TCGA CESC -0.178; TCGA COAD -0.188; TCGA ESCA -0.183; TCGA HNSC -0.259; TCGA KIRC -0.169; TCGA KIRP -0.447; TCGA LIHC -0.069; TCGA LUAD -0.239; TCGA LUSC -0.185; TCGA OV -0.103; TCGA PAAD -0.221; TCGA PRAD -0.059; TCGA SARC -0.137; TCGA STAD -0.205; TCGA UCEC -0.167 |
hsa-miR-200b-3p | RIMKLB | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; PAAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.211; TCGA BRCA -0.125; TCGA CESC -0.148; TCGA COAD -0.673; TCGA ESCA -0.39; TCGA KIRC -0.057; TCGA PAAD -0.169; TCGA SARC -0.077; TCGA STAD -0.367; TCGA UCEC -0.086 |
hsa-miR-200b-3p | CALU | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.208; TCGA BRCA -0.054; TCGA CESC -0.16; TCGA COAD -0.238; TCGA ESCA -0.126; TCGA HNSC -0.286; TCGA KIRC -0.246; TCGA KIRP -0.129; TCGA LUAD -0.177; TCGA LUSC -0.064; TCGA PAAD -0.12; TCGA PRAD -0.055; TCGA SARC -0.107; TCGA STAD -0.092; TCGA UCEC -0.096 |
hsa-miR-200b-3p | AP1S2 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.316; TCGA BRCA -0.174; TCGA CESC -0.207; TCGA COAD -0.449; TCGA ESCA -0.328; TCGA HNSC -0.33; TCGA KIRC -0.262; TCGA KIRP -0.366; TCGA LUAD -0.245; TCGA LUSC -0.314; TCGA OV -0.115; TCGA PAAD -0.362; TCGA PRAD -0.057; TCGA SARC -0.139; TCGA STAD -0.41; TCGA UCEC -0.179 |
hsa-miR-200b-3p | IGF2R | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LGG; LUAD; PAAD; SARC | MirTarget; TargetScan | TCGA BLCA -0.093; TCGA BRCA -0.131; TCGA CESC -0.072; TCGA HNSC -0.132; TCGA KIRP -0.303; TCGA LGG -0.074; TCGA LUAD -0.062; TCGA PAAD -0.129; TCGA SARC -0.085 |
hsa-miR-200b-3p | KLHDC1 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LIHC; LUSC; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.063; TCGA BRCA -0.136; TCGA COAD -0.26; TCGA ESCA -0.129; TCGA HNSC -0.114; TCGA LGG -0.075; TCGA LIHC -0.088; TCGA LUSC -0.205; TCGA OV -0.076; TCGA STAD -0.285; TCGA UCEC -0.296 |
hsa-miR-200b-3p | YAP1 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.119; TCGA BRCA -0.192; TCGA CESC -0.294; TCGA COAD -0.076; TCGA ESCA -0.072; TCGA HNSC -0.122; TCGA SARC -0.103; TCGA STAD -0.105; TCGA UCEC -0.113 |
hsa-miR-200b-3p | MTMR6 | 9 cancers: BLCA; BRCA; CESC; HNSC; LUAD; LUSC; OV; PAAD; UCEC | MirTarget | TCGA BLCA -0.073; TCGA BRCA -0.064; TCGA CESC -0.056; TCGA HNSC -0.111; TCGA LUAD -0.088; TCGA LUSC -0.199; TCGA OV -0.061; TCGA PAAD -0.066; TCGA UCEC -0.107 |
hsa-miR-200b-3p | TBX18 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; PAAD; STAD | MirTarget | TCGA BLCA -0.441; TCGA BRCA -0.357; TCGA CESC -0.407; TCGA COAD -0.571; TCGA ESCA -0.568; TCGA HNSC -0.373; TCGA KIRC -0.215; TCGA KIRP -0.434; TCGA PAAD -0.228; TCGA STAD -0.458 |
hsa-miR-200b-3p | ERRFI1 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; SARC; STAD | MirTarget; TargetScan | TCGA BLCA -0.078; TCGA BRCA -0.064; TCGA CESC -0.164; TCGA COAD -0.165; TCGA HNSC -0.138; TCGA KIRC -0.225; TCGA LUAD -0.155; TCGA LUSC -0.227; TCGA SARC -0.109; TCGA STAD -0.255 |
hsa-miR-200b-3p | ZCCHC24 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.357; TCGA BRCA -0.357; TCGA CESC -0.355; TCGA COAD -0.55; TCGA ESCA -0.357; TCGA HNSC -0.518; TCGA KIRC -0.153; TCGA KIRP -0.371; TCGA LGG -0.157; TCGA LIHC -0.066; TCGA LUAD -0.125; TCGA LUSC -0.44; TCGA OV -0.276; TCGA PAAD -0.308; TCGA PRAD -0.09; TCGA STAD -0.508; TCGA UCEC -0.505 |
hsa-miR-200b-3p | MARCH1 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; SARC | MirTarget | TCGA BLCA -0.191; TCGA CESC -0.15; TCGA COAD -0.293; TCGA ESCA -0.146; TCGA HNSC -0.286; TCGA KIRC -0.208; TCGA KIRP -0.199; TCGA LGG -0.174; TCGA LUAD -0.26; TCGA LUSC -0.394; TCGA PAAD -0.483; TCGA SARC -0.118 |
hsa-miR-200b-3p | TFE3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.097; TCGA BRCA -0.111; TCGA CESC -0.099; TCGA COAD -0.103; TCGA ESCA -0.096; TCGA HNSC -0.096; TCGA KIRC -0.108; TCGA KIRP -0.188; TCGA LUAD -0.067; TCGA PAAD -0.076; TCGA SARC -0.062; TCGA STAD -0.126; TCGA UCEC -0.069 |
hsa-miR-200b-3p | PLCL1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.338; TCGA BRCA -0.187; TCGA CESC -0.456; TCGA COAD -0.465; TCGA ESCA -0.233; TCGA HNSC -0.39; TCGA LUAD -0.082; TCGA LUSC -0.376; TCGA OV -0.187; TCGA PAAD -0.371; TCGA PRAD -0.231; TCGA SARC -0.151; TCGA STAD -0.421; TCGA UCEC -0.507 |
hsa-miR-200b-3p | RGL1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.237; TCGA BRCA -0.323; TCGA CESC -0.093; TCGA COAD -0.377; TCGA ESCA -0.181; TCGA HNSC -0.077; TCGA KIRC -0.232; TCGA KIRP -0.258; TCGA LUAD -0.072; TCGA LUSC -0.125; TCGA PAAD -0.362; TCGA PRAD -0.067; TCGA STAD -0.277; TCGA UCEC -0.18 |
hsa-miR-200b-3p | PRKACB | 12 cancers: BLCA; BRCA; CESC; HNSC; LIHC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.079; TCGA BRCA -0.128; TCGA CESC -0.09; TCGA HNSC -0.232; TCGA LIHC -0.078; TCGA LUAD -0.101; TCGA LUSC -0.173; TCGA OV -0.133; TCGA SARC -0.055; TCGA THCA -0.064; TCGA STAD -0.247; TCGA UCEC -0.222 |
hsa-miR-200b-3p | SGPP1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.186; TCGA BRCA -0.171; TCGA CESC -0.454; TCGA COAD -0.138; TCGA ESCA -0.145; TCGA HNSC -0.362; TCGA KIRP -0.318; TCGA LUSC -0.401; TCGA PAAD -0.122; TCGA PRAD -0.09; TCGA STAD -0.121; TCGA UCEC -0.191 |
hsa-miR-200b-3p | PPM1F | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.103; TCGA BRCA -0.142; TCGA CESC -0.254; TCGA COAD -0.16; TCGA ESCA -0.139; TCGA HNSC -0.121; TCGA KIRC -0.269; TCGA KIRP -0.13; TCGA LUAD -0.139; TCGA LUSC -0.068; TCGA OV -0.139; TCGA PAAD -0.213; TCGA PRAD -0.054; TCGA STAD -0.171; TCGA UCEC -0.244 |
hsa-miR-200b-3p | LHFP | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.294; TCGA BRCA -0.395; TCGA CESC -0.333; TCGA COAD -0.649; TCGA ESCA -0.328; TCGA HNSC -0.434; TCGA KIRC -0.271; TCGA KIRP -0.441; TCGA LUAD -0.133; TCGA LUSC -0.428; TCGA OV -0.158; TCGA PAAD -0.313; TCGA PRAD -0.058; TCGA STAD -0.326; TCGA UCEC -0.385 |
hsa-miR-200b-3p | ZDHHC15 | 9 cancers: BLCA; BRCA; COAD; ESCA; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.236; TCGA BRCA -0.164; TCGA COAD -0.804; TCGA ESCA -0.31; TCGA LUSC -0.318; TCGA OV -0.178; TCGA PAAD -0.198; TCGA STAD -0.53; TCGA UCEC -0.35 |
hsa-miR-200b-3p | HPS5 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; UCEC | MirTarget | TCGA BLCA -0.142; TCGA BRCA -0.082; TCGA CESC -0.09; TCGA COAD -0.103; TCGA ESCA -0.058; TCGA HNSC -0.073; TCGA KIRP -0.226; TCGA LUAD -0.18; TCGA LUSC -0.141; TCGA PAAD -0.151; TCGA UCEC -0.066 |
hsa-miR-200b-3p | TUBB2A | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LIHC; OV; PRAD | MirTarget | TCGA BLCA -0.254; TCGA BRCA -0.094; TCGA CESC -0.137; TCGA COAD -0.233; TCGA HNSC -0.238; TCGA KIRP -0.194; TCGA LIHC -0.085; TCGA OV -0.171; TCGA PRAD -0.11 |
hsa-miR-200b-3p | SEC23A | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.194; TCGA BRCA -0.237; TCGA CESC -0.21; TCGA COAD -0.2; TCGA ESCA -0.167; TCGA HNSC -0.288; TCGA KIRC -0.28; TCGA KIRP -0.274; TCGA LIHC -0.097; TCGA LUAD -0.222; TCGA LUSC -0.152; TCGA OV -0.13; TCGA PAAD -0.146; TCGA PRAD -0.073; TCGA SARC -0.097; TCGA STAD -0.207; TCGA UCEC -0.207 |
hsa-miR-200b-3p | DDIT4L | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.342; TCGA BRCA -0.293; TCGA COAD -0.93; TCGA ESCA -0.335; TCGA HNSC -0.772; TCGA KIRP -0.275; TCGA LIHC -0.087; TCGA PAAD -0.223; TCGA PRAD -0.228; TCGA SARC -0.206; TCGA THCA -0.083; TCGA STAD -0.457 |
hsa-miR-200b-3p | PRKCB | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.45; TCGA BRCA -0.186; TCGA CESC -0.301; TCGA COAD -0.721; TCGA ESCA -0.283; TCGA HNSC -0.253; TCGA KIRC -0.162; TCGA KIRP -0.345; TCGA LUAD -0.14; TCGA LUSC -0.516; TCGA PAAD -0.763; TCGA THCA -0.12; TCGA STAD -0.498; TCGA UCEC -0.321 |
hsa-miR-200b-3p | ATXN1 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.237; TCGA BRCA -0.085; TCGA COAD -0.149; TCGA ESCA -0.118; TCGA HNSC -0.166; TCGA KIRC -0.141; TCGA LUAD -0.063; TCGA PAAD -0.153; TCGA STAD -0.227; TCGA UCEC -0.127 |
hsa-miR-200b-3p | COPS8 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.108; TCGA COAD -0.097; TCGA ESCA -0.082; TCGA HNSC -0.119; TCGA KIRC -0.06; TCGA KIRP -0.183; TCGA LUAD -0.073; TCGA OV -0.105; TCGA PAAD -0.095; TCGA PRAD -0.053; TCGA STAD -0.09; TCGA UCEC -0.062 |
hsa-miR-200b-3p | ADCY2 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.261; TCGA BRCA -0.158; TCGA COAD -0.844; TCGA ESCA -0.494; TCGA HNSC -0.543; TCGA KIRC -0.327; TCGA LGG -0.095; TCGA PRAD -0.093; TCGA STAD -0.621; TCGA UCEC -0.536 |
hsa-miR-200b-3p | GIT2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.068; TCGA BRCA -0.092; TCGA CESC -0.095; TCGA COAD -0.108; TCGA ESCA -0.09; TCGA HNSC -0.09; TCGA KIRC -0.31; TCGA KIRP -0.091; TCGA LUAD -0.089; TCGA LUSC -0.133; TCGA OV -0.059; TCGA PAAD -0.178; TCGA STAD -0.134; TCGA UCEC -0.107 |
hsa-miR-200b-3p | PTHLH | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; PRAD; THCA; STAD | MirTarget; TargetScan | TCGA BLCA -0.414; TCGA BRCA -0.161; TCGA CESC -0.483; TCGA COAD -0.8; TCGA ESCA -0.659; TCGA HNSC -0.231; TCGA KIRC -1.098; TCGA KIRP -0.331; TCGA PRAD -0.104; TCGA THCA -0.068; TCGA STAD -0.34 |
hsa-miR-200b-3p | DENND5A | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.211; TCGA BRCA -0.153; TCGA CESC -0.095; TCGA COAD -0.406; TCGA ESCA -0.279; TCGA HNSC -0.138; TCGA KIRC -0.193; TCGA KIRP -0.207; TCGA LGG -0.106; TCGA LUAD -0.164; TCGA LUSC -0.159; TCGA OV -0.062; TCGA PAAD -0.263; TCGA PRAD -0.054; TCGA SARC -0.083; TCGA STAD -0.335; TCGA UCEC -0.134 |
hsa-miR-200b-3p | FHL1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.627; TCGA BRCA -0.744; TCGA CESC -0.554; TCGA COAD -0.911; TCGA ESCA -0.501; TCGA HNSC -0.765; TCGA KIRC -0.256; TCGA LGG -0.079; TCGA LUAD -0.223; TCGA LUSC -0.616; TCGA OV -0.209; TCGA PAAD -0.37; TCGA PRAD -0.151; TCGA SARC -0.194; TCGA THCA -0.112; TCGA STAD -0.808; TCGA UCEC -0.701 |
hsa-miR-200b-3p | SGIP1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.271; TCGA BRCA -0.073; TCGA CESC -0.288; TCGA COAD -0.523; TCGA ESCA -0.157; TCGA HNSC -0.428; TCGA LUAD -0.103; TCGA LUSC -0.37; TCGA OV -0.23; TCGA SARC -0.268; TCGA STAD -0.268; TCGA UCEC -0.195 |
hsa-miR-200b-3p | IFIT5 | 10 cancers: BLCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.163; TCGA CESC -0.115; TCGA COAD -0.13; TCGA HNSC -0.2; TCGA LGG -0.082; TCGA LUAD -0.115; TCGA LUSC -0.202; TCGA PAAD -0.08; TCGA STAD -0.058; TCGA UCEC -0.085 |
hsa-miR-200b-3p | PHF21A | 9 cancers: BLCA; CESC; COAD; ESCA; KIRC; LGG; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.052; TCGA CESC -0.063; TCGA COAD -0.157; TCGA ESCA -0.144; TCGA KIRC -0.171; TCGA LGG -0.125; TCGA PAAD -0.078; TCGA STAD -0.207; TCGA UCEC -0.098 |
hsa-miR-200b-3p | SPAG9 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.05; TCGA BRCA -0.147; TCGA CESC -0.093; TCGA COAD -0.093; TCGA ESCA -0.059; TCGA HNSC -0.126; TCGA KIRC -0.065; TCGA KIRP -0.101; TCGA LGG -0.07; TCGA LUAD -0.062; TCGA LUSC -0.09; TCGA OV -0.06; TCGA PAAD -0.104; TCGA SARC -0.053; TCGA STAD -0.091; TCGA UCEC -0.139 |
hsa-miR-200b-3p | TFPI | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.215; TCGA BRCA -0.448; TCGA CESC -0.419; TCGA COAD -0.465; TCGA HNSC -0.213; TCGA KIRC -0.297; TCGA LIHC -0.138; TCGA LUAD -0.136; TCGA LUSC -0.362; TCGA OV -0.203; TCGA STAD -0.148; TCGA UCEC -0.374 |
hsa-miR-200b-3p | LAMC1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; SARC; STAD | MirTarget; TargetScan | TCGA BLCA -0.188; TCGA BRCA -0.29; TCGA CESC -0.168; TCGA COAD -0.268; TCGA ESCA -0.148; TCGA HNSC -0.24; TCGA KIRC -0.196; TCGA LUAD -0.105; TCGA LUSC -0.099; TCGA PAAD -0.121; TCGA SARC -0.114; TCGA STAD -0.246 |
hsa-miR-200b-3p | GPRASP2 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LIHC; OV; PAAD; UCEC | MirTarget | TCGA BLCA -0.144; TCGA BRCA -0.181; TCGA CESC -0.131; TCGA COAD -0.221; TCGA ESCA -0.196; TCGA KIRP -0.198; TCGA LIHC -0.086; TCGA OV -0.198; TCGA PAAD -0.133; TCGA UCEC -0.391 |
hsa-miR-200b-3p | ITGA1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.294; TCGA BRCA -0.316; TCGA CESC -0.268; TCGA COAD -0.275; TCGA ESCA -0.117; TCGA HNSC -0.409; TCGA KIRC -0.271; TCGA KIRP -0.466; TCGA LIHC -0.077; TCGA LUAD -0.151; TCGA LUSC -0.475; TCGA OV -0.097; TCGA PAAD -0.19; TCGA PRAD -0.106; TCGA SARC -0.289; TCGA STAD -0.339; TCGA UCEC -0.117 |
hsa-miR-200b-3p | TRIM23 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.072; TCGA BRCA -0.112; TCGA CESC -0.079; TCGA COAD -0.125; TCGA ESCA -0.145; TCGA HNSC -0.144; TCGA KIRC -0.064; TCGA KIRP -0.263; TCGA LGG -0.091; TCGA LIHC -0.079; TCGA LUAD -0.056; TCGA LUSC -0.135; TCGA OV -0.129; TCGA PAAD -0.114; TCGA STAD -0.173; TCGA UCEC -0.176 |
hsa-miR-200b-3p | NALCN | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.117; TCGA BRCA -0.154; TCGA CESC -0.328; TCGA COAD -0.95; TCGA ESCA -0.302; TCGA HNSC -0.366; TCGA KIRP -0.428; TCGA LGG -0.13; TCGA LUSC -0.515; TCGA STAD -0.364; TCGA UCEC -0.292 |
hsa-miR-200b-3p | ELL2 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.161; TCGA BRCA -0.112; TCGA CESC -0.183; TCGA COAD -0.141; TCGA ESCA -0.207; TCGA HNSC -0.17; TCGA KIRC -0.193; TCGA KIRP -0.164; TCGA LIHC -0.111; TCGA LUAD -0.071; TCGA OV -0.126; TCGA PAAD -0.128; TCGA PRAD -0.063; TCGA SARC -0.112; TCGA STAD -0.207; TCGA UCEC -0.083 |
hsa-miR-200b-3p | CUTC | 11 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.08; TCGA BRCA -0.14; TCGA HNSC -0.129; TCGA KIRC -0.066; TCGA KIRP -0.101; TCGA LUAD -0.061; TCGA OV -0.072; TCGA PAAD -0.128; TCGA PRAD -0.065; TCGA STAD -0.092; TCGA UCEC -0.053 |
hsa-miR-200b-3p | RNF38 | 10 cancers: BLCA; BRCA; CESC; ESCA; LGG; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.051; TCGA BRCA -0.052; TCGA CESC -0.051; TCGA ESCA -0.054; TCGA LGG -0.07; TCGA LUSC -0.126; TCGA PAAD -0.08; TCGA SARC -0.118; TCGA STAD -0.164; TCGA UCEC -0.164 |
hsa-miR-200b-3p | MRVI1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.325; TCGA BRCA -0.293; TCGA CESC -0.354; TCGA COAD -0.699; TCGA ESCA -0.359; TCGA HNSC -0.304; TCGA KIRP -0.447; TCGA LUAD -0.094; TCGA LUSC -0.424; TCGA PAAD -0.186; TCGA PRAD -0.09; TCGA SARC -0.44; TCGA STAD -0.568; TCGA UCEC -0.443 |
hsa-miR-200b-3p | CORO1C | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.292; TCGA BRCA -0.168; TCGA CESC -0.142; TCGA COAD -0.153; TCGA ESCA -0.181; TCGA HNSC -0.087; TCGA KIRC -0.294; TCGA KIRP -0.247; TCGA LGG -0.192; TCGA LUAD -0.276; TCGA LUSC -0.085; TCGA PAAD -0.138; TCGA PRAD -0.106; TCGA SARC -0.119; TCGA STAD -0.205; TCGA UCEC -0.175 |
hsa-miR-200b-3p | CACNA1C | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; OV; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.302; TCGA BRCA -0.118; TCGA CESC -0.334; TCGA COAD -0.292; TCGA ESCA -0.217; TCGA HNSC -0.403; TCGA KIRC -0.238; TCGA KIRP -0.418; TCGA LUSC -0.407; TCGA OV -0.205; TCGA SARC -0.153; TCGA STAD -0.534; TCGA UCEC -0.43 |
hsa-miR-200b-3p | DENND5B | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan; mirMAP | TCGA BLCA -0.338; TCGA BRCA -0.214; TCGA CESC -0.269; TCGA COAD -0.296; TCGA HNSC -0.374; TCGA KIRC -0.124; TCGA KIRP -0.333; TCGA LGG -0.123; TCGA LIHC -0.066; TCGA LUAD -0.119; TCGA LUSC -0.27; TCGA OV -0.091; TCGA PAAD -0.17; TCGA STAD -0.061; TCGA UCEC -0.25 |
hsa-miR-200b-3p | RELN | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.487; TCGA BRCA -0.657; TCGA COAD -1.167; TCGA ESCA -0.769; TCGA HNSC -0.471; TCGA LUAD -0.233; TCGA LUSC -0.556; TCGA PAAD -0.428; TCGA PRAD -0.24; TCGA STAD -0.635; TCGA UCEC -0.501 |
hsa-miR-200b-3p | PHLDB1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.162; TCGA BRCA -0.234; TCGA CESC -0.15; TCGA COAD -0.157; TCGA ESCA -0.123; TCGA HNSC -0.441; TCGA LUSC -0.268; TCGA OV -0.076; TCGA PAAD -0.155; TCGA STAD -0.243; TCGA UCEC -0.109 |
hsa-miR-200b-3p | ULK2 | 9 cancers: BLCA; COAD; ESCA; HNSC; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.054; TCGA COAD -0.206; TCGA ESCA -0.221; TCGA HNSC -0.058; TCGA LUSC -0.103; TCGA PAAD -0.171; TCGA SARC -0.069; TCGA STAD -0.232; TCGA UCEC -0.106 |
hsa-miR-200b-3p | KIAA1462 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.313; TCGA BRCA -0.3; TCGA CESC -0.307; TCGA COAD -0.692; TCGA ESCA -0.138; TCGA HNSC -0.463; TCGA KIRC -0.255; TCGA KIRP -0.336; TCGA LGG -0.074; TCGA LUAD -0.236; TCGA LUSC -0.583; TCGA OV -0.231; TCGA PAAD -0.212; TCGA PRAD -0.071; TCGA SARC -0.068; TCGA STAD -0.233; TCGA UCEC -0.481 |
hsa-miR-200b-3p | ENTPD1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; mirMAP | TCGA BLCA -0.198; TCGA BRCA -0.073; TCGA CESC -0.161; TCGA COAD -0.36; TCGA ESCA -0.099; TCGA HNSC -0.172; TCGA KIRC -0.219; TCGA LUAD -0.152; TCGA LUSC -0.256; TCGA OV -0.065; TCGA PAAD -0.259; TCGA PRAD -0.088; TCGA SARC -0.123; TCGA STAD -0.168; TCGA UCEC -0.18 |
hsa-miR-200b-3p | CDK17 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.097; TCGA CESC -0.185; TCGA COAD -0.16; TCGA ESCA -0.175; TCGA HNSC -0.106; TCGA KIRC -0.204; TCGA KIRP -0.07; TCGA LUAD -0.136; TCGA LUSC -0.066; TCGA PAAD -0.142; TCGA SARC -0.067; TCGA STAD -0.122; TCGA UCEC -0.17 |
hsa-miR-200b-3p | HS3ST3A1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; STAD | MirTarget; TargetScan | TCGA BLCA -0.541; TCGA CESC -0.324; TCGA COAD -0.555; TCGA ESCA -0.426; TCGA HNSC -0.366; TCGA KIRP -0.507; TCGA LUAD -0.364; TCGA PAAD -0.176; TCGA STAD -0.282 |
hsa-miR-200b-3p | LPAR1 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; OV; PAAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.188; TCGA BRCA -0.308; TCGA COAD -0.389; TCGA ESCA -0.286; TCGA HNSC -0.222; TCGA OV -0.162; TCGA PAAD -0.452; TCGA SARC -0.09; TCGA STAD -0.352; TCGA UCEC -0.131 |
hsa-miR-200b-3p | FSCN1 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; OV; PRAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.083; TCGA CESC -0.537; TCGA COAD -0.392; TCGA ESCA -0.376; TCGA HNSC -0.223; TCGA KIRC -0.436; TCGA LUAD -0.277; TCGA OV -0.137; TCGA PRAD -0.096; TCGA UCEC -0.131 |
hsa-miR-200b-3p | ACTC1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -1.071; TCGA BRCA -0.359; TCGA CESC -0.509; TCGA COAD -1.418; TCGA ESCA -0.422; TCGA HNSC -1.611; TCGA KIRP -0.968; TCGA LUSC -0.264; TCGA OV -0.489; TCGA PAAD -0.478; TCGA PRAD -0.217; TCGA SARC -0.472; TCGA STAD -0.661; TCGA UCEC -0.405 |
hsa-miR-200b-3p | SYNC | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.226; TCGA CESC -0.294; TCGA COAD -0.88; TCGA ESCA -0.507; TCGA HNSC -0.437; TCGA LUSC -0.375; TCGA OV -0.172; TCGA PAAD -0.275; TCGA PRAD -0.126; TCGA STAD -0.163; TCGA UCEC -0.136 |
hsa-miR-200b-3p | PICALM | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; LUSC; PAAD; UCEC | MirTarget | TCGA BLCA -0.057; TCGA BRCA -0.13; TCGA CESC -0.165; TCGA COAD -0.069; TCGA HNSC -0.137; TCGA LUAD -0.112; TCGA LUSC -0.102; TCGA PAAD -0.066; TCGA UCEC -0.074 |
hsa-miR-200b-3p | ARHGAP20 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.415; TCGA BRCA -0.588; TCGA CESC -0.44; TCGA COAD -0.741; TCGA ESCA -0.426; TCGA HNSC -0.225; TCGA KIRC -0.209; TCGA KIRP -0.427; TCGA LUAD -0.167; TCGA LUSC -0.34; TCGA PAAD -0.385; TCGA SARC -0.348; TCGA STAD -0.525; TCGA UCEC -0.59 |
hsa-miR-200b-3p | MSN | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.402; TCGA BRCA -0.169; TCGA CESC -0.521; TCGA COAD -0.5; TCGA ESCA -0.376; TCGA HNSC -0.312; TCGA KIRC -0.134; TCGA KIRP -0.224; TCGA LUAD -0.181; TCGA LUSC -0.254; TCGA PAAD -0.284; TCGA PRAD -0.073; TCGA SARC -0.136; TCGA STAD -0.25; TCGA UCEC -0.147 |
hsa-miR-200b-3p | MAP2 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUSC; OV; PRAD; STAD | MirTarget; TargetScan | TCGA BLCA -0.229; TCGA BRCA -0.128; TCGA COAD -0.682; TCGA ESCA -0.179; TCGA HNSC -0.221; TCGA KIRP -0.234; TCGA LGG -0.253; TCGA LIHC -0.122; TCGA LUSC -0.237; TCGA OV -0.253; TCGA PRAD -0.226; TCGA STAD -0.331 |
hsa-miR-200b-3p | DIXDC1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.407; TCGA BRCA -0.225; TCGA CESC -0.191; TCGA COAD -0.377; TCGA ESCA -0.215; TCGA HNSC -0.27; TCGA LUAD -0.06; TCGA LUSC -0.329; TCGA OV -0.11; TCGA PAAD -0.145; TCGA PRAD -0.08; TCGA SARC -0.115; TCGA STAD -0.485; TCGA UCEC -0.365 |
hsa-miR-200b-3p | RBM20 | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LIHC; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.154; TCGA BRCA -0.15; TCGA COAD -0.52; TCGA ESCA -0.196; TCGA KIRC -0.227; TCGA KIRP -0.33; TCGA LIHC -0.144; TCGA PAAD -0.223; TCGA STAD -0.592; TCGA UCEC -0.298 |
hsa-miR-200b-3p | NOG | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUSC; OV; STAD | MirTarget; TargetScan | TCGA BLCA -0.308; TCGA BRCA -0.25; TCGA CESC -0.209; TCGA ESCA -0.536; TCGA HNSC -0.798; TCGA KIRC -0.606; TCGA LGG -0.536; TCGA LUSC -0.469; TCGA OV -0.214; TCGA STAD -0.477 |
hsa-miR-200b-3p | GJC1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.253; TCGA BRCA -0.176; TCGA CESC -0.282; TCGA COAD -0.567; TCGA ESCA -0.281; TCGA HNSC -0.379; TCGA KIRC -0.643; TCGA KIRP -0.454; TCGA LUAD -0.215; TCGA LUSC -0.146; TCGA OV -0.187; TCGA PAAD -0.257; TCGA PRAD -0.12; TCGA SARC -0.155; TCGA STAD -0.471; TCGA UCEC -0.454 |
hsa-miR-200b-3p | FOXF1 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; OV; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.211; TCGA BRCA -0.145; TCGA COAD -0.384; TCGA ESCA -0.183; TCGA HNSC -0.115; TCGA KIRC -0.3; TCGA KIRP -0.21; TCGA LUSC -0.386; TCGA OV -0.107; TCGA PRAD -0.068; TCGA STAD -0.474; TCGA UCEC -0.16 |
hsa-miR-200b-3p | PHEX | 9 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LUAD; SARC; UCEC | MirTarget | TCGA BLCA -0.173; TCGA BRCA -0.1; TCGA CESC -0.263; TCGA ESCA -0.377; TCGA KIRC -0.306; TCGA KIRP -0.645; TCGA LUAD -0.205; TCGA SARC -0.287; TCGA UCEC -0.152 |
hsa-miR-200b-3p | FRMD4A | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; STAD | MirTarget; TargetScan | TCGA BLCA -0.111; TCGA BRCA -0.167; TCGA CESC -0.107; TCGA COAD -0.203; TCGA ESCA -0.167; TCGA HNSC -0.149; TCGA LGG -0.116; TCGA LUAD -0.181; TCGA LUSC -0.217; TCGA PAAD -0.312; TCGA STAD -0.242 |
hsa-miR-200b-3p | PCDH10 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.324; TCGA BRCA -0.262; TCGA CESC -0.228; TCGA ESCA -0.653; TCGA HNSC -0.411; TCGA LUAD -0.221; TCGA LUSC -0.262; TCGA OV -0.271; TCGA PAAD -0.188; TCGA STAD -1.084; TCGA UCEC -0.395 |
hsa-miR-200b-3p | SIRPA | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.389; TCGA BRCA -0.218; TCGA CESC -0.461; TCGA COAD -0.455; TCGA ESCA -0.295; TCGA HNSC -0.438; TCGA KIRC -0.317; TCGA KIRP -0.256; TCGA LUAD -0.324; TCGA LUSC -0.447; TCGA PAAD -0.294; TCGA STAD -0.065; TCGA UCEC -0.165 |
hsa-miR-200b-3p | ZNF532 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.167; TCGA BRCA -0.117; TCGA CESC -0.195; TCGA COAD -0.478; TCGA ESCA -0.238; TCGA HNSC -0.127; TCGA KIRC -0.249; TCGA LUAD -0.077; TCGA OV -0.067; TCGA PAAD -0.225; TCGA PRAD -0.088; TCGA STAD -0.242; TCGA UCEC -0.146 |
hsa-miR-200b-3p | MPRIP | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.08; TCGA BRCA -0.134; TCGA CESC -0.134; TCGA COAD -0.11; TCGA HNSC -0.155; TCGA KIRC -0.086; TCGA LUSC -0.171; TCGA OV -0.082; TCGA PAAD -0.079; TCGA PRAD -0.051; TCGA SARC -0.111; TCGA STAD -0.099; TCGA UCEC -0.164 |
hsa-miR-200b-3p | ARHGAP28 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.102; TCGA BRCA -0.368; TCGA CESC -0.273; TCGA COAD -0.29; TCGA ESCA -0.263; TCGA HNSC -0.467; TCGA KIRP -0.328; TCGA LGG -0.317; TCGA LUAD -0.208; TCGA OV -0.281; TCGA PAAD -0.51; TCGA PRAD -0.157; TCGA THCA -0.056; TCGA STAD -0.211; TCGA UCEC -0.246 |
hsa-miR-200b-3p | ST3GAL2 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.182; TCGA BRCA -0.153; TCGA CESC -0.198; TCGA COAD -0.141; TCGA HNSC -0.392; TCGA KIRC -0.197; TCGA KIRP -0.269; TCGA LUAD -0.213; TCGA LUSC -0.279; TCGA OV -0.097; TCGA PAAD -0.148; TCGA STAD -0.143; TCGA UCEC -0.19 |
hsa-miR-200b-3p | PSIP1 | 10 cancers: BLCA; BRCA; ESCA; LGG; LUAD; OV; PAAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.146; TCGA BRCA -0.066; TCGA ESCA -0.082; TCGA LGG -0.077; TCGA LUAD -0.082; TCGA OV -0.112; TCGA PAAD -0.213; TCGA SARC -0.053; TCGA STAD -0.134; TCGA UCEC -0.129 |
hsa-miR-200b-3p | JAZF1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.381; TCGA BRCA -0.217; TCGA CESC -0.319; TCGA COAD -0.535; TCGA ESCA -0.226; TCGA HNSC -0.333; TCGA KIRC -0.269; TCGA KIRP -0.199; TCGA LIHC -0.081; TCGA LUAD -0.083; TCGA LUSC -0.285; TCGA PAAD -0.168; TCGA PRAD -0.089; TCGA STAD -0.294; TCGA UCEC -0.245 |
hsa-miR-200b-3p | ASAP1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.154; TCGA BRCA -0.112; TCGA CESC -0.159; TCGA COAD -0.223; TCGA ESCA -0.187; TCGA HNSC -0.123; TCGA KIRC -0.305; TCGA KIRP -0.384; TCGA LUAD -0.223; TCGA LUSC -0.069; TCGA PAAD -0.206; TCGA PRAD -0.075; TCGA SARC -0.071; TCGA STAD -0.098; TCGA UCEC -0.128 |
hsa-miR-200b-3p | KCTD15 | 12 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LUAD; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.221; TCGA CESC -0.217; TCGA COAD -0.367; TCGA ESCA -0.342; TCGA KIRC -0.174; TCGA KIRP -0.529; TCGA LGG -0.056; TCGA LUAD -0.094; TCGA OV -0.118; TCGA PAAD -0.114; TCGA STAD -0.329; TCGA UCEC -0.322 |
hsa-miR-200b-3p | MPDZ | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.135; TCGA BRCA -0.227; TCGA CESC -0.349; TCGA COAD -0.791; TCGA ESCA -0.381; TCGA HNSC -0.351; TCGA KIRP -0.183; TCGA LIHC -0.228; TCGA LUAD -0.1; TCGA LUSC -0.287; TCGA OV -0.178; TCGA PAAD -0.313; TCGA SARC -0.104; TCGA STAD -0.522; TCGA UCEC -0.217 |
hsa-miR-200b-3p | WWC3 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.163; TCGA CESC -0.129; TCGA COAD -0.145; TCGA ESCA -0.236; TCGA HNSC -0.074; TCGA KIRC -0.186; TCGA KIRP -0.147; TCGA LUSC -0.178; TCGA PAAD -0.125; TCGA STAD -0.293; TCGA UCEC -0.154 |
hsa-miR-200b-3p | NAP1L5 | 12 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.063; TCGA BRCA -0.103; TCGA COAD -0.191; TCGA ESCA -0.201; TCGA KIRP -0.166; TCGA LGG -0.076; TCGA LUAD -0.072; TCGA LUSC -0.133; TCGA OV -0.143; TCGA PAAD -0.153; TCGA STAD -0.381; TCGA UCEC -0.201 |
hsa-miR-200b-3p | CHRDL1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.751; TCGA BRCA -0.738; TCGA CESC -0.603; TCGA COAD -1.796; TCGA ESCA -0.828; TCGA HNSC -0.455; TCGA KIRP -0.788; TCGA LUSC -0.83; TCGA OV -0.382; TCGA PAAD -0.858; TCGA PRAD -0.134; TCGA SARC -0.303; TCGA STAD -1.012; TCGA UCEC -0.844 |
hsa-miR-200b-3p | ZMAT3 | 9 cancers: BLCA; BRCA; COAD; KIRP; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.082; TCGA BRCA -0.199; TCGA COAD -0.153; TCGA KIRP -0.137; TCGA LUSC -0.096; TCGA PAAD -0.173; TCGA PRAD -0.099; TCGA STAD -0.089; TCGA UCEC -0.076 |
hsa-miR-200b-3p | CFL2 | 18 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.42; TCGA BRCA -0.298; TCGA CESC -0.19; TCGA COAD -0.68; TCGA ESCA -0.369; TCGA HNSC -0.497; TCGA KIRC -0.101; TCGA KIRP -0.393; TCGA LIHC -0.149; TCGA LUAD -0.295; TCGA LUSC -0.347; TCGA OV -0.133; TCGA PAAD -0.258; TCGA PRAD -0.167; TCGA SARC -0.224; TCGA THCA -0.08; TCGA STAD -0.612; TCGA UCEC -0.335 |
hsa-miR-200b-3p | FLI1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.298; TCGA BRCA -0.29; TCGA CESC -0.436; TCGA COAD -0.495; TCGA ESCA -0.216; TCGA HNSC -0.377; TCGA KIRC -0.334; TCGA KIRP -0.255; TCGA LUAD -0.206; TCGA LUSC -0.549; TCGA OV -0.102; TCGA PAAD -0.493; TCGA PRAD -0.067; TCGA STAD -0.167; TCGA UCEC -0.297 |
hsa-miR-200b-3p | DOCK4 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.168; TCGA BRCA -0.206; TCGA CESC -0.327; TCGA COAD -0.375; TCGA ESCA -0.108; TCGA HNSC -0.26; TCGA KIRC -0.217; TCGA KIRP -0.164; TCGA LUAD -0.159; TCGA LUSC -0.333; TCGA PAAD -0.205; TCGA STAD -0.123; TCGA UCEC -0.274 |
hsa-miR-200b-3p | GREM1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.579; TCGA BRCA -0.088; TCGA CESC -0.395; TCGA COAD -1.242; TCGA ESCA -0.584; TCGA HNSC -0.454; TCGA KIRP -0.824; TCGA LUAD -0.415; TCGA LUSC -0.221; TCGA PAAD -0.389; TCGA STAD -0.48; TCGA UCEC -0.328 |
hsa-miR-200b-3p | MARCH8 | 11 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LIHC; LUSC; PAAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.111; TCGA BRCA -0.151; TCGA HNSC -0.1; TCGA KIRP -0.256; TCGA LGG -0.212; TCGA LIHC -0.077; TCGA LUSC -0.236; TCGA PAAD -0.118; TCGA SARC -0.119; TCGA STAD -0.139; TCGA UCEC -0.196 |
hsa-miR-200b-3p | BCAP29 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.078; TCGA BRCA -0.082; TCGA COAD -0.063; TCGA ESCA -0.084; TCGA HNSC -0.088; TCGA KIRC -0.126; TCGA LUAD -0.131; TCGA LUSC -0.094; TCGA THCA -0.053; TCGA STAD -0.091; TCGA UCEC -0.133 |
hsa-miR-200b-3p | TFEC | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; SARC | MirTarget | TCGA BLCA -0.388; TCGA BRCA -0.062; TCGA CESC -0.306; TCGA COAD -0.469; TCGA ESCA -0.249; TCGA HNSC -0.371; TCGA KIRC -0.304; TCGA LUAD -0.349; TCGA LUSC -0.595; TCGA PAAD -0.526; TCGA SARC -0.119 |
hsa-miR-200b-3p | LRRC8A | 11 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; OV; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.096; TCGA CESC -0.099; TCGA COAD -0.11; TCGA ESCA -0.096; TCGA KIRC -0.177; TCGA KIRP -0.103; TCGA LGG -0.152; TCGA OV -0.071; TCGA SARC -0.059; TCGA STAD -0.053; TCGA UCEC -0.076 |
hsa-miR-200b-3p | HIPK3 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.177; TCGA BRCA -0.255; TCGA COAD -0.164; TCGA ESCA -0.087; TCGA HNSC -0.236; TCGA LUAD -0.069; TCGA LUSC -0.147; TCGA SARC -0.18; TCGA STAD -0.205; TCGA UCEC -0.188 |
hsa-miR-200b-3p | NEK9 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BLCA -0.074; TCGA BRCA -0.093; TCGA CESC -0.064; TCGA COAD -0.092; TCGA ESCA -0.112; TCGA HNSC -0.065; TCGA PAAD -0.071; TCGA STAD -0.155; TCGA UCEC -0.175 |
hsa-miR-200b-3p | DCBLD2 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; PAAD; SARC; STAD | MirTarget; TargetScan | TCGA BLCA -0.29; TCGA BRCA -0.163; TCGA COAD -0.449; TCGA ESCA -0.434; TCGA HNSC -0.196; TCGA LUAD -0.221; TCGA PAAD -0.214; TCGA SARC -0.064; TCGA STAD -0.315 |
hsa-miR-200b-3p | TCP11L1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.249; TCGA BRCA -0.088; TCGA CESC -0.22; TCGA COAD -0.168; TCGA ESCA -0.16; TCGA HNSC -0.218; TCGA KIRC -0.209; TCGA KIRP -0.235; TCGA LGG -0.051; TCGA LUAD -0.105; TCGA PAAD -0.11; TCGA STAD -0.199; TCGA UCEC -0.136 |
hsa-miR-200b-3p | ABCA1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; STAD | TargetScan | TCGA BLCA -0.117; TCGA BRCA -0.284; TCGA CESC -0.271; TCGA COAD -0.281; TCGA ESCA -0.258; TCGA HNSC -0.26; TCGA KIRC -0.365; TCGA KIRP -0.195; TCGA LUAD -0.175; TCGA LUSC -0.099; TCGA PAAD -0.193; TCGA STAD -0.164 |
hsa-miR-200b-3p | ADAMTS3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.384; TCGA BRCA -0.358; TCGA CESC -0.494; TCGA COAD -0.593; TCGA ESCA -0.242; TCGA HNSC -0.336; TCGA LUAD -0.301; TCGA LUSC -0.264; TCGA OV -0.291; TCGA PAAD -0.552; TCGA THCA -0.069; TCGA STAD -0.181; TCGA UCEC -0.308 |
hsa-miR-200b-3p | ADCY9 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.257; TCGA CESC -0.132; TCGA COAD -0.087; TCGA ESCA -0.134; TCGA HNSC -0.159; TCGA KIRP -0.101; TCGA LUSC -0.172; TCGA PRAD -0.078; TCGA SARC -0.118; TCGA STAD -0.214; TCGA UCEC -0.293 |
hsa-miR-200b-3p | AHNAK | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.2; TCGA BRCA -0.264; TCGA CESC -0.196; TCGA COAD -0.21; TCGA ESCA -0.154; TCGA HNSC -0.155; TCGA LUAD -0.183; TCGA LUSC -0.189; TCGA SARC -0.068; TCGA STAD -0.316; TCGA UCEC -0.253 |
hsa-miR-200b-3p | AKAP2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; SARC; UCEC | TargetScan | TCGA BLCA -0.541; TCGA BRCA -0.405; TCGA CESC -0.537; TCGA COAD -0.5; TCGA ESCA -0.174; TCGA HNSC -0.651; TCGA KIRP -0.423; TCGA LUAD -0.346; TCGA LUSC -0.763; TCGA OV -0.1; TCGA PAAD -0.362; TCGA SARC -0.271; TCGA UCEC -0.487 |
hsa-miR-200b-3p | ANKH | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.278; TCGA BRCA -0.127; TCGA CESC -0.283; TCGA ESCA -0.094; TCGA HNSC -0.186; TCGA KIRC -0.14; TCGA KIRP -0.206; TCGA LUAD -0.08; TCGA PAAD -0.092; TCGA SARC -0.086; TCGA STAD -0.065; TCGA UCEC -0.085 |
hsa-miR-200b-3p | ANO5 | 10 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUSC; OV; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.161; TCGA BRCA -0.373; TCGA COAD -0.731; TCGA HNSC -0.653; TCGA LIHC -0.133; TCGA LUSC -0.449; TCGA OV -0.277; TCGA THCA -0.101; TCGA STAD -0.49; TCGA UCEC -0.373 |
hsa-miR-200b-3p | ARHGEF17 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.195; TCGA CESC -0.144; TCGA COAD -0.501; TCGA ESCA -0.205; TCGA HNSC -0.229; TCGA KIRC -0.121; TCGA LGG -0.083; TCGA LUSC -0.283; TCGA PAAD -0.146; TCGA SARC -0.079; TCGA STAD -0.337; TCGA UCEC -0.156 |
hsa-miR-200b-3p | ARL2BP | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.088; TCGA BRCA -0.09; TCGA CESC -0.148; TCGA COAD -0.073; TCGA ESCA -0.132; TCGA HNSC -0.076; TCGA KIRC -0.091; TCGA KIRP -0.123; TCGA LUAD -0.056; TCGA LUSC -0.096; TCGA PAAD -0.1; TCGA STAD -0.112; TCGA UCEC -0.096 |
hsa-miR-200b-3p | BACH2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; OV; PAAD; STAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.471; TCGA BRCA -0.279; TCGA CESC -0.198; TCGA COAD -0.747; TCGA ESCA -0.392; TCGA HNSC -0.271; TCGA KIRP -0.617; TCGA LGG -0.111; TCGA LUAD -0.181; TCGA OV -0.273; TCGA PAAD -0.528; TCGA STAD -0.276; TCGA UCEC -0.381 |
hsa-miR-200b-3p | BASP1 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; OV; PAAD; PRAD; STAD | TargetScan | TCGA BLCA -0.184; TCGA CESC -0.727; TCGA COAD -0.645; TCGA ESCA -0.396; TCGA HNSC -0.544; TCGA KIRC -0.204; TCGA KIRP -0.176; TCGA LGG -0.153; TCGA LUSC -0.138; TCGA OV -0.152; TCGA PAAD -0.433; TCGA PRAD -0.06; TCGA STAD -0.082 |
hsa-miR-200b-3p | BICC1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.45; TCGA BRCA -0.437; TCGA CESC -0.471; TCGA COAD -0.771; TCGA ESCA -0.323; TCGA HNSC -0.686; TCGA LUAD -0.234; TCGA LUSC -0.65; TCGA OV -0.169; TCGA PAAD -0.29; TCGA STAD -0.292; TCGA UCEC -0.267 |
hsa-miR-200b-3p | BICD2 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.083; TCGA BRCA -0.083; TCGA CESC -0.258; TCGA COAD -0.113; TCGA ESCA -0.283; TCGA LUAD -0.073; TCGA OV -0.07; TCGA PAAD -0.209; TCGA STAD -0.169; TCGA UCEC -0.1 |
hsa-miR-200b-3p | BRMS1L | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LGG; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.113; TCGA BRCA -0.063; TCGA COAD -0.118; TCGA ESCA -0.11; TCGA KIRP -0.094; TCGA LGG -0.118; TCGA PAAD -0.083; TCGA PRAD -0.057; TCGA STAD -0.096; TCGA UCEC -0.128 |
hsa-miR-200b-3p | CACNA2D1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.558; TCGA BRCA -0.611; TCGA CESC -0.311; TCGA COAD -1.301; TCGA ESCA -0.317; TCGA HNSC -0.271; TCGA KIRP -0.513; TCGA LGG -0.217; TCGA LUAD -0.422; TCGA LUSC -0.278; TCGA OV -0.419; TCGA PAAD -0.411; TCGA SARC -0.172; TCGA STAD -0.427; TCGA UCEC -0.584 |
hsa-miR-200b-3p | CDC42EP3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.232; TCGA BRCA -0.144; TCGA CESC -0.273; TCGA COAD -0.316; TCGA ESCA -0.318; TCGA HNSC -0.376; TCGA LUAD -0.086; TCGA LUSC -0.249; TCGA OV -0.068; TCGA PAAD -0.099; TCGA PRAD -0.071; TCGA SARC -0.117; TCGA STAD -0.373; TCGA UCEC -0.275 |
hsa-miR-200b-3p | CDH11 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.329; TCGA BRCA -0.094; TCGA CESC -0.37; TCGA COAD -0.591; TCGA ESCA -0.275; TCGA HNSC -0.558; TCGA KIRC -0.426; TCGA KIRP -0.527; TCGA LUAD -0.243; TCGA LUSC -0.405; TCGA PAAD -0.351; TCGA STAD -0.202; TCGA UCEC -0.273 |
hsa-miR-200b-3p | CELF2 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; PRAD; STAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.444; TCGA BRCA -0.381; TCGA CESC -0.262; TCGA ESCA -0.386; TCGA HNSC -0.295; TCGA KIRC -0.156; TCGA LGG -0.078; TCGA LUSC -0.533; TCGA PAAD -0.58; TCGA PRAD -0.104; TCGA STAD -0.432; TCGA UCEC -0.304 |
hsa-miR-200b-3p | CHSY1 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; UCEC | TargetScan | TCGA BLCA -0.106; TCGA CESC -0.173; TCGA COAD -0.222; TCGA ESCA -0.109; TCGA HNSC -0.226; TCGA KIRC -0.198; TCGA LUAD -0.119; TCGA LUSC -0.061; TCGA OV -0.11; TCGA PAAD -0.242; TCGA UCEC -0.09 |
hsa-miR-200b-3p | CHSY3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; UCEC | TargetScan | TCGA BLCA -0.313; TCGA BRCA -0.2; TCGA CESC -0.298; TCGA COAD -0.582; TCGA ESCA -0.17; TCGA HNSC -0.362; TCGA KIRC -0.686; TCGA KIRP -0.442; TCGA LIHC -0.058; TCGA LUAD -0.243; TCGA LUSC -0.253; TCGA OV -0.191; TCGA PAAD -0.295; TCGA UCEC -0.252 |
hsa-miR-200b-3p | CLIP1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.066; TCGA BRCA -0.067; TCGA CESC -0.168; TCGA COAD -0.147; TCGA ESCA -0.167; TCGA HNSC -0.08; TCGA LUAD -0.106; TCGA PRAD -0.051; TCGA SARC -0.135; TCGA STAD -0.196; TCGA UCEC -0.078 |
hsa-miR-200b-3p | CNTFR | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.286; TCGA BRCA -0.555; TCGA CESC -0.445; TCGA COAD -0.595; TCGA ESCA -0.379; TCGA HNSC -0.224; TCGA KIRP -0.363; TCGA LGG -0.194; TCGA OV -0.344; TCGA PAAD -0.611; TCGA PRAD -0.132; TCGA THCA -0.185; TCGA STAD -0.487; TCGA UCEC -0.507 |
hsa-miR-200b-3p | CNTN4 | 10 cancers: BLCA; BRCA; COAD; HNSC; LGG; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.101; TCGA BRCA -0.263; TCGA COAD -0.689; TCGA HNSC -0.358; TCGA LGG -0.139; TCGA LUSC -0.421; TCGA OV -0.289; TCGA PAAD -0.195; TCGA STAD -0.278; TCGA UCEC -0.404 |
hsa-miR-200b-3p | COL4A3 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.192; TCGA BRCA -0.138; TCGA CESC -0.224; TCGA ESCA -0.239; TCGA HNSC -0.272; TCGA LGG -0.154; TCGA LUSC -0.582; TCGA PAAD -0.551; TCGA STAD -0.329; TCGA UCEC -0.279 |
hsa-miR-200b-3p | CREB5 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; STAD | TargetScan | TCGA BLCA -0.435; TCGA BRCA -0.364; TCGA COAD -0.361; TCGA ESCA -0.187; TCGA HNSC -0.324; TCGA KIRC -0.261; TCGA LUAD -0.117; TCGA PAAD -0.201; TCGA STAD -0.278 |
hsa-miR-200b-3p | CRTAP | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.188; TCGA BRCA -0.23; TCGA CESC -0.186; TCGA COAD -0.118; TCGA ESCA -0.163; TCGA HNSC -0.181; TCGA KIRC -0.108; TCGA KIRP -0.26; TCGA LIHC -0.069; TCGA LUAD -0.162; TCGA LUSC -0.195; TCGA OV -0.067; TCGA PAAD -0.175; TCGA PRAD -0.068; TCGA SARC -0.082; TCGA STAD -0.253; TCGA UCEC -0.188 |
hsa-miR-200b-3p | CYP1B1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.424; TCGA BRCA -0.17; TCGA CESC -0.327; TCGA COAD -1.058; TCGA ESCA -0.579; TCGA HNSC -0.359; TCGA KIRP -0.457; TCGA LUAD -0.314; TCGA LUSC -0.504; TCGA OV -0.147; TCGA PAAD -0.582; TCGA PRAD -0.142; TCGA SARC -0.224; TCGA STAD -0.626; TCGA UCEC -0.508 |
hsa-miR-200b-3p | DACT1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.366; TCGA BRCA -0.171; TCGA CESC -0.316; TCGA COAD -0.456; TCGA ESCA -0.159; TCGA HNSC -0.748; TCGA LUAD -0.204; TCGA LUSC -0.528; TCGA OV -0.209; TCGA PAAD -0.175; TCGA THCA -0.062; TCGA STAD -0.196; TCGA UCEC -0.301 |
hsa-miR-200b-3p | DCUN1D3 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; UCEC | TargetScan | TCGA BLCA -0.072; TCGA BRCA -0.181; TCGA CESC -0.114; TCGA COAD -0.112; TCGA HNSC -0.098; TCGA KIRC -0.131; TCGA KIRP -0.113; TCGA LGG -0.072; TCGA LUAD -0.118; TCGA LUSC -0.203; TCGA PAAD -0.085; TCGA UCEC -0.06 |
hsa-miR-200b-3p | DLC1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.153; TCGA BRCA -0.353; TCGA CESC -0.275; TCGA COAD -0.451; TCGA ESCA -0.135; TCGA HNSC -0.461; TCGA KIRC -0.106; TCGA LUSC -0.66; TCGA OV -0.132; TCGA PAAD -0.32; TCGA PRAD -0.125; TCGA STAD -0.322; TCGA UCEC -0.233 |
hsa-miR-200b-3p | DMD | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; OV; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.414; TCGA BRCA -0.51; TCGA CESC -0.463; TCGA COAD -0.536; TCGA ESCA -0.259; TCGA HNSC -0.314; TCGA KIRC -0.081; TCGA LIHC -0.106; TCGA OV -0.124; TCGA PAAD -0.16; TCGA SARC -0.234; TCGA STAD -0.602; TCGA UCEC -0.356 |
hsa-miR-200b-3p | DNAJB5 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.463; TCGA BRCA -0.162; TCGA CESC -0.346; TCGA COAD -0.834; TCGA ESCA -0.502; TCGA HNSC -0.406; TCGA KIRC -0.13; TCGA KIRP -0.14; TCGA LGG -0.109; TCGA LUAD -0.183; TCGA LUSC -0.127; TCGA OV -0.113; TCGA PAAD -0.322; TCGA PRAD -0.097; TCGA SARC -0.169; TCGA STAD -0.684; TCGA UCEC -0.249 |
hsa-miR-200b-3p | DNAJB9 | 10 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; UCEC | TargetScan | TCGA BLCA -0.08; TCGA BRCA -0.056; TCGA COAD -0.087; TCGA KIRC -0.078; TCGA KIRP -0.105; TCGA LIHC -0.083; TCGA LUAD -0.072; TCGA LUSC -0.185; TCGA PRAD -0.06; TCGA UCEC -0.071 |
hsa-miR-200b-3p | DNAJC18 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.159; TCGA BRCA -0.169; TCGA CESC -0.159; TCGA COAD -0.183; TCGA ESCA -0.239; TCGA HNSC -0.208; TCGA KIRP -0.149; TCGA LGG -0.09; TCGA LUAD -0.101; TCGA LUSC -0.201; TCGA OV -0.088; TCGA PAAD -0.154; TCGA STAD -0.393; TCGA UCEC -0.247 |
hsa-miR-200b-3p | DUSP7 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; OV; UCEC | TargetScan | TCGA BLCA -0.132; TCGA BRCA -0.088; TCGA CESC -0.276; TCGA COAD -0.097; TCGA ESCA -0.172; TCGA KIRC -0.228; TCGA LUAD -0.073; TCGA OV -0.066; TCGA UCEC -0.107 |
hsa-miR-200b-3p | EGR3 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.447; TCGA BRCA -0.225; TCGA CESC -0.155; TCGA COAD -0.454; TCGA ESCA -0.199; TCGA HNSC -0.197; TCGA LUSC -0.353; TCGA PAAD -0.178; TCGA PRAD -0.112; TCGA STAD -0.28; TCGA UCEC -0.117 |
hsa-miR-200b-3p | ELK3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.184; TCGA BRCA -0.224; TCGA CESC -0.35; TCGA COAD -0.399; TCGA ESCA -0.147; TCGA HNSC -0.282; TCGA KIRC -0.24; TCGA LUAD -0.266; TCGA LUSC -0.279; TCGA PAAD -0.197; TCGA STAD -0.128; TCGA UCEC -0.268 |
hsa-miR-200b-3p | ENDOD1 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.099; TCGA BRCA -0.074; TCGA CESC -0.127; TCGA ESCA -0.084; TCGA HNSC -0.235; TCGA PRAD -0.102; TCGA SARC -0.12; TCGA STAD -0.086; TCGA UCEC -0.093 |
hsa-miR-200b-3p | ERC1 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; STAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.19; TCGA BRCA -0.092; TCGA CESC -0.104; TCGA COAD -0.112; TCGA ESCA -0.135; TCGA HNSC -0.101; TCGA LUAD -0.072; TCGA STAD -0.201; TCGA UCEC -0.06 |
hsa-miR-200b-3p | ERG | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.209; TCGA BRCA -0.342; TCGA CESC -0.426; TCGA COAD -0.564; TCGA ESCA -0.191; TCGA HNSC -0.332; TCGA KIRC -0.169; TCGA KIRP -0.271; TCGA LUAD -0.143; TCGA LUSC -0.328; TCGA OV -0.132; TCGA PAAD -0.42; TCGA STAD -0.222; TCGA UCEC -0.239 |
hsa-miR-200b-3p | FAM126A | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.305; TCGA BRCA -0.338; TCGA CESC -0.522; TCGA COAD -0.489; TCGA ESCA -0.309; TCGA HNSC -0.217; TCGA KIRC -0.233; TCGA KIRP -0.144; TCGA LUAD -0.268; TCGA OV -0.159; TCGA PAAD -0.379; TCGA PRAD -0.057; TCGA SARC -0.069; TCGA STAD -0.136; TCGA UCEC -0.177 |
hsa-miR-200b-3p | FAM19A5 | 9 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LGG; LUSC; STAD; UCEC | TargetScan | TCGA BLCA -0.133; TCGA COAD -0.591; TCGA HNSC -0.321; TCGA KIRC -0.371; TCGA KIRP -0.39; TCGA LGG -0.09; TCGA LUSC -0.211; TCGA STAD -0.191; TCGA UCEC -0.257 |
hsa-miR-200b-3p | FBXO30 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.117; TCGA BRCA -0.053; TCGA CESC -0.077; TCGA COAD -0.09; TCGA ESCA -0.129; TCGA HNSC -0.102; TCGA KIRP -0.176; TCGA LGG -0.058; TCGA LUAD -0.112; TCGA PAAD -0.157; TCGA SARC -0.125; TCGA STAD -0.237; TCGA UCEC -0.147 |
hsa-miR-200b-3p | FERMT2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.444; TCGA BRCA -0.386; TCGA CESC -0.309; TCGA COAD -0.811; TCGA ESCA -0.399; TCGA HNSC -0.468; TCGA LUAD -0.259; TCGA LUSC -0.489; TCGA OV -0.165; TCGA PAAD -0.352; TCGA PRAD -0.141; TCGA SARC -0.155; TCGA STAD -0.568; TCGA UCEC -0.311 |
hsa-miR-200b-3p | FEZ2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.114; TCGA BRCA -0.195; TCGA CESC -0.102; TCGA COAD -0.12; TCGA ESCA -0.1; TCGA HNSC -0.152; TCGA KIRP -0.152; TCGA LUAD -0.122; TCGA LUSC -0.111; TCGA OV -0.085; TCGA PAAD -0.072; TCGA PRAD -0.089; TCGA STAD -0.187; TCGA UCEC -0.161 |
hsa-miR-200b-3p | FOXN2 | 10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; UCEC | TargetScan | TCGA BLCA -0.055; TCGA BRCA -0.216; TCGA HNSC -0.084; TCGA KIRC -0.132; TCGA KIRP -0.141; TCGA LGG -0.086; TCGA LUAD -0.155; TCGA LUSC -0.066; TCGA PAAD -0.095; TCGA UCEC -0.055 |
hsa-miR-200b-3p | FRMD6 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; OV; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.13; TCGA BRCA -0.152; TCGA CESC -0.509; TCGA COAD -0.767; TCGA ESCA -0.526; TCGA HNSC -0.089; TCGA KIRC -0.213; TCGA LUAD -0.265; TCGA OV -0.117; TCGA PAAD -0.286; TCGA SARC -0.14; TCGA STAD -0.408; TCGA UCEC -0.42 |
hsa-miR-200b-3p | FYN | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.296; TCGA BRCA -0.256; TCGA CESC -0.373; TCGA COAD -0.361; TCGA HNSC -0.348; TCGA KIRC -0.331; TCGA LGG -0.13; TCGA LUAD -0.155; TCGA LUSC -0.277; TCGA OV -0.146; TCGA PAAD -0.297; TCGA PRAD -0.05; TCGA STAD -0.176; TCGA UCEC -0.252 |
hsa-miR-200b-3p | GAB1 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.078; TCGA BRCA -0.092; TCGA CESC -0.088; TCGA ESCA -0.122; TCGA HNSC -0.114; TCGA LUAD -0.086; TCGA LUSC -0.127; TCGA OV -0.111; TCGA PAAD -0.069; TCGA STAD -0.218; TCGA UCEC -0.193 |
hsa-miR-200b-3p | GDF6 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.294; TCGA BRCA -0.235; TCGA CESC -0.609; TCGA COAD -1.187; TCGA ESCA -0.717; TCGA HNSC -0.405; TCGA KIRC -0.879; TCGA KIRP -0.884; TCGA LUAD -0.407; TCGA LUSC -0.269; TCGA OV -0.452; TCGA PAAD -0.43; TCGA STAD -0.586; TCGA UCEC -0.388 |
hsa-miR-200b-3p | GLI3 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.225; TCGA BRCA -0.081; TCGA CESC -0.678; TCGA COAD -0.998; TCGA ESCA -0.565; TCGA HNSC -0.32; TCGA KIRC -0.297; TCGA LUAD -0.176; TCGA OV -0.151; TCGA PAAD -0.396; TCGA STAD -0.484; TCGA UCEC -0.455 |
hsa-miR-200b-3p | GLIS2 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.286; TCGA CESC -0.193; TCGA COAD -0.584; TCGA ESCA -0.21; TCGA HNSC -0.213; TCGA LGG -0.181; TCGA LUSC -0.332; TCGA OV -0.12; TCGA PAAD -0.133; TCGA STAD -0.259; TCGA UCEC -0.208 |
hsa-miR-200b-3p | GPC6 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.576; TCGA BRCA -0.377; TCGA CESC -0.371; TCGA COAD -0.784; TCGA ESCA -0.301; TCGA HNSC -0.732; TCGA KIRC -0.261; TCGA LUAD -0.552; TCGA LUSC -0.581; TCGA OV -0.173; TCGA PAAD -0.359; TCGA PRAD -0.057; TCGA STAD -0.284; TCGA UCEC -0.2 |
hsa-miR-200b-3p | GPM6A | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.49; TCGA BRCA -0.372; TCGA CESC -0.364; TCGA COAD -1.877; TCGA ESCA -0.877; TCGA HNSC -0.298; TCGA LGG -0.146; TCGA LUAD -0.331; TCGA LUSC -0.927; TCGA PAAD -0.528; TCGA PRAD -0.184; TCGA SARC -0.162; TCGA STAD -0.985; TCGA UCEC -0.847 |
hsa-miR-200b-3p | GPR146 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.125; TCGA BRCA -0.367; TCGA COAD -0.34; TCGA ESCA -0.129; TCGA HNSC -0.075; TCGA KIRC -0.181; TCGA KIRP -0.243; TCGA LIHC -0.106; TCGA LUSC -0.286; TCGA PAAD -0.155; TCGA SARC -0.085; TCGA STAD -0.25; TCGA UCEC -0.146 |
hsa-miR-200b-3p | GPRIN3 | 9 cancers: BLCA; BRCA; HNSC; KIRP; LUAD; LUSC; PAAD; SARC; THCA | TargetScan | TCGA BLCA -0.23; TCGA BRCA -0.094; TCGA HNSC -0.367; TCGA KIRP -0.471; TCGA LUAD -0.169; TCGA LUSC -0.617; TCGA PAAD -0.161; TCGA SARC -0.122; TCGA THCA -0.054 |
hsa-miR-200b-3p | GRAP2 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LUAD; LUSC; PAAD; UCEC | TargetScan | TCGA BLCA -0.368; TCGA BRCA -0.096; TCGA CESC -0.279; TCGA HNSC -0.129; TCGA KIRC -0.482; TCGA LUAD -0.131; TCGA LUSC -0.408; TCGA PAAD -0.434; TCGA UCEC -0.138 |
hsa-miR-200b-3p | GREM2 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.158; TCGA BRCA -0.456; TCGA CESC -0.33; TCGA COAD -1.203; TCGA ESCA -0.384; TCGA LIHC -0.331; TCGA LUSC -0.505; TCGA PAAD -0.311; TCGA STAD -0.651; TCGA UCEC -0.384 |
hsa-miR-200b-3p | GRIN2A | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.326; TCGA BRCA -0.267; TCGA CESC -0.371; TCGA COAD -1.118; TCGA ESCA -0.345; TCGA KIRC -0.363; TCGA KIRP -0.378; TCGA SARC -0.321; TCGA STAD -0.663; TCGA UCEC -0.45 |
hsa-miR-200b-3p | GRK5 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; STAD; UCEC | TargetScan | TCGA BLCA -0.265; TCGA BRCA -0.2; TCGA CESC -0.283; TCGA COAD -0.153; TCGA HNSC -0.251; TCGA KIRC -0.374; TCGA KIRP -0.263; TCGA LUAD -0.123; TCGA LUSC -0.432; TCGA OV -0.219; TCGA STAD -0.074; TCGA UCEC -0.339 |
hsa-miR-200b-3p | GUCY1A3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; OV; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.21; TCGA BRCA -0.201; TCGA CESC -0.213; TCGA COAD -0.876; TCGA ESCA -0.351; TCGA HNSC -0.356; TCGA KIRC -0.138; TCGA KIRP -0.195; TCGA LUSC -0.301; TCGA OV -0.146; TCGA PAAD -0.411; TCGA SARC -0.172; TCGA STAD -0.452; TCGA UCEC -0.153 |
hsa-miR-200b-3p | HAS2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.351; TCGA BRCA -0.382; TCGA CESC -0.517; TCGA COAD -0.303; TCGA ESCA -0.344; TCGA HNSC -0.565; TCGA LUAD -0.314; TCGA LUSC -0.448; TCGA OV -0.223; TCGA PAAD -0.313; TCGA STAD -0.105; TCGA UCEC -0.193 |
hsa-miR-200b-3p | HCFC2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.117; TCGA BRCA -0.148; TCGA CESC -0.117; TCGA COAD -0.236; TCGA ESCA -0.103; TCGA HNSC -0.171; TCGA KIRP -0.089; TCGA LGG -0.093; TCGA LUAD -0.08; TCGA LUSC -0.122; TCGA OV -0.063; TCGA PAAD -0.148; TCGA SARC -0.065; TCGA STAD -0.225; TCGA UCEC -0.189 |
hsa-miR-200b-3p | HECW2 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; UCEC | TargetScan | TCGA BLCA -0.066; TCGA BRCA -0.184; TCGA CESC -0.215; TCGA COAD -0.299; TCGA HNSC -0.122; TCGA KIRC -0.459; TCGA KIRP -0.906; TCGA LGG -0.054; TCGA LUSC -0.312; TCGA PAAD -0.195; TCGA PRAD -0.079; TCGA UCEC -0.125 |
hsa-miR-200b-3p | HEG1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.337; TCGA BRCA -0.288; TCGA CESC -0.41; TCGA COAD -0.547; TCGA ESCA -0.261; TCGA HNSC -0.343; TCGA KIRC -0.118; TCGA KIRP -0.328; TCGA LUAD -0.261; TCGA LUSC -0.417; TCGA OV -0.173; TCGA PAAD -0.31; TCGA PRAD -0.053; TCGA SARC -0.119; TCGA STAD -0.262; TCGA UCEC -0.287 |
hsa-miR-200b-3p | HIVEP3 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; STAD; UCEC | TargetScan | TCGA BLCA -0.241; TCGA CESC -0.307; TCGA COAD -0.25; TCGA ESCA -0.183; TCGA HNSC -0.224; TCGA KIRC -0.111; TCGA LUAD -0.16; TCGA LUSC -0.28; TCGA STAD -0.094; TCGA UCEC -0.073 |
hsa-miR-200b-3p | HSPA13 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; UCEC | TargetScan | TCGA BLCA -0.127; TCGA CESC -0.077; TCGA COAD -0.074; TCGA ESCA -0.097; TCGA HNSC -0.108; TCGA KIRC -0.093; TCGA KIRP -0.248; TCGA LGG -0.092; TCGA LUAD -0.164; TCGA LUSC -0.113; TCGA OV -0.115; TCGA PAAD -0.14; TCGA UCEC -0.125 |
hsa-miR-200b-3p | IL6ST | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.3; TCGA BRCA -0.262; TCGA COAD -0.322; TCGA ESCA -0.124; TCGA HNSC -0.324; TCGA KIRP -0.441; TCGA LUSC -0.456; TCGA PAAD -0.222; TCGA SARC -0.219; TCGA STAD -0.225; TCGA UCEC -0.25 |
hsa-miR-200b-3p | INHBA | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; UCEC | TargetScan | TCGA BLCA -0.408; TCGA CESC -0.556; TCGA COAD -0.705; TCGA ESCA -0.351; TCGA HNSC -0.813; TCGA KIRC -0.362; TCGA KIRP -0.5; TCGA LUAD -0.44; TCGA LUSC -0.571; TCGA OV -0.247; TCGA UCEC -0.12 |
hsa-miR-200b-3p | ITPR1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.234; TCGA BRCA -0.153; TCGA CESC -0.317; TCGA COAD -0.533; TCGA ESCA -0.272; TCGA HNSC -0.11; TCGA KIRP -0.185; TCGA LUSC -0.342; TCGA PAAD -0.339; TCGA SARC -0.256; TCGA STAD -0.354; TCGA UCEC -0.399 |
hsa-miR-200b-3p | ITSN1 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.072; TCGA BRCA -0.304; TCGA COAD -0.116; TCGA HNSC -0.099; TCGA KIRC -0.057; TCGA KIRP -0.137; TCGA LUAD -0.084; TCGA LUSC -0.168; TCGA PAAD -0.099; TCGA PRAD -0.056; TCGA STAD -0.109; TCGA UCEC -0.134 |
hsa-miR-200b-3p | KANK2 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.274; TCGA BRCA -0.256; TCGA CESC -0.13; TCGA COAD -0.528; TCGA ESCA -0.293; TCGA HNSC -0.302; TCGA KIRC -0.134; TCGA KIRP -0.147; TCGA LUAD -0.103; TCGA LUSC -0.428; TCGA OV -0.149; TCGA PAAD -0.189; TCGA PRAD -0.08; TCGA SARC -0.219; TCGA STAD -0.478; TCGA UCEC -0.381 |
hsa-miR-200b-3p | KATNAL1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.438; TCGA BRCA -0.167; TCGA CESC -0.221; TCGA COAD -0.376; TCGA ESCA -0.307; TCGA HNSC -0.331; TCGA KIRC -0.153; TCGA KIRP -0.124; TCGA LIHC -0.067; TCGA LUAD -0.143; TCGA LUSC -0.256; TCGA OV -0.152; TCGA PAAD -0.132; TCGA STAD -0.356; TCGA UCEC -0.31 |
hsa-miR-200b-3p | KBTBD8 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD | TargetScan | TCGA BLCA -0.16; TCGA BRCA -0.115; TCGA CESC -0.118; TCGA HNSC -0.178; TCGA KIRC -0.136; TCGA LIHC -0.057; TCGA LUAD -0.177; TCGA LUSC -0.335; TCGA OV -0.105; TCGA PAAD -0.466 |
hsa-miR-200b-3p | KCNB1 | 12 cancers: BLCA; BRCA; COAD; ESCA; LGG; LIHC; LUAD; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.46; TCGA BRCA -0.624; TCGA COAD -1.295; TCGA ESCA -0.583; TCGA LGG -0.229; TCGA LIHC -0.299; TCGA LUAD -0.231; TCGA PAAD -0.402; TCGA PRAD -0.18; TCGA SARC -0.243; TCGA STAD -1.163; TCGA UCEC -0.669 |
hsa-miR-200b-3p | KDELC1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.185; TCGA BRCA -0.106; TCGA CESC -0.211; TCGA COAD -0.32; TCGA ESCA -0.168; TCGA HNSC -0.281; TCGA KIRC -0.29; TCGA KIRP -0.21; TCGA LGG -0.116; TCGA LUAD -0.267; TCGA LUSC -0.117; TCGA OV -0.208; TCGA PAAD -0.233; TCGA STAD -0.064; TCGA UCEC -0.213 |
hsa-miR-200b-3p | KIF13A | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.138; TCGA BRCA -0.153; TCGA CESC -0.146; TCGA ESCA -0.08; TCGA HNSC -0.175; TCGA KIRP -0.118; TCGA LGG -0.169; TCGA SARC -0.127; TCGA STAD -0.092; TCGA UCEC -0.16 |
hsa-miR-200b-3p | KLF10 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; STAD; UCEC | TargetScan | TCGA BLCA -0.207; TCGA BRCA -0.189; TCGA CESC -0.139; TCGA COAD -0.117; TCGA ESCA -0.15; TCGA HNSC -0.306; TCGA LUAD -0.12; TCGA LUSC -0.228; TCGA STAD -0.26; TCGA UCEC -0.107 |
hsa-miR-200b-3p | KLF12 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.285; TCGA BRCA -0.126; TCGA COAD -0.315; TCGA ESCA -0.231; TCGA HNSC -0.118; TCGA LGG -0.186; TCGA LIHC -0.09; TCGA LUAD -0.083; TCGA LUSC -0.182; TCGA OV -0.104; TCGA PAAD -0.277; TCGA PRAD -0.105; TCGA STAD -0.273; TCGA UCEC -0.191 |
hsa-miR-200b-3p | KLF6 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; STAD; UCEC | TargetScan | TCGA BLCA -0.117; TCGA BRCA -0.187; TCGA CESC -0.238; TCGA ESCA -0.086; TCGA HNSC -0.225; TCGA KIRC -0.112; TCGA LUAD -0.188; TCGA LUSC -0.432; TCGA STAD -0.055; TCGA UCEC -0.187 |
hsa-miR-200b-3p | KLF9 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.368; TCGA BRCA -0.288; TCGA CESC -0.16; TCGA COAD -0.416; TCGA ESCA -0.179; TCGA HNSC -0.21; TCGA LIHC -0.159; TCGA LUAD -0.109; TCGA LUSC -0.385; TCGA OV -0.1; TCGA PAAD -0.225; TCGA SARC -0.07; TCGA STAD -0.398; TCGA UCEC -0.29 |
hsa-miR-200b-3p | LATS2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.24; TCGA BRCA -0.242; TCGA CESC -0.241; TCGA COAD -0.379; TCGA ESCA -0.113; TCGA HNSC -0.311; TCGA KIRC -0.054; TCGA KIRP -0.139; TCGA LUAD -0.182; TCGA LUSC -0.38; TCGA OV -0.108; TCGA PAAD -0.183; TCGA PRAD -0.058; TCGA STAD -0.191; TCGA UCEC -0.247 |
hsa-miR-200b-3p | LOX | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD | TargetScan | TCGA BLCA -0.435; TCGA BRCA -0.302; TCGA CESC -0.159; TCGA COAD -0.686; TCGA ESCA -0.296; TCGA HNSC -0.427; TCGA KIRC -1.029; TCGA KIRP -0.472; TCGA LUAD -0.374; TCGA LUSC -0.163; TCGA OV -0.286; TCGA PAAD -0.275 |
hsa-miR-200b-3p | LRIG1 | 9 cancers: BLCA; COAD; KIRC; KIRP; LGG; LIHC; SARC; THCA; STAD | TargetScan | TCGA BLCA -0.4; TCGA COAD -0.136; TCGA KIRC -0.141; TCGA KIRP -0.142; TCGA LGG -0.198; TCGA LIHC -0.092; TCGA SARC -0.083; TCGA THCA -0.067; TCGA STAD -0.238 |
hsa-miR-200b-3p | LRP1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.235; TCGA BRCA -0.391; TCGA CESC -0.235; TCGA COAD -0.146; TCGA ESCA -0.145; TCGA HNSC -0.215; TCGA KIRC -0.243; TCGA KIRP -0.209; TCGA LIHC -0.099; TCGA LUAD -0.128; TCGA LUSC -0.229; TCGA OV -0.165; TCGA PAAD -0.148; TCGA STAD -0.19; TCGA UCEC -0.303 |
hsa-miR-200b-3p | LYSMD3 | 9 cancers: BLCA; BRCA; HNSC; KIRP; LIHC; LUSC; OV; PAAD; UCEC | TargetScan | TCGA BLCA -0.058; TCGA BRCA -0.061; TCGA HNSC -0.11; TCGA KIRP -0.141; TCGA LIHC -0.074; TCGA LUSC -0.21; TCGA OV -0.058; TCGA PAAD -0.079; TCGA UCEC -0.08 |
hsa-miR-200b-3p | MAF | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.341; TCGA BRCA -0.27; TCGA CESC -0.429; TCGA COAD -0.486; TCGA ESCA -0.369; TCGA HNSC -0.322; TCGA KIRC -0.391; TCGA KIRP -0.454; TCGA LIHC -0.053; TCGA LUAD -0.168; TCGA OV -0.151; TCGA PAAD -0.255; TCGA PRAD -0.113; TCGA STAD -0.232; TCGA UCEC -0.417 |
hsa-miR-200b-3p | MAP1B | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.462; TCGA BRCA -0.32; TCGA CESC -0.347; TCGA COAD -0.75; TCGA ESCA -0.394; TCGA HNSC -0.281; TCGA KIRC -0.328; TCGA KIRP -0.669; TCGA LUAD -0.27; TCGA OV -0.206; TCGA PAAD -0.209; TCGA PRAD -0.099; TCGA SARC -0.222; TCGA THCA -0.059; TCGA STAD -0.541; TCGA UCEC -0.231 |
hsa-miR-200b-3p | MAP4K4 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD | TargetScan | TCGA BLCA -0.151; TCGA BRCA -0.169; TCGA CESC -0.163; TCGA COAD -0.178; TCGA ESCA -0.106; TCGA HNSC -0.17; TCGA KIRC -0.386; TCGA KIRP -0.111; TCGA LGG -0.053; TCGA LUAD -0.088; TCGA LUSC -0.074; TCGA OV -0.084; TCGA PAAD -0.068 |
hsa-miR-200b-3p | MBNL1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.142; TCGA BRCA -0.175; TCGA CESC -0.091; TCGA COAD -0.088; TCGA ESCA -0.146; TCGA HNSC -0.057; TCGA KIRC -0.15; TCGA KIRP -0.119; TCGA PAAD -0.185; TCGA SARC -0.159; TCGA STAD -0.183; TCGA UCEC -0.15 |
hsa-miR-200b-3p | MCC | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.067; TCGA BRCA -0.178; TCGA CESC -0.481; TCGA COAD -0.605; TCGA ESCA -0.408; TCGA HNSC -0.103; TCGA LUAD -0.133; TCGA OV -0.138; TCGA PAAD -0.214; TCGA STAD -0.367; TCGA UCEC -0.238 |
hsa-miR-200b-3p | MEF2D | 11 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LUSC; OV; SARC; STAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.126; TCGA CESC -0.171; TCGA COAD -0.112; TCGA HNSC -0.173; TCGA KIRC -0.142; TCGA KIRP -0.08; TCGA LUSC -0.182; TCGA OV -0.052; TCGA SARC -0.05; TCGA STAD -0.168; TCGA UCEC -0.148 |
hsa-miR-200b-3p | MEX3B | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LGG; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.097; TCGA COAD -0.426; TCGA ESCA -0.286; TCGA HNSC -0.157; TCGA KIRC -0.43; TCGA LGG -0.382; TCGA OV -0.291; TCGA PAAD -0.204; TCGA STAD -0.154; TCGA UCEC -0.228 |
hsa-miR-200b-3p | MFAP5 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.828; TCGA BRCA -0.417; TCGA CESC -0.724; TCGA COAD -1.285; TCGA ESCA -0.757; TCGA HNSC -0.765; TCGA KIRC -0.378; TCGA KIRP -0.899; TCGA LUAD -0.533; TCGA LUSC -0.589; TCGA PAAD -0.318; TCGA SARC -0.335; TCGA STAD -0.566; TCGA UCEC -0.392 |
hsa-miR-200b-3p | MMD | 15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.288; TCGA BRCA -0.462; TCGA COAD -0.157; TCGA ESCA -0.168; TCGA HNSC -0.117; TCGA KIRC -0.087; TCGA KIRP -0.225; TCGA LUAD -0.295; TCGA LUSC -0.159; TCGA OV -0.102; TCGA PAAD -0.26; TCGA PRAD -0.068; TCGA THCA -0.065; TCGA STAD -0.211; TCGA UCEC -0.076 |
hsa-miR-200b-3p | MMP16 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.318; TCGA BRCA -0.271; TCGA CESC -0.351; TCGA COAD -0.666; TCGA ESCA -0.198; TCGA HNSC -0.652; TCGA KIRC -0.906; TCGA KIRP -0.328; TCGA LGG -0.26; TCGA LUAD -0.15; TCGA LUSC -0.343; TCGA OV -0.329; TCGA PAAD -0.306; TCGA PRAD -0.123; TCGA STAD -0.362; TCGA UCEC -0.268 |
hsa-miR-200b-3p | MYLK | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.526; TCGA BRCA -0.31; TCGA CESC -0.549; TCGA COAD -0.952; TCGA ESCA -0.544; TCGA HNSC -0.219; TCGA KIRP -0.644; TCGA LIHC -0.094; TCGA LUAD -0.2; TCGA LUSC -0.31; TCGA OV -0.177; TCGA PAAD -0.323; TCGA PRAD -0.093; TCGA SARC -0.51; TCGA STAD -0.798; TCGA UCEC -0.583 |
hsa-miR-200b-3p | MYO9A | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.098; TCGA BRCA -0.205; TCGA COAD -0.119; TCGA ESCA -0.111; TCGA HNSC -0.131; TCGA LUSC -0.124; TCGA PAAD -0.125; TCGA SARC -0.129; TCGA STAD -0.211; TCGA UCEC -0.134 |
hsa-miR-200b-3p | NACC2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.255; TCGA BRCA -0.089; TCGA CESC -0.084; TCGA COAD -0.177; TCGA ESCA -0.108; TCGA HNSC -0.066; TCGA KIRP -0.269; TCGA LUAD -0.067; TCGA LUSC -0.108; TCGA SARC -0.096; TCGA STAD -0.329; TCGA UCEC -0.105 |
hsa-miR-200b-3p | NCAM1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.645; TCGA BRCA -0.426; TCGA CESC -0.33; TCGA COAD -0.636; TCGA ESCA -0.436; TCGA HNSC -0.861; TCGA KIRP -0.342; TCGA LGG -0.147; TCGA PRAD -0.132; TCGA THCA -0.223; TCGA STAD -0.683; TCGA UCEC -0.631 |
hsa-miR-200b-3p | NCS1 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.254; TCGA CESC -0.327; TCGA COAD -0.426; TCGA ESCA -0.499; TCGA HNSC -0.129; TCGA KIRP -0.212; TCGA LUAD -0.168; TCGA PAAD -0.183; TCGA PRAD -0.052; TCGA SARC -0.084; TCGA STAD -0.558; TCGA UCEC -0.246 |
hsa-miR-200b-3p | NDST1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.133; TCGA BRCA -0.068; TCGA CESC -0.21; TCGA COAD -0.121; TCGA ESCA -0.17; TCGA HNSC -0.244; TCGA KIRC -0.091; TCGA KIRP -0.081; TCGA LIHC -0.058; TCGA LUAD -0.069; TCGA LUSC -0.24; TCGA OV -0.075; TCGA PAAD -0.183; TCGA STAD -0.134; TCGA UCEC -0.074 |
hsa-miR-200b-3p | NEGR1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.529; TCGA BRCA -0.382; TCGA CESC -0.453; TCGA COAD -0.75; TCGA ESCA -0.289; TCGA HNSC -0.521; TCGA KIRP -0.311; TCGA LGG -0.087; TCGA LUSC -0.46; TCGA OV -0.4; TCGA PAAD -0.184; TCGA PRAD -0.163; TCGA STAD -0.662; TCGA UCEC -0.532 |
hsa-miR-200b-3p | NFASC | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.231; TCGA CESC -0.414; TCGA COAD -0.376; TCGA ESCA -0.545; TCGA HNSC -0.175; TCGA KIRP -0.319; TCGA LUSC -0.291; TCGA OV -0.235; TCGA PAAD -0.232; TCGA PRAD -0.06; TCGA SARC -0.268; TCGA STAD -0.685; TCGA UCEC -0.401 |
hsa-miR-200b-3p | NFIB | 9 cancers: BLCA; BRCA; KIRC; LGG; LUSC; OV; PAAD; SARC; STAD | TargetScan | TCGA BLCA -0.142; TCGA BRCA -0.234; TCGA KIRC -0.163; TCGA LGG -0.196; TCGA LUSC -0.137; TCGA OV -0.087; TCGA PAAD -0.201; TCGA SARC -0.096; TCGA STAD -0.115 |
hsa-miR-200b-3p | NFIC | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.227; TCGA BRCA -0.074; TCGA COAD -0.268; TCGA ESCA -0.129; TCGA HNSC -0.162; TCGA KIRP -0.201; TCGA LIHC -0.092; TCGA LUSC -0.105; TCGA SARC -0.161; TCGA STAD -0.244; TCGA UCEC -0.105 |
hsa-miR-200b-3p | NKD1 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LGG; LIHC; LUSC; STAD | TargetScan | TCGA BLCA -0.139; TCGA BRCA -0.077; TCGA CESC -0.246; TCGA HNSC -0.233; TCGA KIRP -0.324; TCGA LGG -0.303; TCGA LIHC -0.178; TCGA LUSC -0.41; TCGA STAD -0.303 |
hsa-miR-200b-3p | NOVA2 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.065; TCGA BRCA -0.182; TCGA CESC -0.296; TCGA COAD -0.413; TCGA HNSC -0.309; TCGA KIRC -0.437; TCGA KIRP -0.34; TCGA LGG -0.082; TCGA LUAD -0.198; TCGA LUSC -0.455; TCGA OV -0.181; TCGA PAAD -0.144; TCGA PRAD -0.105; TCGA STAD -0.135; TCGA UCEC -0.213 |
hsa-miR-200b-3p | NPTX1 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUSC; OV; STAD; UCEC | TargetScan | TCGA BLCA -0.193; TCGA BRCA -0.129; TCGA CESC -0.554; TCGA COAD -1.322; TCGA ESCA -0.822; TCGA KIRP -0.432; TCGA LUSC -0.309; TCGA OV -0.184; TCGA STAD -1.061; TCGA UCEC -0.238 |
hsa-miR-200b-3p | NR3C1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.353; TCGA BRCA -0.337; TCGA CESC -0.237; TCGA COAD -0.542; TCGA ESCA -0.299; TCGA HNSC -0.135; TCGA KIRC -0.233; TCGA KIRP -0.25; TCGA LGG -0.077; TCGA LIHC -0.066; TCGA LUAD -0.101; TCGA LUSC -0.187; TCGA PAAD -0.215; TCGA SARC -0.065; TCGA STAD -0.297; TCGA UCEC -0.374 |
hsa-miR-200b-3p | NR5A2 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LUAD; LUSC; UCEC | TargetScan | TCGA BLCA -0.088; TCGA BRCA -0.349; TCGA CESC -0.162; TCGA HNSC -0.252; TCGA KIRC -0.312; TCGA LGG -0.133; TCGA LUAD -0.192; TCGA LUSC -0.408; TCGA UCEC -0.137 |
hsa-miR-200b-3p | NRG1 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUAD; PAAD; UCEC | TargetScan | TCGA BLCA -0.407; TCGA BRCA -0.31; TCGA CESC -0.309; TCGA ESCA -0.228; TCGA HNSC -0.148; TCGA KIRP -0.73; TCGA LUAD -0.313; TCGA PAAD -0.229; TCGA UCEC -0.156 |
hsa-miR-200b-3p | NRP2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.47; TCGA BRCA -0.212; TCGA CESC -0.187; TCGA COAD -0.706; TCGA ESCA -0.341; TCGA HNSC -0.187; TCGA KIRC -0.448; TCGA KIRP -0.421; TCGA LGG -0.073; TCGA LUAD -0.208; TCGA LUSC -0.327; TCGA PAAD -0.141; TCGA PRAD -0.124; TCGA STAD -0.486; TCGA UCEC -0.268 |
hsa-miR-200b-3p | OSMR | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.502; TCGA BRCA -0.204; TCGA CESC -0.305; TCGA COAD -0.767; TCGA ESCA -0.226; TCGA HNSC -0.197; TCGA KIRC -0.327; TCGA KIRP -0.266; TCGA LUAD -0.237; TCGA LUSC -0.135; TCGA PAAD -0.193; TCGA SARC -0.245; TCGA STAD -0.169; TCGA UCEC -0.111 |
hsa-miR-200b-3p | PAK3 | 10 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUSC; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.223; TCGA BRCA -0.377; TCGA HNSC -0.399; TCGA KIRC -0.209; TCGA LGG -0.307; TCGA LUSC -0.394; TCGA PRAD -0.124; TCGA THCA -0.103; TCGA STAD -0.374; TCGA UCEC -0.477 |
hsa-miR-200b-3p | PALM2-AKAP2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.398; TCGA BRCA -0.362; TCGA CESC -0.391; TCGA COAD -0.448; TCGA ESCA -0.172; TCGA HNSC -0.433; TCGA KIRC -0.167; TCGA KIRP -0.268; TCGA LUAD -0.259; TCGA LUSC -0.597; TCGA OV -0.111; TCGA PAAD -0.332; TCGA SARC -0.102; TCGA STAD -0.282; TCGA UCEC -0.332 |
hsa-miR-200b-3p | PAPLN | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.242; TCGA BRCA -0.186; TCGA CESC -0.232; TCGA COAD -0.488; TCGA ESCA -0.358; TCGA HNSC -0.201; TCGA PAAD -0.342; TCGA STAD -0.364; TCGA UCEC -0.273 |
hsa-miR-200b-3p | PBX3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.164; TCGA BRCA -0.052; TCGA CESC -0.142; TCGA COAD -0.443; TCGA ESCA -0.239; TCGA HNSC -0.114; TCGA KIRC -0.056; TCGA KIRP -0.128; TCGA LUAD -0.116; TCGA LUSC -0.199; TCGA OV -0.123; TCGA PAAD -0.151; TCGA STAD -0.375; TCGA UCEC -0.405 |
hsa-miR-200b-3p | PCDH7 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; PAAD; SARC; STAD | TargetScan | TCGA BLCA -0.453; TCGA BRCA -0.232; TCGA COAD -0.896; TCGA ESCA -0.314; TCGA HNSC -0.491; TCGA LGG -0.162; TCGA LUAD -0.273; TCGA PAAD -0.181; TCGA SARC -0.376; TCGA STAD -0.507 |
hsa-miR-200b-3p | PCSK5 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUSC; OV; PAAD; PRAD; UCEC | TargetScan | TCGA BLCA -0.404; TCGA BRCA -0.461; TCGA COAD -0.471; TCGA HNSC -0.253; TCGA KIRC -0.204; TCGA KIRP -0.874; TCGA LUSC -0.251; TCGA OV -0.145; TCGA PAAD -0.164; TCGA PRAD -0.126; TCGA UCEC -0.218 |
hsa-miR-200b-3p | PIP4K2A | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD | TargetScan | TCGA BLCA -0.244; TCGA BRCA -0.075; TCGA COAD -0.261; TCGA ESCA -0.092; TCGA HNSC -0.105; TCGA KIRC -0.224; TCGA KIRP -0.25; TCGA LUAD -0.198; TCGA LUSC -0.238; TCGA PAAD -0.286; TCGA PRAD -0.066; TCGA STAD -0.146 |
hsa-miR-200b-3p | PKD1 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; OV; STAD; UCEC | TargetScan | TCGA BLCA -0.081; TCGA BRCA -0.059; TCGA COAD -0.113; TCGA ESCA -0.176; TCGA HNSC -0.062; TCGA KIRC -0.168; TCGA OV -0.082; TCGA STAD -0.295; TCGA UCEC -0.169 |
hsa-miR-200b-3p | PLK2 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PRAD; UCEC | TargetScan | TCGA BLCA -0.201; TCGA CESC -0.449; TCGA COAD -0.231; TCGA ESCA -0.142; TCGA HNSC -0.369; TCGA KIRC -0.467; TCGA KIRP -0.236; TCGA LUSC -0.211; TCGA PRAD -0.085; TCGA UCEC -0.121 |
hsa-miR-200b-3p | PLS3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.139; TCGA BRCA -0.282; TCGA CESC -0.308; TCGA COAD -0.24; TCGA ESCA -0.206; TCGA HNSC -0.114; TCGA KIRP -0.497; TCGA LUAD -0.166; TCGA LUSC -0.093; TCGA OV -0.15; TCGA PRAD -0.071; TCGA SARC -0.104; TCGA STAD -0.065; TCGA UCEC -0.193 |
hsa-miR-200b-3p | PLXNA4 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; SARC; STAD | TargetScan | TCGA BLCA -0.541; TCGA BRCA -0.56; TCGA COAD -0.993; TCGA ESCA -0.38; TCGA HNSC -0.47; TCGA LUAD -0.17; TCGA LUSC -0.534; TCGA PAAD -0.464; TCGA SARC -0.216; TCGA STAD -0.475 |
hsa-miR-200b-3p | PLXNC1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.389; TCGA BRCA -0.195; TCGA CESC -0.286; TCGA COAD -0.629; TCGA ESCA -0.193; TCGA HNSC -0.556; TCGA KIRC -0.362; TCGA KIRP -0.536; TCGA LUAD -0.225; TCGA LUSC -0.683; TCGA PAAD -0.335; TCGA SARC -0.109; TCGA STAD -0.082; TCGA UCEC -0.299 |
hsa-miR-200b-3p | POU6F1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.216; TCGA BRCA -0.16; TCGA CESC -0.107; TCGA COAD -0.321; TCGA ESCA -0.228; TCGA HNSC -0.219; TCGA LGG -0.124; TCGA LUSC -0.243; TCGA OV -0.105; TCGA PAAD -0.209; TCGA PRAD -0.055; TCGA STAD -0.417; TCGA UCEC -0.224 |
hsa-miR-200b-3p | PPFIBP1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.165; TCGA BRCA -0.161; TCGA CESC -0.157; TCGA COAD -0.16; TCGA ESCA -0.134; TCGA HNSC -0.239; TCGA LUAD -0.231; TCGA LUSC -0.169; TCGA PRAD -0.051; TCGA STAD -0.104; TCGA UCEC -0.113 |
hsa-miR-200b-3p | PPP1R12B | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.244; TCGA BRCA -0.302; TCGA CESC -0.247; TCGA COAD -0.575; TCGA ESCA -0.276; TCGA HNSC -0.166; TCGA KIRP -0.133; TCGA LUSC -0.166; TCGA OV -0.116; TCGA PAAD -0.139; TCGA PRAD -0.075; TCGA SARC -0.391; TCGA STAD -0.61; TCGA UCEC -0.536 |
hsa-miR-200b-3p | PPP2R2C | 10 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LUAD; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.307; TCGA CESC -0.541; TCGA ESCA -0.51; TCGA KIRC -0.242; TCGA KIRP -1.236; TCGA LUAD -0.274; TCGA PRAD -0.143; TCGA THCA -0.213; TCGA STAD -0.342; TCGA UCEC -0.19 |
hsa-miR-200b-3p | PRDM1 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; UCEC | TargetScan | TCGA BLCA -0.159; TCGA BRCA -0.089; TCGA CESC -0.2; TCGA COAD -0.195; TCGA HNSC -0.086; TCGA KIRC -0.546; TCGA KIRP -0.293; TCGA LUAD -0.188; TCGA LUSC -0.225; TCGA PAAD -0.25; TCGA PRAD -0.07; TCGA UCEC -0.156 |
hsa-miR-200b-3p | PRKAR2B | 9 cancers: BLCA; BRCA; COAD; ESCA; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.189; TCGA BRCA -0.281; TCGA COAD -0.438; TCGA ESCA -0.341; TCGA OV -0.101; TCGA PAAD -0.308; TCGA PRAD -0.111; TCGA STAD -0.504; TCGA UCEC -0.395 |
hsa-miR-200b-3p | PRKCA | 12 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | TargetScan | TCGA BLCA -0.115; TCGA BRCA -0.338; TCGA HNSC -0.342; TCGA LGG -0.083; TCGA LIHC -0.051; TCGA LUAD -0.109; TCGA LUSC -0.313; TCGA OV -0.137; TCGA PRAD -0.058; TCGA THCA -0.084; TCGA STAD -0.108; TCGA UCEC -0.311 |
hsa-miR-200b-3p | PRKG1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.434; TCGA BRCA -0.354; TCGA CESC -0.318; TCGA COAD -0.434; TCGA ESCA -0.183; TCGA HNSC -0.555; TCGA LUAD -0.286; TCGA LUSC -0.564; TCGA OV -0.176; TCGA PRAD -0.14; TCGA SARC -0.303; TCGA STAD -0.415; TCGA UCEC -0.521 |
hsa-miR-200b-3p | PTEN | 12 cancers: BLCA; BRCA; CESC; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.064; TCGA BRCA -0.131; TCGA CESC -0.112; TCGA HNSC -0.171; TCGA LGG -0.052; TCGA LUAD -0.077; TCGA LUSC -0.202; TCGA OV -0.074; TCGA PAAD -0.127; TCGA PRAD -0.12; TCGA STAD -0.072; TCGA UCEC -0.096 |
hsa-miR-200b-3p | PTGDR | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.42; TCGA BRCA -0.306; TCGA CESC -0.412; TCGA ESCA -0.216; TCGA HNSC -0.483; TCGA KIRC -0.542; TCGA LUAD -0.152; TCGA LUSC -0.487; TCGA PAAD -0.498; TCGA SARC -0.221; TCGA STAD -0.24; TCGA UCEC -0.3 |
hsa-miR-200b-3p | PTPN11 | 9 cancers: BLCA; BRCA; HNSC; KIRP; LUAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.07; TCGA BRCA -0.132; TCGA HNSC -0.071; TCGA KIRP -0.093; TCGA LUAD -0.076; TCGA PRAD -0.051; TCGA SARC -0.059; TCGA STAD -0.065; TCGA UCEC -0.086 |
hsa-miR-200b-3p | PTPN21 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; LUSC; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.103; TCGA BRCA -0.258; TCGA CESC -0.079; TCGA COAD -0.103; TCGA HNSC -0.252; TCGA LUAD -0.096; TCGA LUSC -0.415; TCGA PRAD -0.081; TCGA STAD -0.177; TCGA UCEC -0.224 |
hsa-miR-200b-3p | QKI | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.122; TCGA BRCA -0.277; TCGA CESC -0.228; TCGA COAD -0.508; TCGA ESCA -0.327; TCGA HNSC -0.24; TCGA KIRC -0.119; TCGA KIRP -0.186; TCGA LGG -0.056; TCGA LUAD -0.22; TCGA LUSC -0.191; TCGA OV -0.125; TCGA PAAD -0.298; TCGA PRAD -0.052; TCGA STAD -0.29; TCGA UCEC -0.21 |
hsa-miR-200b-3p | RAB23 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; OV; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.299; TCGA BRCA -0.104; TCGA CESC -0.11; TCGA COAD -0.375; TCGA ESCA -0.237; TCGA HNSC -0.201; TCGA KIRC -0.076; TCGA KIRP -0.141; TCGA LIHC -0.054; TCGA LUAD -0.218; TCGA OV -0.102; TCGA PAAD -0.214; TCGA SARC -0.28; TCGA STAD -0.405; TCGA UCEC -0.262 |
hsa-miR-200b-3p | RAB37 | 10 cancers: BLCA; COAD; KIRC; KIRP; LIHC; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.274; TCGA COAD -0.165; TCGA KIRC -0.455; TCGA KIRP -0.214; TCGA LIHC -0.074; TCGA LUSC -0.396; TCGA OV -0.168; TCGA PAAD -0.229; TCGA STAD -0.101; TCGA UCEC -0.125 |
hsa-miR-200b-3p | RAPGEF1 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.151; TCGA BRCA -0.116; TCGA CESC -0.095; TCGA ESCA -0.109; TCGA HNSC -0.171; TCGA KIRC -0.148; TCGA KIRP -0.138; TCGA LUSC -0.165; TCGA PAAD -0.137; TCGA STAD -0.1; TCGA UCEC -0.097 |
hsa-miR-200b-3p | RASSF8 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.31; TCGA BRCA -0.184; TCGA CESC -0.239; TCGA COAD -0.572; TCGA ESCA -0.355; TCGA HNSC -0.402; TCGA KIRP -0.234; TCGA LUAD -0.257; TCGA LUSC -0.276; TCGA OV -0.161; TCGA PAAD -0.273; TCGA PRAD -0.052; TCGA SARC -0.088; TCGA STAD -0.483; TCGA UCEC -0.434 |
hsa-miR-200b-3p | RECK | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.358; TCGA BRCA -0.404; TCGA CESC -0.539; TCGA COAD -0.536; TCGA ESCA -0.299; TCGA HNSC -0.533; TCGA KIRC -0.084; TCGA KIRP -0.207; TCGA LUAD -0.289; TCGA LUSC -0.558; TCGA OV -0.202; TCGA PAAD -0.368; TCGA PRAD -0.105; TCGA STAD -0.423; TCGA UCEC -0.452 |
hsa-miR-200b-3p | RIMS3 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.233; TCGA BRCA -0.127; TCGA CESC -0.378; TCGA ESCA -0.213; TCGA HNSC -0.339; TCGA LUSC -0.311; TCGA PAAD -0.12; TCGA PRAD -0.052; TCGA SARC -0.158; TCGA STAD -0.418; TCGA UCEC -0.384 |
hsa-miR-200b-3p | RPS6KA2 | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.065; TCGA BRCA -0.196; TCGA CESC -0.14; TCGA COAD -0.194; TCGA HNSC -0.256; TCGA LUSC -0.371; TCGA PAAD -0.104; TCGA STAD -0.183; TCGA UCEC -0.138 |
hsa-miR-200b-3p | RUNX1T1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.399; TCGA BRCA -0.525; TCGA CESC -0.326; TCGA COAD -0.76; TCGA ESCA -0.325; TCGA HNSC -0.487; TCGA KIRP -0.408; TCGA LGG -0.232; TCGA LUAD -0.126; TCGA LUSC -0.659; TCGA PAAD -0.2; TCGA PRAD -0.13; TCGA SARC -0.146; TCGA STAD -0.499; TCGA UCEC -0.547 |
hsa-miR-200b-3p | RUSC2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.283; TCGA BRCA -0.107; TCGA CESC -0.211; TCGA COAD -0.288; TCGA ESCA -0.103; TCGA HNSC -0.38; TCGA KIRP -0.165; TCGA LGG -0.06; TCGA LUAD -0.18; TCGA LUSC -0.338; TCGA OV -0.12; TCGA PRAD -0.073; TCGA SARC -0.101; TCGA STAD -0.277; TCGA UCEC -0.271 |
hsa-miR-200b-3p | SCHIP1 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; PAAD; PRAD; SARC; UCEC | TargetScan | TCGA BLCA -0.222; TCGA BRCA -0.149; TCGA COAD -0.59; TCGA ESCA -0.321; TCGA HNSC -0.162; TCGA LIHC -0.062; TCGA LUAD -0.217; TCGA PAAD -0.238; TCGA PRAD -0.075; TCGA SARC -0.147; TCGA UCEC -0.217 |
hsa-miR-200b-3p | SCN3B | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.379; TCGA BRCA -0.48; TCGA CESC -0.268; TCGA COAD -0.896; TCGA ESCA -0.329; TCGA HNSC -0.448; TCGA KIRP -0.329; TCGA LGG -0.23; TCGA LUAD -0.296; TCGA LUSC -0.243; TCGA PAAD -0.228; TCGA STAD -0.457; TCGA UCEC -0.505 |
hsa-miR-200b-3p | SDC2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.274; TCGA BRCA -0.226; TCGA CESC -0.304; TCGA COAD -0.56; TCGA ESCA -0.252; TCGA HNSC -0.489; TCGA LIHC -0.062; TCGA LUAD -0.105; TCGA LUSC -0.275; TCGA OV -0.184; TCGA PAAD -0.193; TCGA PRAD -0.11; TCGA SARC -0.061; TCGA STAD -0.293; TCGA UCEC -0.219 |
hsa-miR-200b-3p | SEMA6D | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.182; TCGA BRCA -0.342; TCGA CESC -0.275; TCGA ESCA -0.232; TCGA HNSC -0.22; TCGA OV -0.147; TCGA PAAD -0.214; TCGA STAD -0.282; TCGA UCEC -0.219 |
hsa-miR-200b-3p | SERPINI1 | 11 cancers: BLCA; BRCA; CESC; COAD; KIRP; LIHC; LUAD; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.087; TCGA BRCA -0.083; TCGA CESC -0.13; TCGA COAD -0.268; TCGA KIRP -0.432; TCGA LIHC -0.084; TCGA LUAD -0.113; TCGA OV -0.281; TCGA PAAD -0.177; TCGA STAD -0.136; TCGA UCEC -0.19 |
hsa-miR-200b-3p | SETD7 | 13 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.129; TCGA BRCA -0.194; TCGA CESC -0.119; TCGA HNSC -0.16; TCGA KIRC -0.148; TCGA KIRP -0.174; TCGA LIHC -0.104; TCGA LUAD -0.071; TCGA LUSC -0.147; TCGA PAAD -0.088; TCGA SARC -0.113; TCGA STAD -0.215; TCGA UCEC -0.293 |
hsa-miR-200b-3p | SGCE | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.295; TCGA BRCA -0.244; TCGA COAD -0.73; TCGA ESCA -0.232; TCGA HNSC -0.261; TCGA LUAD -0.273; TCGA LUSC -0.366; TCGA OV -0.163; TCGA PAAD -0.231; TCGA PRAD -0.066; TCGA STAD -0.452; TCGA UCEC -0.379 |
hsa-miR-200b-3p | SH3PXD2A | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.102; TCGA BRCA -0.107; TCGA CESC -0.085; TCGA COAD -0.098; TCGA ESCA -0.102; TCGA HNSC -0.123; TCGA KIRC -0.35; TCGA KIRP -0.117; TCGA OV -0.107; TCGA PAAD -0.126; TCGA STAD -0.154; TCGA UCEC -0.214 |
hsa-miR-200b-3p | SLC16A2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.36; TCGA BRCA -0.244; TCGA CESC -0.615; TCGA COAD -0.567; TCGA ESCA -0.117; TCGA HNSC -0.472; TCGA KIRP -0.28; TCGA LGG -0.055; TCGA LIHC -0.18; TCGA LUAD -0.21; TCGA LUSC -0.385; TCGA OV -0.133; TCGA PAAD -0.2; TCGA STAD -0.218; TCGA UCEC -0.373 |
hsa-miR-200b-3p | SLC2A14 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; UCEC | TargetScan | TCGA BLCA -0.387; TCGA BRCA -0.204; TCGA CESC -0.307; TCGA COAD -0.589; TCGA ESCA -0.23; TCGA HNSC -0.401; TCGA KIRC -0.668; TCGA KIRP -0.177; TCGA LUAD -0.414; TCGA LUSC -0.58; TCGA PAAD -0.279; TCGA PRAD -0.143; TCGA UCEC -0.157 |
hsa-miR-200b-3p | SLC2A3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.388; TCGA BRCA -0.247; TCGA CESC -0.267; TCGA COAD -0.572; TCGA ESCA -0.222; TCGA HNSC -0.375; TCGA KIRC -0.657; TCGA KIRP -0.172; TCGA LUAD -0.391; TCGA LUSC -0.602; TCGA OV -0.113; TCGA PAAD -0.264; TCGA PRAD -0.13; TCGA STAD -0.113; TCGA UCEC -0.185 |
hsa-miR-200b-3p | SLC39A14 | 14 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | TargetScan | TCGA BLCA -0.306; TCGA BRCA -0.114; TCGA CESC -0.135; TCGA HNSC -0.294; TCGA KIRC -0.488; TCGA KIRP -0.537; TCGA LGG -0.077; TCGA LIHC -0.068; TCGA LUAD -0.11; TCGA LUSC -0.079; TCGA PRAD -0.075; TCGA SARC -0.095; TCGA THCA -0.082; TCGA UCEC -0.115 |
hsa-miR-200b-3p | SLC6A17 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; SARC; THCA; STAD | TargetScan; mirMAP | TCGA BLCA -0.324; TCGA CESC -0.417; TCGA COAD -0.817; TCGA ESCA -0.313; TCGA HNSC -0.475; TCGA KIRP -0.537; TCGA LUAD -0.442; TCGA LUSC -0.33; TCGA SARC -0.239; TCGA THCA -0.187; TCGA STAD -0.399 |
hsa-miR-200b-3p | SLIT2 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.617; TCGA BRCA -0.431; TCGA COAD -1.22; TCGA ESCA -0.8; TCGA HNSC -0.242; TCGA LUAD -0.176; TCGA LUSC -0.709; TCGA OV -0.187; TCGA PAAD -0.57; TCGA PRAD -0.12; TCGA STAD -0.676; TCGA UCEC -0.24 |
hsa-miR-200b-3p | SMAD7 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.112; TCGA CESC -0.134; TCGA ESCA -0.063; TCGA HNSC -0.191; TCGA KIRC -0.077; TCGA LGG -0.1; TCGA LUSC -0.267; TCGA PAAD -0.092; TCGA UCEC -0.1 |
hsa-miR-200b-3p | SNAI2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.267; TCGA BRCA -0.245; TCGA CESC -0.649; TCGA COAD -0.504; TCGA ESCA -0.481; TCGA HNSC -0.308; TCGA KIRC -0.229; TCGA LIHC -0.114; TCGA LUAD -0.443; TCGA OV -0.237; TCGA PAAD -0.351; TCGA STAD -0.165; TCGA UCEC -0.389 |
hsa-miR-200b-3p | SNTB2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; OV; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.076; TCGA BRCA -0.216; TCGA CESC -0.105; TCGA COAD -0.073; TCGA ESCA -0.124; TCGA HNSC -0.07; TCGA OV -0.057; TCGA PAAD -0.119; TCGA SARC -0.083; TCGA STAD -0.079; TCGA UCEC -0.181 |
hsa-miR-200b-3p | SOAT1 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD | TargetScan | TCGA BLCA -0.143; TCGA BRCA -0.053; TCGA COAD -0.259; TCGA ESCA -0.109; TCGA HNSC -0.172; TCGA KIRP -0.293; TCGA LUAD -0.092; TCGA LUSC -0.239; TCGA PAAD -0.126 |
hsa-miR-200b-3p | SPG20 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.102; TCGA BRCA -0.156; TCGA CESC -0.225; TCGA COAD -0.653; TCGA ESCA -0.442; TCGA KIRP -0.192; TCGA LUAD -0.117; TCGA LUSC -0.127; TCGA OV -0.076; TCGA PAAD -0.298; TCGA PRAD -0.134; TCGA STAD -0.397; TCGA UCEC -0.186 |
hsa-miR-200b-3p | ST6GALNAC5 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; STAD | TargetScan | TCGA BLCA -0.35; TCGA CESC -0.248; TCGA COAD -1.07; TCGA ESCA -0.259; TCGA HNSC -0.19; TCGA LUAD -0.325; TCGA LUSC -0.403; TCGA PAAD -0.279; TCGA STAD -0.449 |
hsa-miR-200b-3p | STARD13 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.314; TCGA BRCA -0.165; TCGA CESC -0.235; TCGA COAD -0.167; TCGA HNSC -0.475; TCGA KIRC -0.102; TCGA KIRP -0.155; TCGA LIHC -0.063; TCGA LUAD -0.202; TCGA LUSC -0.488; TCGA PAAD -0.189; TCGA PRAD -0.061; TCGA STAD -0.251; TCGA UCEC -0.193 |
hsa-miR-200b-3p | TBCEL | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.064; TCGA BRCA -0.084; TCGA COAD -0.285; TCGA ESCA -0.281; TCGA HNSC -0.114; TCGA LGG -0.068; TCGA LUAD -0.076; TCGA LUSC -0.146; TCGA PAAD -0.208; TCGA STAD -0.195; TCGA UCEC -0.07 |
hsa-miR-200b-3p | TCF4 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; OV; PAAD; STAD; UCEC | TargetScan; mirMAP | TCGA BLCA -0.24; TCGA BRCA -0.313; TCGA COAD -0.534; TCGA ESCA -0.191; TCGA HNSC -0.187; TCGA KIRC -0.314; TCGA KIRP -0.195; TCGA LGG -0.156; TCGA LUAD -0.163; TCGA OV -0.158; TCGA PAAD -0.346; TCGA STAD -0.225; TCGA UCEC -0.245 |
hsa-miR-200b-3p | TEAD1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.148; TCGA BRCA -0.247; TCGA CESC -0.081; TCGA COAD -0.145; TCGA ESCA -0.066; TCGA HNSC -0.182; TCGA LGG -0.104; TCGA LUAD -0.088; TCGA LUSC -0.096; TCGA SARC -0.073; TCGA STAD -0.328; TCGA UCEC -0.165 |
hsa-miR-200b-3p | THSD7A | 10 cancers: BLCA; BRCA; COAD; HNSC; LGG; LUAD; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.181; TCGA BRCA -0.401; TCGA COAD -0.911; TCGA HNSC -0.382; TCGA LGG -0.17; TCGA LUAD -0.181; TCGA LUSC -0.534; TCGA PAAD -0.313; TCGA STAD -0.272; TCGA UCEC -0.1 |
hsa-miR-200b-3p | TIMP2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BLCA -0.417; TCGA BRCA -0.282; TCGA CESC -0.352; TCGA COAD -0.713; TCGA ESCA -0.259; TCGA HNSC -0.514; TCGA KIRC -0.118; TCGA KIRP -0.177; TCGA LUAD -0.275; TCGA LUSC -0.518; TCGA OV -0.182; TCGA PAAD -0.208; TCGA PRAD -0.08; TCGA STAD -0.34; TCGA UCEC -0.404 |
hsa-miR-200b-3p | TLN1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.244; TCGA BRCA -0.163; TCGA CESC -0.204; TCGA COAD -0.216; TCGA ESCA -0.189; TCGA HNSC -0.293; TCGA KIRC -0.098; TCGA KIRP -0.157; TCGA LUAD -0.121; TCGA LUSC -0.332; TCGA OV -0.09; TCGA PAAD -0.179; TCGA PRAD -0.054; TCGA SARC -0.134; TCGA STAD -0.329; TCGA UCEC -0.187 |
hsa-miR-200b-3p | TMEM136 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; STAD; UCEC | TargetScan | TCGA BLCA -0.16; TCGA CESC -0.128; TCGA COAD -0.287; TCGA ESCA -0.154; TCGA HNSC -0.187; TCGA KIRC -0.053; TCGA KIRP -0.214; TCGA LGG -0.105; TCGA LUAD -0.089; TCGA LUSC -0.089; TCGA STAD -0.273; TCGA UCEC -0.173 |
hsa-miR-200b-3p | TMEM170B | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LGG; LIHC; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.079; TCGA BRCA -0.266; TCGA COAD -0.198; TCGA HNSC -0.138; TCGA KIRP -0.19; TCGA LGG -0.129; TCGA LIHC -0.13; TCGA LUSC -0.147; TCGA OV -0.129; TCGA PAAD -0.236; TCGA STAD -0.308; TCGA UCEC -0.188 |
hsa-miR-200b-3p | TOR1AIP1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; OV; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.089; TCGA BRCA -0.064; TCGA CESC -0.051; TCGA COAD -0.102; TCGA ESCA -0.103; TCGA HNSC -0.079; TCGA KIRP -0.117; TCGA LUSC -0.146; TCGA OV -0.054; TCGA PAAD -0.064; TCGA SARC -0.067; TCGA STAD -0.202; TCGA UCEC -0.118 |
hsa-miR-200b-3p | TRIO | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.096; TCGA BRCA -0.094; TCGA CESC -0.109; TCGA ESCA -0.154; TCGA HNSC -0.204; TCGA KIRC -0.162; TCGA KIRP -0.143; TCGA LUAD -0.095; TCGA PAAD -0.118; TCGA SARC -0.124; TCGA STAD -0.137; TCGA UCEC -0.104 |
hsa-miR-200b-3p | USP25 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.073; TCGA BRCA -0.097; TCGA CESC -0.078; TCGA ESCA -0.094; TCGA HNSC -0.112; TCGA LUAD -0.072; TCGA LUSC -0.19; TCGA PAAD -0.074; TCGA STAD -0.093; TCGA UCEC -0.086 |
hsa-miR-200b-3p | VLDLR | 9 cancers: BLCA; BRCA; ESCA; KIRP; OV; PAAD; SARC; THCA; STAD | TargetScan | TCGA BLCA -0.128; TCGA BRCA -0.315; TCGA ESCA -0.254; TCGA KIRP -0.302; TCGA OV -0.093; TCGA PAAD -0.149; TCGA SARC -0.246; TCGA THCA -0.07; TCGA STAD -0.437 |
hsa-miR-200b-3p | WASF1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LUAD; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.088; TCGA BRCA -0.155; TCGA CESC -0.165; TCGA COAD -0.378; TCGA ESCA -0.209; TCGA KIRC -0.229; TCGA KIRP -0.133; TCGA LGG -0.182; TCGA LUAD -0.232; TCGA OV -0.164; TCGA PAAD -0.217; TCGA STAD -0.436; TCGA UCEC -0.075 |
hsa-miR-200b-3p | ZBTB16 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.38; TCGA BRCA -0.662; TCGA CESC -0.443; TCGA COAD -1.17; TCGA ESCA -0.451; TCGA HNSC -0.366; TCGA LGG -0.151; TCGA LIHC -0.192; TCGA LUSC -0.752; TCGA PAAD -0.552; TCGA SARC -0.243; TCGA STAD -0.861; TCGA UCEC -0.735 |
hsa-miR-200b-3p | ZBTB20 | 9 cancers: BLCA; BRCA; HNSC; LGG; LUSC; OV; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.072; TCGA BRCA -0.244; TCGA HNSC -0.145; TCGA LGG -0.215; TCGA LUSC -0.145; TCGA OV -0.113; TCGA SARC -0.141; TCGA STAD -0.284; TCGA UCEC -0.11 |
hsa-miR-200b-3p | ZBTB38 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUAD; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.103; TCGA BRCA -0.123; TCGA CESC -0.139; TCGA HNSC -0.101; TCGA KIRP -0.206; TCGA LUAD -0.098; TCGA PAAD -0.109; TCGA SARC -0.12; TCGA STAD -0.111; TCGA UCEC -0.19 |
hsa-miR-200b-3p | ZC3H12C | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BLCA -0.078; TCGA BRCA -0.284; TCGA CESC -0.179; TCGA ESCA -0.134; TCGA HNSC -0.17; TCGA KIRP -0.195; TCGA LUAD -0.085; TCGA LUSC -0.101; TCGA PAAD -0.132; TCGA SARC -0.054; TCGA STAD -0.194; TCGA UCEC -0.209 |
hsa-miR-200b-3p | ZFHX4 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; OV; PAAD; STAD; UCEC | TargetScan | TCGA BLCA -0.459; TCGA BRCA -0.427; TCGA COAD -1.227; TCGA ESCA -0.486; TCGA HNSC -0.387; TCGA KIRP -0.461; TCGA LIHC -0.089; TCGA LUAD -0.214; TCGA OV -0.316; TCGA PAAD -0.394; TCGA STAD -0.487; TCGA UCEC -0.404 |
hsa-miR-200b-3p | ZNF281 | 9 cancers: BLCA; COAD; HNSC; KIRP; LGG; LUSC; OV; PAAD; SARC | TargetScan | TCGA BLCA -0.124; TCGA COAD -0.175; TCGA HNSC -0.272; TCGA KIRP -0.289; TCGA LGG -0.107; TCGA LUSC -0.177; TCGA OV -0.068; TCGA PAAD -0.129; TCGA SARC -0.138 |
hsa-miR-200b-3p | FOXN3 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LIHC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.102; TCGA BRCA -0.332; TCGA COAD -0.127; TCGA ESCA -0.134; TCGA HNSC -0.095; TCGA KIRC -0.092; TCGA LGG -0.087; TCGA LIHC -0.066; TCGA OV -0.099; TCGA PAAD -0.205; TCGA PRAD -0.06; TCGA SARC -0.109; TCGA STAD -0.229; TCGA UCEC -0.233 |
hsa-miR-200b-3p | CDON | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LGG; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.341; TCGA BRCA -0.095; TCGA COAD -0.498; TCGA ESCA -0.145; TCGA KIRC -0.492; TCGA KIRP -0.401; TCGA LGG -0.256; TCGA OV -0.128; TCGA PAAD -0.247; TCGA STAD -0.529; TCGA UCEC -0.352 |
hsa-miR-200b-3p | OSBPL6 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LUSC; OV; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.596; TCGA BRCA -0.1; TCGA CESC -0.245; TCGA COAD -0.516; TCGA ESCA -0.667; TCGA KIRP -0.675; TCGA LUSC -0.182; TCGA OV -0.374; TCGA SARC -0.163; TCGA THCA -0.075; TCGA STAD -0.372 |
hsa-miR-200b-3p | DRP2 | 9 cancers: BLCA; CESC; ESCA; HNSC; LGG; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.182; TCGA CESC -0.178; TCGA ESCA -0.17; TCGA HNSC -0.398; TCGA LGG -0.207; TCGA OV -0.136; TCGA PAAD -0.211; TCGA STAD -0.448; TCGA UCEC -0.287 |
hsa-miR-200b-3p | SLC30A4 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.339; TCGA BRCA -0.2; TCGA CESC -0.161; TCGA COAD -0.141; TCGA ESCA -0.086; TCGA HNSC -0.269; TCGA KIRP -0.317; TCGA LIHC -0.08; TCGA LUAD -0.222; TCGA LUSC -0.128; TCGA PAAD -0.165; TCGA SARC -0.09; TCGA STAD -0.119; TCGA UCEC -0.181 |
hsa-miR-200b-3p | FKBP14 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.102; TCGA BRCA -0.164; TCGA CESC -0.151; TCGA COAD -0.188; TCGA ESCA -0.103; TCGA HNSC -0.266; TCGA KIRC -0.095; TCGA LUAD -0.165; TCGA OV -0.097; TCGA PAAD -0.172; TCGA PRAD -0.06; TCGA STAD -0.097; TCGA UCEC -0.058 |
hsa-miR-200b-3p | TGFBR1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; OV; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.185; TCGA BRCA -0.133; TCGA CESC -0.255; TCGA COAD -0.215; TCGA ESCA -0.088; TCGA HNSC -0.197; TCGA KIRP -0.206; TCGA LUSC -0.139; TCGA OV -0.061; TCGA PRAD -0.052; TCGA STAD -0.153; TCGA UCEC -0.121 |
hsa-miR-200b-3p | PPARGC1A | 9 cancers: BLCA; BRCA; CESC; HNSC; LUSC; OV; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.434; TCGA BRCA -0.325; TCGA CESC -0.341; TCGA HNSC -0.316; TCGA LUSC -0.199; TCGA OV -0.466; TCGA SARC -0.189; TCGA THCA -0.155; TCGA UCEC -0.329 |
hsa-miR-200b-3p | LNPEP | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; SARC; STAD | mirMAP | TCGA BLCA -0.114; TCGA BRCA -0.221; TCGA ESCA -0.066; TCGA HNSC -0.131; TCGA KIRP -0.195; TCGA LIHC -0.056; TCGA LUAD -0.141; TCGA LUSC -0.13; TCGA SARC -0.129; TCGA STAD -0.155 |
hsa-miR-200b-3p | PDE4D | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.164; TCGA BRCA -0.191; TCGA CESC -0.132; TCGA COAD -0.166; TCGA ESCA -0.121; TCGA HNSC -0.108; TCGA LUSC -0.232; TCGA OV -0.214; TCGA SARC -0.186; TCGA STAD -0.223; TCGA UCEC -0.238 |
hsa-miR-200b-3p | KCNJ5 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.246; TCGA BRCA -0.182; TCGA COAD -0.689; TCGA ESCA -0.212; TCGA HNSC -0.333; TCGA LUSC -0.522; TCGA PAAD -0.44; TCGA STAD -0.25; TCGA UCEC -0.104 |
hsa-miR-200b-3p | ARHGEF6 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.133; TCGA BRCA -0.285; TCGA CESC -0.279; TCGA COAD -0.494; TCGA ESCA -0.241; TCGA HNSC -0.404; TCGA KIRC -0.285; TCGA KIRP -0.228; TCGA LUAD -0.199; TCGA LUSC -0.575; TCGA PAAD -0.445; TCGA SARC -0.078; TCGA STAD -0.268; TCGA UCEC -0.296 |
hsa-miR-200b-3p | STARD8 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.317; TCGA BRCA -0.269; TCGA CESC -0.363; TCGA COAD -0.505; TCGA ESCA -0.124; TCGA HNSC -0.451; TCGA KIRP -0.258; TCGA LUAD -0.258; TCGA LUSC -0.603; TCGA OV -0.123; TCGA PAAD -0.391; TCGA PRAD -0.12; TCGA STAD -0.197; TCGA UCEC -0.334 |
hsa-miR-200b-3p | SYT11 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.375; TCGA BRCA -0.208; TCGA CESC -0.211; TCGA COAD -0.653; TCGA ESCA -0.22; TCGA HNSC -0.353; TCGA KIRC -0.071; TCGA LUAD -0.171; TCGA LUSC -0.358; TCGA OV -0.117; TCGA PAAD -0.22; TCGA PRAD -0.085; TCGA SARC -0.097; TCGA STAD -0.377; TCGA UCEC -0.237 |
hsa-miR-200b-3p | RAB30 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; OV; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.202; TCGA CESC -0.15; TCGA COAD -0.162; TCGA ESCA -0.094; TCGA HNSC -0.154; TCGA KIRP -0.336; TCGA LGG -0.079; TCGA LIHC -0.05; TCGA LUAD -0.101; TCGA OV -0.113; TCGA PAAD -0.174; TCGA SARC -0.124; TCGA STAD -0.156; TCGA UCEC -0.177 |
hsa-miR-200b-3p | FGF2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.443; TCGA BRCA -0.474; TCGA CESC -0.51; TCGA COAD -0.764; TCGA ESCA -0.354; TCGA HNSC -0.133; TCGA LIHC -0.169; TCGA LUAD -0.237; TCGA LUSC -0.246; TCGA OV -0.32; TCGA PAAD -0.263; TCGA PRAD -0.092; TCGA SARC -0.131; TCGA STAD -0.486; TCGA UCEC -0.581 |
hsa-miR-200b-3p | ENPEP | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.212; TCGA BRCA -0.263; TCGA CESC -0.524; TCGA COAD -0.233; TCGA ESCA -0.143; TCGA HNSC -0.508; TCGA KIRC -0.358; TCGA KIRP -0.499; TCGA LIHC -0.178; TCGA LUAD -0.218; TCGA LUSC -0.308; TCGA PAAD -0.299; TCGA PRAD -0.191; TCGA STAD -0.109; TCGA UCEC -0.348 |
hsa-miR-200b-3p | ST6GAL2 | 10 cancers: BLCA; COAD; ESCA; HNSC; LGG; OV; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.142; TCGA COAD -0.779; TCGA ESCA -0.6; TCGA HNSC -0.339; TCGA LGG -0.307; TCGA OV -0.303; TCGA PAAD -0.378; TCGA SARC -0.207; TCGA STAD -0.668; TCGA UCEC -0.272 |
hsa-miR-200b-3p | ITGA9 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.289; TCGA BRCA -0.296; TCGA CESC -0.28; TCGA COAD -0.472; TCGA ESCA -0.242; TCGA HNSC -0.363; TCGA KIRP -0.252; TCGA LUSC -0.492; TCGA PAAD -0.382; TCGA PRAD -0.134; TCGA SARC -0.074; TCGA STAD -0.458; TCGA UCEC -0.251 |
hsa-miR-200b-3p | ADAMTS12 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; UCEC | mirMAP | TCGA BLCA -0.466; TCGA BRCA -0.265; TCGA CESC -0.488; TCGA COAD -0.729; TCGA HNSC -0.692; TCGA KIRC -0.564; TCGA KIRP -0.416; TCGA LUAD -0.352; TCGA LUSC -0.42; TCGA PAAD -0.258; TCGA PRAD -0.117; TCGA UCEC -0.245 |
hsa-miR-200b-3p | GFRA1 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.246; TCGA CESC -0.536; TCGA COAD -0.797; TCGA ESCA -0.301; TCGA HNSC -0.251; TCGA LGG -0.512; TCGA LIHC -0.24; TCGA LUSC -0.337; TCGA OV -0.409; TCGA PAAD -0.42; TCGA PRAD -0.096; TCGA THCA -0.105; TCGA STAD -0.706; TCGA UCEC -0.493 |
hsa-miR-200b-3p | DST | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; OV; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.143; TCGA BRCA -0.294; TCGA CESC -0.398; TCGA COAD -0.216; TCGA ESCA -0.196; TCGA HNSC -0.14; TCGA KIRP -0.088; TCGA LGG -0.08; TCGA LUAD -0.215; TCGA OV -0.141; TCGA SARC -0.18; TCGA STAD -0.316; TCGA UCEC -0.245 |
hsa-miR-200b-3p | SCN3A | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; OV; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.201; TCGA BRCA -0.558; TCGA CESC -0.355; TCGA COAD -0.425; TCGA ESCA -0.195; TCGA HNSC -0.243; TCGA LGG -0.439; TCGA LUSC -0.239; TCGA OV -0.261; TCGA PAAD -0.348; TCGA SARC -0.335; TCGA STAD -0.234; TCGA UCEC -0.319 |
hsa-miR-200b-3p | ADAMTS5 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.233; TCGA BRCA -0.537; TCGA CESC -0.422; TCGA COAD -0.421; TCGA ESCA -0.156; TCGA HNSC -0.583; TCGA KIRC -0.22; TCGA LGG -0.292; TCGA LUAD -0.302; TCGA LUSC -0.344; TCGA OV -0.188; TCGA PAAD -0.307; TCGA PRAD -0.146; TCGA STAD -0.165; TCGA UCEC -0.376 |
hsa-miR-200b-3p | MARVELD1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.3; TCGA BRCA -0.096; TCGA CESC -0.284; TCGA COAD -0.254; TCGA ESCA -0.34; TCGA HNSC -0.316; TCGA KIRC -0.322; TCGA LUAD -0.253; TCGA LUSC -0.134; TCGA OV -0.128; TCGA PAAD -0.095; TCGA STAD -0.315; TCGA UCEC -0.317 |
hsa-miR-200b-3p | GBP4 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; UCEC | mirMAP | TCGA BLCA -0.131; TCGA BRCA -0.159; TCGA CESC -0.227; TCGA COAD -0.369; TCGA HNSC -0.191; TCGA KIRC -0.215; TCGA KIRP -0.427; TCGA LIHC -0.08; TCGA LUAD -0.272; TCGA LUSC -0.447; TCGA PAAD -0.169; TCGA SARC -0.121; TCGA UCEC -0.126 |
hsa-miR-200b-3p | FUNDC2 | 9 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; STAD | mirMAP | TCGA BLCA -0.111; TCGA ESCA -0.054; TCGA HNSC -0.132; TCGA KIRC -0.064; TCGA KIRP -0.17; TCGA LGG -0.062; TCGA LUAD -0.076; TCGA PAAD -0.092; TCGA STAD -0.153 |
hsa-miR-200b-3p | SLFN5 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; SARC; STAD | mirMAP | TCGA BLCA -0.102; TCGA BRCA -0.249; TCGA COAD -0.343; TCGA HNSC -0.104; TCGA KIRC -0.172; TCGA LUAD -0.08; TCGA LUSC -0.107; TCGA PAAD -0.157; TCGA SARC -0.115; TCGA STAD -0.085 |
hsa-miR-200b-3p | SHE | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.254; TCGA BRCA -0.408; TCGA CESC -0.234; TCGA COAD -0.602; TCGA ESCA -0.161; TCGA HNSC -0.27; TCGA LUSC -0.6; TCGA OV -0.207; TCGA PAAD -0.405; TCGA PRAD -0.074; TCGA SARC -0.135; TCGA STAD -0.295; TCGA UCEC -0.438 |
hsa-miR-200b-3p | NLGN1 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LGG; OV; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.275; TCGA BRCA -0.532; TCGA COAD -1.278; TCGA ESCA -0.47; TCGA KIRC -0.269; TCGA KIRP -0.311; TCGA LGG -0.186; TCGA OV -0.267; TCGA SARC -0.193; TCGA STAD -0.823; TCGA UCEC -0.473 |
hsa-miR-200b-3p | SGCD | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.538; TCGA BRCA -0.348; TCGA COAD -0.865; TCGA ESCA -0.31; TCGA HNSC -0.901; TCGA LUAD -0.186; TCGA LUSC -0.47; TCGA PAAD -0.338; TCGA PRAD -0.288; TCGA SARC -0.118; TCGA THCA -0.102; TCGA STAD -0.502; TCGA UCEC -0.122 |
hsa-miR-200b-3p | PYGO1 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.323; TCGA BRCA -0.39; TCGA CESC -0.253; TCGA ESCA -0.3; TCGA HNSC -0.257; TCGA KIRP -0.585; TCGA LGG -0.193; TCGA LUAD -0.171; TCGA LUSC -0.216; TCGA OV -0.177; TCGA PAAD -0.336; TCGA STAD -0.514; TCGA UCEC -0.356 |
hsa-miR-200b-3p | CHST11 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.422; TCGA CESC -0.478; TCGA COAD -0.547; TCGA ESCA -0.259; TCGA HNSC -0.411; TCGA KIRC -0.464; TCGA KIRP -0.483; TCGA LGG -0.093; TCGA LUAD -0.348; TCGA LUSC -0.415; TCGA PAAD -0.274; TCGA STAD -0.141; TCGA UCEC -0.13 |
hsa-miR-200b-3p | SYNPO2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.465; TCGA BRCA -0.469; TCGA CESC -0.303; TCGA COAD -1.23; TCGA ESCA -0.512; TCGA HNSC -0.575; TCGA KIRP -0.426; TCGA LUAD -0.206; TCGA LUSC -0.256; TCGA PAAD -0.412; TCGA SARC -0.545; TCGA STAD -0.968; TCGA UCEC -0.572 |
hsa-miR-200b-3p | THEMIS | 9 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LUAD; LUSC; PAAD | mirMAP | TCGA BLCA -0.34; TCGA BRCA -0.135; TCGA CESC -0.166; TCGA COAD -0.258; TCGA KIRC -0.618; TCGA KIRP -0.267; TCGA LUAD -0.257; TCGA LUSC -0.354; TCGA PAAD -0.644 |
hsa-miR-200b-3p | MSRB3 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.52; TCGA BRCA -0.416; TCGA CESC -0.52; TCGA COAD -0.96; TCGA ESCA -0.477; TCGA HNSC -0.577; TCGA KIRC -0.213; TCGA KIRP -0.32; TCGA LUAD -0.267; TCGA LUSC -0.624; TCGA OV -0.256; TCGA PAAD -0.314; TCGA PRAD -0.084; TCGA SARC -0.146; TCGA THCA -0.074; TCGA STAD -0.647; TCGA UCEC -0.599 |
hsa-miR-200b-3p | FZD4 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.085; TCGA BRCA -0.443; TCGA CESC -0.238; TCGA COAD -0.331; TCGA HNSC -0.359; TCGA KIRC -0.112; TCGA LIHC -0.096; TCGA LUAD -0.097; TCGA LUSC -0.397; TCGA PAAD -0.321; TCGA STAD -0.215; TCGA UCEC -0.269 |
hsa-miR-200b-3p | ARL10 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.202; TCGA BRCA -0.227; TCGA CESC -0.3; TCGA COAD -0.477; TCGA ESCA -0.334; TCGA HNSC -0.135; TCGA KIRC -0.108; TCGA LGG -0.155; TCGA LUAD -0.184; TCGA PAAD -0.191; TCGA SARC -0.08; TCGA STAD -0.327; TCGA UCEC -0.276 |
hsa-miR-200b-3p | FAM26E | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.402; TCGA BRCA -0.337; TCGA CESC -0.365; TCGA COAD -0.746; TCGA ESCA -0.282; TCGA HNSC -0.642; TCGA KIRC -0.141; TCGA KIRP -0.563; TCGA LUAD -0.324; TCGA LUSC -0.443; TCGA PAAD -0.339; TCGA PRAD -0.085; TCGA SARC -0.196; TCGA STAD -0.187; TCGA UCEC -0.321 |
hsa-miR-200b-3p | SNX18 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUSC; OV; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.067; TCGA BRCA -0.141; TCGA COAD -0.234; TCGA ESCA -0.072; TCGA HNSC -0.067; TCGA LGG -0.052; TCGA LUSC -0.057; TCGA OV -0.078; TCGA PAAD -0.128; TCGA SARC -0.124; TCGA STAD -0.112; TCGA UCEC -0.131 |
hsa-miR-200b-3p | CIITA | 9 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; SARC | mirMAP | TCGA BLCA -0.269; TCGA COAD -0.343; TCGA HNSC -0.176; TCGA KIRC -0.161; TCGA KIRP -0.196; TCGA LUAD -0.099; TCGA LUSC -0.525; TCGA PAAD -0.399; TCGA SARC -0.142 |
hsa-miR-200b-3p | SV2B | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; OV; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.458; TCGA BRCA -0.403; TCGA CESC -0.411; TCGA COAD -1.131; TCGA ESCA -0.478; TCGA HNSC -0.249; TCGA KIRP -0.648; TCGA LUAD -0.243; TCGA OV -0.307; TCGA PAAD -0.356; TCGA SARC -0.156; TCGA STAD -0.417; TCGA UCEC -0.415 |
hsa-miR-200b-3p | BEND4 | 9 cancers: BLCA; COAD; ESCA; LGG; LUAD; LUSC; OV; PAAD; UCEC | mirMAP | TCGA BLCA -0.252; TCGA COAD -0.447; TCGA ESCA -0.245; TCGA LGG -0.372; TCGA LUAD -0.267; TCGA LUSC -0.378; TCGA OV -0.354; TCGA PAAD -0.611; TCGA UCEC -0.358 |
hsa-miR-200b-3p | MYO5A | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.23; TCGA BRCA -0.103; TCGA CESC -0.308; TCGA COAD -0.606; TCGA ESCA -0.353; TCGA HNSC -0.22; TCGA KIRP -0.261; TCGA LGG -0.103; TCGA LIHC -0.057; TCGA LUAD -0.206; TCGA LUSC -0.115; TCGA PAAD -0.33; TCGA STAD -0.21; TCGA UCEC -0.171 |
hsa-miR-200b-3p | DNM3 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.131; TCGA BRCA -0.205; TCGA CESC -0.144; TCGA COAD -0.334; TCGA HNSC -0.323; TCGA LGG -0.188; TCGA LUAD -0.132; TCGA LUSC -0.367; TCGA OV -0.154; TCGA PAAD -0.22; TCGA STAD -0.182; TCGA UCEC -0.146 |
hsa-miR-200b-3p | SFMBT2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.302; TCGA BRCA -0.152; TCGA CESC -0.423; TCGA COAD -0.549; TCGA ESCA -0.239; TCGA HNSC -0.218; TCGA KIRP -0.236; TCGA LUAD -0.204; TCGA LUSC -0.371; TCGA PAAD -0.414; TCGA THCA -0.069; TCGA STAD -0.171; TCGA UCEC -0.372 |
hsa-miR-200b-3p | C17orf51 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.222; TCGA BRCA -0.313; TCGA CESC -0.244; TCGA COAD -0.231; TCGA ESCA -0.101; TCGA HNSC -0.167; TCGA KIRP -0.18; TCGA LUAD -0.115; TCGA PAAD -0.235; TCGA SARC -0.063; TCGA STAD -0.2; TCGA UCEC -0.279 |
hsa-miR-200b-3p | TMEM110 | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC | mirMAP | TCGA BLCA -0.061; TCGA CESC -0.061; TCGA HNSC -0.108; TCGA KIRP -0.112; TCGA LIHC -0.109; TCGA LUAD -0.064; TCGA LUSC -0.183; TCGA PAAD -0.087; TCGA SARC -0.054 |
hsa-miR-200b-3p | FLT1 | 12 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; TargetScan | TCGA BRCA -0.237; TCGA CESC -0.233; TCGA COAD -0.267; TCGA HNSC -0.215; TCGA KIRC -0.401; TCGA KIRP -0.402; TCGA LUAD -0.149; TCGA LUSC -0.268; TCGA OV -0.098; TCGA PAAD -0.131; TCGA PRAD -0.131; TCGA UCEC -0.118 |
hsa-miR-200b-3p | CEP68 | 9 cancers: BRCA; CESC; ESCA; KIRP; LGG; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.157; TCGA CESC -0.081; TCGA ESCA -0.104; TCGA KIRP -0.08; TCGA LGG -0.12; TCGA PAAD -0.109; TCGA SARC -0.07; TCGA STAD -0.17; TCGA UCEC -0.15 |
hsa-miR-200b-3p | RAB11FIP2 | 10 cancers: BRCA; CESC; COAD; HNSC; LGG; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.155; TCGA CESC -0.135; TCGA COAD -0.115; TCGA HNSC -0.155; TCGA LGG -0.051; TCGA LUSC -0.208; TCGA OV -0.066; TCGA PAAD -0.108; TCGA STAD -0.144; TCGA UCEC -0.193 |
hsa-miR-200b-3p | ZBTB10 | 9 cancers: BRCA; HNSC; KIRP; LGG; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.125; TCGA HNSC -0.171; TCGA KIRP -0.115; TCGA LGG -0.132; TCGA LUSC -0.196; TCGA PAAD -0.157; TCGA PRAD -0.067; TCGA STAD -0.266; TCGA UCEC -0.058 |
hsa-miR-200b-3p | TMEM43 | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.131; TCGA CESC -0.159; TCGA COAD -0.097; TCGA ESCA -0.133; TCGA HNSC -0.07; TCGA KIRC -0.129; TCGA LUAD -0.073; TCGA LUSC -0.094; TCGA PAAD -0.064; TCGA SARC -0.073; TCGA STAD -0.194; TCGA UCEC -0.181 |
hsa-miR-200b-3p | FIGN | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD | MirTarget; TargetScan | TCGA BRCA -0.309; TCGA CESC -0.511; TCGA COAD -0.756; TCGA ESCA -0.403; TCGA HNSC -0.532; TCGA KIRC -0.152; TCGA LUAD -0.222; TCGA LUSC -0.443; TCGA OV -0.154; TCGA PAAD -0.25; TCGA PRAD -0.099; TCGA SARC -0.178; TCGA STAD -0.458 |
hsa-miR-200b-3p | SWAP70 | 10 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.093; TCGA COAD -0.157; TCGA ESCA -0.114; TCGA KIRC -0.083; TCGA KIRP -0.069; TCGA LUAD -0.051; TCGA LUSC -0.157; TCGA PAAD -0.233; TCGA STAD -0.094; TCGA UCEC -0.051 |
hsa-miR-200b-3p | TSC22D2 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.086; TCGA CESC -0.146; TCGA ESCA -0.124; TCGA HNSC -0.207; TCGA KIRP -0.157; TCGA LUAD -0.212; TCGA LUSC -0.073; TCGA SARC -0.086; TCGA STAD -0.101; TCGA UCEC -0.106 |
hsa-miR-200b-3p | FAT3 | 14 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.473; TCGA CESC -0.247; TCGA COAD -0.642; TCGA ESCA -0.58; TCGA HNSC -0.391; TCGA KIRP -0.568; TCGA LGG -0.064; TCGA LUSC -0.307; TCGA OV -0.32; TCGA PAAD -0.402; TCGA PRAD -0.106; TCGA SARC -0.239; TCGA STAD -0.882; TCGA UCEC -0.425 |
hsa-miR-200b-3p | ARHGAP6 | 10 cancers: BRCA; CESC; COAD; HNSC; LUAD; LUSC; OV; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.336; TCGA CESC -0.292; TCGA COAD -0.395; TCGA HNSC -0.406; TCGA LUAD -0.109; TCGA LUSC -0.489; TCGA OV -0.132; TCGA SARC -0.16; TCGA STAD -0.295; TCGA UCEC -0.62 |
hsa-miR-200b-3p | ZNF423 | 13 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.383; TCGA COAD -0.416; TCGA ESCA -0.307; TCGA HNSC -0.434; TCGA KIRC -0.188; TCGA LGG -0.177; TCGA LUAD -0.166; TCGA LUSC -0.479; TCGA OV -0.216; TCGA PAAD -0.286; TCGA PRAD -0.067; TCGA STAD -0.441; TCGA UCEC -0.234 |
hsa-miR-200b-3p | KIAA0355 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.135; TCGA CESC -0.086; TCGA ESCA -0.07; TCGA HNSC -0.092; TCGA KIRC -0.058; TCGA LUAD -0.058; TCGA LUSC -0.165; TCGA PAAD -0.114; TCGA STAD -0.112; TCGA UCEC -0.125 |
hsa-miR-200b-3p | USP31 | 9 cancers: BRCA; CESC; ESCA; KIRC; LIHC; LUAD; PAAD; SARC; UCEC | MirTarget; TargetScan | TCGA BRCA -0.062; TCGA CESC -0.164; TCGA ESCA -0.155; TCGA KIRC -0.081; TCGA LIHC -0.082; TCGA LUAD -0.064; TCGA PAAD -0.061; TCGA SARC -0.074; TCGA UCEC -0.154 |
hsa-miR-200b-3p | MARCKS | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.081; TCGA CESC -0.093; TCGA COAD -0.105; TCGA ESCA -0.07; TCGA HNSC -0.173; TCGA KIRC -0.317; TCGA LGG -0.251; TCGA LUAD -0.135; TCGA OV -0.116; TCGA PAAD -0.124; TCGA STAD -0.061; TCGA UCEC -0.096 |
hsa-miR-200b-3p | SLC6A1 | 12 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.079; TCGA CESC -0.354; TCGA COAD -0.306; TCGA HNSC -0.328; TCGA KIRC -0.503; TCGA KIRP -0.3; TCGA LGG -0.089; TCGA LIHC -0.17; TCGA LUSC -0.369; TCGA OV -0.212; TCGA STAD -0.167; TCGA UCEC -0.282 |
hsa-miR-200b-3p | PKIA | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.352; TCGA CESC -0.279; TCGA COAD -0.653; TCGA ESCA -0.28; TCGA HNSC -0.384; TCGA LGG -0.118; TCGA LUAD -0.164; TCGA OV -0.44; TCGA PAAD -0.148; TCGA PRAD -0.097; TCGA STAD -0.456; TCGA UCEC -0.367 |
hsa-miR-200b-3p | ATP11C | 13 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; OV; PAAD; PRAD; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.173; TCGA CESC -0.113; TCGA COAD -0.137; TCGA ESCA -0.081; TCGA KIRC -0.059; TCGA KIRP -0.187; TCGA LIHC -0.154; TCGA LUAD -0.128; TCGA OV -0.102; TCGA PAAD -0.247; TCGA PRAD -0.062; TCGA STAD -0.054; TCGA UCEC -0.14 |
hsa-miR-200b-3p | KCND2 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; SARC; STAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.204; TCGA CESC -0.348; TCGA COAD -1.108; TCGA ESCA -0.404; TCGA HNSC -0.503; TCGA LGG -0.235; TCGA LUAD -0.204; TCGA LUSC -0.147; TCGA SARC -0.22; TCGA STAD -0.28; TCGA UCEC -0.284 |
hsa-miR-200b-3p | ARL15 | 9 cancers: BRCA; CESC; HNSC; KIRP; LUSC; OV; PAAD; SARC; UCEC | MirTarget | TCGA BRCA -0.168; TCGA CESC -0.124; TCGA HNSC -0.21; TCGA KIRP -0.225; TCGA LUSC -0.066; TCGA OV -0.067; TCGA PAAD -0.112; TCGA SARC -0.081; TCGA UCEC -0.139 |
hsa-miR-200b-3p | RAP1B | 9 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.072; TCGA CESC -0.091; TCGA HNSC -0.085; TCGA KIRC -0.076; TCGA KIRP -0.052; TCGA LUAD -0.101; TCGA LUSC -0.05; TCGA PAAD -0.06; TCGA UCEC -0.059 |
hsa-miR-200b-3p | PAG1 | 11 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; UCEC | MirTarget; TargetScan | TCGA BRCA -0.093; TCGA CESC -0.136; TCGA HNSC -0.358; TCGA KIRC -0.374; TCGA KIRP -0.137; TCGA LGG -0.154; TCGA LUAD -0.095; TCGA LUSC -0.451; TCGA OV -0.112; TCGA PAAD -0.191; TCGA UCEC -0.083 |
hsa-miR-200b-3p | ANO6 | 15 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BRCA -0.284; TCGA CESC -0.188; TCGA COAD -0.172; TCGA ESCA -0.126; TCGA HNSC -0.268; TCGA KIRC -0.097; TCGA KIRP -0.186; TCGA LIHC -0.055; TCGA LUAD -0.196; TCGA LUSC -0.251; TCGA PAAD -0.116; TCGA PRAD -0.058; TCGA SARC -0.057; TCGA STAD -0.164; TCGA UCEC -0.253 |
hsa-miR-200b-3p | C4orf32 | 10 cancers: BRCA; CESC; COAD; HNSC; LUAD; LUSC; OV; SARC; STAD; UCEC | TargetScan | TCGA BRCA -0.11; TCGA CESC -0.196; TCGA COAD -0.125; TCGA HNSC -0.221; TCGA LUAD -0.121; TCGA LUSC -0.262; TCGA OV -0.175; TCGA SARC -0.092; TCGA STAD -0.067; TCGA UCEC -0.205 |
hsa-miR-200b-3p | CECR2 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; PAAD; STAD; UCEC | TargetScan | TCGA BRCA -0.259; TCGA CESC -0.362; TCGA ESCA -0.51; TCGA HNSC -0.247; TCGA KIRP -0.379; TCGA LGG -0.227; TCGA LIHC -0.298; TCGA PAAD -0.21; TCGA STAD -0.379; TCGA UCEC -0.429 |
hsa-miR-200b-3p | CHST2 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; OV; PAAD | TargetScan | TCGA BRCA -0.123; TCGA CESC -0.423; TCGA COAD -0.319; TCGA ESCA -0.273; TCGA HNSC -0.228; TCGA KIRC -0.146; TCGA KIRP -0.187; TCGA OV -0.176; TCGA PAAD -0.284 |
hsa-miR-200b-3p | CITED2 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; SARC; STAD; UCEC | TargetScan | TCGA BRCA -0.111; TCGA CESC -0.174; TCGA COAD -0.178; TCGA ESCA -0.219; TCGA HNSC -0.173; TCGA LUSC -0.335; TCGA PAAD -0.203; TCGA PRAD -0.057; TCGA SARC -0.162; TCGA STAD -0.292; TCGA UCEC -0.277 |
hsa-miR-200b-3p | EFNB2 | 9 cancers: BRCA; CESC; HNSC; KIRC; LUAD; LUSC; OV; PRAD; UCEC | TargetScan | TCGA BRCA -0.154; TCGA CESC -0.138; TCGA HNSC -0.259; TCGA KIRC -0.218; TCGA LUAD -0.105; TCGA LUSC -0.171; TCGA OV -0.143; TCGA PRAD -0.166; TCGA UCEC -0.16 |
hsa-miR-200b-3p | EXOC6B | 9 cancers: BRCA; CESC; COAD; ESCA; KIRP; LUAD; SARC; STAD; UCEC | TargetScan | TCGA BRCA -0.198; TCGA CESC -0.271; TCGA COAD -0.145; TCGA ESCA -0.095; TCGA KIRP -0.228; TCGA LUAD -0.085; TCGA SARC -0.147; TCGA STAD -0.093; TCGA UCEC -0.178 |
hsa-miR-200b-3p | FGF12 | 9 cancers: BRCA; COAD; ESCA; LGG; LIHC; LUAD; PAAD; STAD; UCEC | TargetScan | TCGA BRCA -0.165; TCGA COAD -0.399; TCGA ESCA -0.175; TCGA LGG -0.282; TCGA LIHC -0.167; TCGA LUAD -0.237; TCGA PAAD -0.34; TCGA STAD -0.207; TCGA UCEC -0.124 |
hsa-miR-200b-3p | FOXF2 | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; PRAD; STAD | TargetScan | TCGA BRCA -0.121; TCGA COAD -0.365; TCGA ESCA -0.262; TCGA HNSC -0.284; TCGA KIRC -0.579; TCGA KIRP -0.249; TCGA LGG -0.151; TCGA PRAD -0.184; TCGA STAD -0.482 |
hsa-miR-200b-3p | GATA2 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; OV; PAAD; STAD; UCEC | TargetScan | TCGA BRCA -0.155; TCGA CESC -0.166; TCGA COAD -0.255; TCGA ESCA -0.184; TCGA HNSC -0.139; TCGA LGG -0.2; TCGA LUSC -0.352; TCGA OV -0.233; TCGA PAAD -0.21; TCGA STAD -0.159; TCGA UCEC -0.106 |
hsa-miR-200b-3p | GM2A | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; STAD | TargetScan | TCGA BRCA -0.082; TCGA CESC -0.247; TCGA COAD -0.121; TCGA ESCA -0.255; TCGA HNSC -0.086; TCGA KIRC -0.261; TCGA KIRP -0.198; TCGA LIHC -0.051; TCGA LUAD -0.161; TCGA PAAD -0.198; TCGA STAD -0.084 |
hsa-miR-200b-3p | IDS | 10 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; STAD; UCEC | TargetScan | TCGA BRCA -0.077; TCGA COAD -0.207; TCGA ESCA -0.071; TCGA HNSC -0.118; TCGA KIRC -0.096; TCGA KIRP -0.122; TCGA LUAD -0.133; TCGA LUSC -0.132; TCGA STAD -0.164; TCGA UCEC -0.11 |
hsa-miR-200b-3p | INPP4A | 9 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; PAAD; STAD; UCEC | TargetScan | TCGA BRCA -0.058; TCGA CESC -0.076; TCGA COAD -0.153; TCGA ESCA -0.127; TCGA KIRC -0.081; TCGA KIRP -0.094; TCGA PAAD -0.164; TCGA STAD -0.148; TCGA UCEC -0.078 |
hsa-miR-200b-3p | IRS1 | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; SARC; STAD; UCEC | TargetScan | TCGA BRCA -0.095; TCGA CESC -0.158; TCGA COAD -0.309; TCGA ESCA -0.126; TCGA HNSC -0.329; TCGA LGG -0.121; TCGA LIHC -0.137; TCGA SARC -0.117; TCGA STAD -0.179; TCGA UCEC -0.287 |
hsa-miR-200b-3p | MOCS1 | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; PAAD; STAD | TargetScan | TCGA BRCA -0.309; TCGA CESC -0.159; TCGA COAD -0.172; TCGA ESCA -0.146; TCGA HNSC -0.35; TCGA KIRP -0.13; TCGA LIHC -0.133; TCGA LUSC -0.348; TCGA PAAD -0.215; TCGA STAD -0.326 |
hsa-miR-200b-3p | MXI1 | 9 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LIHC; PRAD; STAD; UCEC | TargetScan | TCGA BRCA -0.109; TCGA ESCA -0.132; TCGA KIRC -0.187; TCGA KIRP -0.109; TCGA LGG -0.094; TCGA LIHC -0.074; TCGA PRAD -0.058; TCGA STAD -0.19; TCGA UCEC -0.114 |
hsa-miR-200b-3p | NLGN4X | 12 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; STAD | TargetScan | TCGA BRCA -0.328; TCGA COAD -0.735; TCGA ESCA -0.456; TCGA HNSC -0.453; TCGA KIRC -0.178; TCGA KIRP -0.321; TCGA LGG -0.099; TCGA LIHC -0.123; TCGA LUAD -0.217; TCGA LUSC -0.177; TCGA PAAD -0.514; TCGA STAD -0.452 |
hsa-miR-200b-3p | PDE7B | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BRCA -0.349; TCGA CESC -0.346; TCGA COAD -0.536; TCGA ESCA -0.205; TCGA HNSC -0.368; TCGA LUSC -0.127; TCGA OV -0.22; TCGA PAAD -0.354; TCGA SARC -0.149; TCGA STAD -0.517; TCGA UCEC -0.397 |
hsa-miR-200b-3p | PIK3CA | 9 cancers: BRCA; COAD; ESCA; LGG; LUAD; PAAD; SARC; STAD; UCEC | TargetScan | TCGA BRCA -0.164; TCGA COAD -0.082; TCGA ESCA -0.088; TCGA LGG -0.097; TCGA LUAD -0.082; TCGA PAAD -0.125; TCGA SARC -0.068; TCGA STAD -0.085; TCGA UCEC -0.056 |
hsa-miR-200b-3p | PIP4K2B | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; OV; PAAD; STAD; UCEC | TargetScan | TCGA BRCA -0.069; TCGA CESC -0.062; TCGA COAD -0.081; TCGA ESCA -0.079; TCGA HNSC -0.079; TCGA KIRC -0.068; TCGA LGG -0.082; TCGA OV -0.054; TCGA PAAD -0.063; TCGA STAD -0.134; TCGA UCEC -0.129 |
hsa-miR-200b-3p | PLCXD3 | 10 cancers: BRCA; COAD; ESCA; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | TargetScan | TCGA BRCA -0.611; TCGA COAD -1.243; TCGA ESCA -0.299; TCGA LUSC -0.6; TCGA PAAD -0.224; TCGA PRAD -0.183; TCGA SARC -0.174; TCGA THCA -0.077; TCGA STAD -0.672; TCGA UCEC -0.602 |
hsa-miR-200b-3p | PRKAR1A | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BRCA -0.095; TCGA CESC -0.07; TCGA COAD -0.091; TCGA ESCA -0.056; TCGA HNSC -0.054; TCGA LUSC -0.104; TCGA PAAD -0.088; TCGA STAD -0.105; TCGA UCEC -0.119 |
hsa-miR-200b-3p | RAB8B | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | TargetScan; mirMAP | TCGA BRCA -0.17; TCGA CESC -0.211; TCGA COAD -0.251; TCGA ESCA -0.084; TCGA HNSC -0.223; TCGA KIRC -0.131; TCGA LUAD -0.217; TCGA LUSC -0.339; TCGA OV -0.117; TCGA PAAD -0.18; TCGA THCA -0.051; TCGA STAD -0.079; TCGA UCEC -0.269 |
hsa-miR-200b-3p | SLC23A2 | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; PAAD; STAD; UCEC | TargetScan | TCGA BRCA -0.129; TCGA CESC -0.165; TCGA COAD -0.153; TCGA ESCA -0.1; TCGA HNSC -0.094; TCGA LIHC -0.057; TCGA LUSC -0.09; TCGA PAAD -0.095; TCGA STAD -0.131; TCGA UCEC -0.264 |
hsa-miR-200b-3p | SLC38A2 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; PAAD; STAD; UCEC | TargetScan | TCGA BRCA -0.103; TCGA CESC -0.187; TCGA COAD -0.092; TCGA ESCA -0.225; TCGA HNSC -0.168; TCGA KIRC -0.111; TCGA LGG -0.062; TCGA LUAD -0.094; TCGA PAAD -0.124; TCGA STAD -0.051; TCGA UCEC -0.085 |
hsa-miR-200b-3p | SLC38A4 | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LIHC; PRAD; SARC; UCEC | TargetScan | TCGA BRCA -0.413; TCGA CESC -0.601; TCGA ESCA -0.211; TCGA HNSC -0.489; TCGA KIRP -0.421; TCGA LIHC -0.2; TCGA PRAD -0.31; TCGA SARC -0.235; TCGA UCEC -0.273 |
hsa-miR-200b-3p | SMAD9 | 9 cancers: BRCA; ESCA; HNSC; LGG; LUSC; OV; THCA; STAD; UCEC | TargetScan | TCGA BRCA -0.433; TCGA ESCA -0.279; TCGA HNSC -0.239; TCGA LGG -0.25; TCGA LUSC -0.3; TCGA OV -0.266; TCGA THCA -0.081; TCGA STAD -0.441; TCGA UCEC -0.141 |
hsa-miR-200b-3p | ZYG11B | 9 cancers: BRCA; ESCA; HNSC; KIRP; LIHC; PAAD; PRAD; STAD; UCEC | TargetScan | TCGA BRCA -0.137; TCGA ESCA -0.056; TCGA HNSC -0.105; TCGA KIRP -0.06; TCGA LIHC -0.112; TCGA PAAD -0.083; TCGA PRAD -0.069; TCGA STAD -0.154; TCGA UCEC -0.157 |
hsa-miR-200b-3p | PDE10A | 9 cancers: BRCA; CESC; COAD; HNSC; LGG; OV; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.23; TCGA CESC -0.296; TCGA COAD -0.517; TCGA HNSC -0.142; TCGA LGG -0.169; TCGA OV -0.279; TCGA SARC -0.199; TCGA STAD -0.192; TCGA UCEC -0.336 |
hsa-miR-200b-3p | ZFP37 | 9 cancers: BRCA; COAD; ESCA; LGG; LUAD; OV; PAAD; STAD; UCEC | mirMAP | TCGA BRCA -0.121; TCGA COAD -0.207; TCGA ESCA -0.159; TCGA LGG -0.201; TCGA LUAD -0.138; TCGA OV -0.166; TCGA PAAD -0.194; TCGA STAD -0.176; TCGA UCEC -0.151 |
hsa-miR-200b-3p | BNIP2 | 10 cancers: BRCA; CESC; COAD; ESCA; KIRC; LUAD; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.128; TCGA CESC -0.111; TCGA COAD -0.108; TCGA ESCA -0.101; TCGA KIRC -0.076; TCGA LUAD -0.095; TCGA PAAD -0.148; TCGA SARC -0.064; TCGA STAD -0.133; TCGA UCEC -0.066 |
hsa-miR-200b-3p | VGLL3 | 14 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.405; TCGA CESC -0.582; TCGA COAD -0.932; TCGA ESCA -0.403; TCGA HNSC -0.668; TCGA KIRP -0.346; TCGA LUAD -0.35; TCGA LUSC -0.686; TCGA OV -0.217; TCGA PAAD -0.352; TCGA PRAD -0.386; TCGA SARC -0.389; TCGA STAD -0.416; TCGA UCEC -0.541 |
hsa-miR-200b-3p | PPP1R9B | 9 cancers: CESC; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; UCEC | MirTarget; TargetScan | TCGA CESC -0.09; TCGA ESCA -0.06; TCGA HNSC -0.139; TCGA KIRC -0.205; TCGA LUAD -0.056; TCGA LUSC -0.113; TCGA OV -0.075; TCGA PAAD -0.105; TCGA UCEC -0.071 |
hsa-miR-200b-3p | AMFR | 9 cancers: CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; STAD; UCEC | TargetScan | TCGA CESC -0.102; TCGA ESCA -0.08; TCGA HNSC -0.093; TCGA KIRP -0.192; TCGA LIHC -0.073; TCGA LUAD -0.116; TCGA LUSC -0.099; TCGA STAD -0.066; TCGA UCEC -0.094 |
hsa-miR-200b-3p | JAKMIP2 | 11 cancers: CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; STAD; UCEC | TargetScan | TCGA CESC -0.369; TCGA COAD -0.864; TCGA ESCA -0.328; TCGA KIRC -0.421; TCGA KIRP -0.314; TCGA LIHC -0.216; TCGA LUAD -0.211; TCGA LUSC -0.307; TCGA OV -0.271; TCGA STAD -0.526; TCGA UCEC -0.314 |
hsa-miR-200b-3p | ZNF365 | 9 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; STAD | TargetScan | TCGA CESC -0.272; TCGA COAD -0.873; TCGA ESCA -0.575; TCGA HNSC -0.325; TCGA KIRC -0.303; TCGA KIRP -0.424; TCGA LUAD -0.279; TCGA LUSC -0.298; TCGA STAD -0.379 |
hsa-miR-200b-3p | ADCY1 | 9 cancers: CESC; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; SARC; THCA | mirMAP | TCGA CESC -0.212; TCGA COAD -0.298; TCGA ESCA -0.185; TCGA HNSC -0.292; TCGA KIRP -0.617; TCGA LUSC -0.135; TCGA PAAD -0.308; TCGA SARC -0.131; TCGA THCA -0.091 |
hsa-miR-200b-3p | PHTF2 | 9 cancers: COAD; ESCA; HNSC; KIRC; LGG; LUAD; OV; PAAD; UCEC | MirTarget; TargetScan | TCGA COAD -0.177; TCGA ESCA -0.197; TCGA HNSC -0.12; TCGA KIRC -0.153; TCGA LGG -0.059; TCGA LUAD -0.102; TCGA OV -0.058; TCGA PAAD -0.202; TCGA UCEC -0.074 |
hsa-miR-200b-3p | TRAM1L1 | 9 cancers: COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; STAD | MirTarget | TCGA COAD -0.395; TCGA ESCA -0.224; TCGA HNSC -0.335; TCGA KIRP -0.241; TCGA LGG -0.096; TCGA LUAD -0.128; TCGA LUSC -0.112; TCGA PAAD -0.126; TCGA STAD -0.376 |
hsa-miR-200b-3p | GNA13 | 9 cancers: COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | TargetScan; mirMAP | TCGA COAD -0.07; TCGA HNSC -0.07; TCGA KIRC -0.134; TCGA KIRP -0.16; TCGA LUAD -0.148; TCGA LUSC -0.062; TCGA PAAD -0.158; TCGA STAD -0.055; TCGA UCEC -0.085 |
hsa-miR-200b-3p | MAPK7 | 9 cancers: ESCA; HNSC; KIRC; LGG; OV; PAAD; SARC; STAD; UCEC | MirTarget | TCGA ESCA -0.097; TCGA HNSC -0.069; TCGA KIRC -0.153; TCGA LGG -0.057; TCGA OV -0.094; TCGA PAAD -0.067; TCGA SARC -0.101; TCGA STAD -0.119; TCGA UCEC -0.078 |
hsa-miR-200b-3p | PAIP2 | 10 cancers: ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget; TargetScan | TCGA ESCA -0.109; TCGA HNSC -0.069; TCGA KIRP -0.107; TCGA LIHC -0.052; TCGA LUAD -0.051; TCGA LUSC -0.059; TCGA OV -0.056; TCGA PAAD -0.1; TCGA STAD -0.167; TCGA UCEC -0.08 |
Enriched cancer pathways of putative targets